0001655210-26-000055 | 10-Q | XBRL Viewer

Print Document

Share-Based Compensation - Schedule of PSU Activity (Details)	6 Months Ended
	Jun. 27, 2026 $ / shares shares
Performance Shares
Number of Units
Unvested, beginning balance (in shares) \| shares	145,660
Granted (in shares) \| shares	0
Vested (in shares) \| shares	0
Canceled/Forfeited (in shares) \| shares	(74,714)
Unvested, ending balance (in shares) \| shares	70,946
Weighted Average Grant Date Fair Value Per Unit
Unvested, beginning balance (in dollars per share) \| $ / shares	$ 14.88
Granted (in dollars per share) \| $ / shares	0
Vested (in dollars per share) \| $ / shares	0
Canceled/Forfeited (in dollars per share) \| $ / shares	14.50
Unvested, ending balance (in dollars per share) \| $ / shares	$ 15.27
MIP PSUs
Number of Units
Unvested, beginning balance (in shares) \| shares	0
Granted (in shares) \| shares	10,154,868
Vested (in shares) \| shares	0
Canceled/Forfeited (in shares) \| shares	0
Unvested, ending balance (in shares) \| shares	10,154,868
Weighted Average Grant Date Fair Value Per Unit
Unvested, beginning balance (in dollars per share) \| $ / shares	$ 0
Granted (in dollars per share) \| $ / shares	0
Vested (in dollars per share) \| $ / shares	0
Canceled/Forfeited (in dollars per share) \| $ / shares	0
Unvested, ending balance (in dollars per share) \| $ / shares	$ 0

Revenue Recognition - Schedule of Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 27, 2026	Jun. 28, 2025	Jun. 27, 2026	Jun. 28, 2025
Disaggregation of Revenue [Line Items]
Net revenues	$ 68,832	$ 74,958	$ 127,038	$ 143,689
U.S. net revenues
Disaggregation of Revenue [Line Items]
Net revenues	37,642	43,964	70,815	84,737
U.S. net revenues \| Retail(1)
Disaggregation of Revenue [Line Items]
Net revenues	29,637	32,909	56,191	64,269
U.S. net revenues \| Foodservice
Disaggregation of Revenue [Line Items]
Net revenues	8,005	11,055	14,624	20,468
International net revenues
Disaggregation of Revenue [Line Items]
Net revenues	31,190	30,994	56,223	58,952
International net revenues \| Retail(1)
Disaggregation of Revenue [Line Items]
Net revenues	18,479	15,867	32,188	28,549
International net revenues \| Foodservice
Disaggregation of Revenue [Line Items]
Net revenues	$ 12,711	$ 15,127	$ 24,035	$ 30,403

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-7

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

+ Details

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

+ Details

Summary of Significant Accounting Policies

6 Months Ended

Jun. 27, 2026

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Basis of Presentation

The unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the unaudited condensed consolidated financial statements include all adjustments necessary, which are of a normal and recurring nature, for the fair presentation of the Company’s financial position and of the results of operations and cash flows for the periods presented. These interim results are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2026 or for any other interim period or for any other future fiscal year.

These unaudited condensed consolidated financial statements should be read in conjunction with the Company's audited financial statements and notes thereto included in the 2025 10-K. A detailed description of the Company's significant accounting policies can be found in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on April 9, 2026 (the “2025 10-K”). There have been no material changes in the Company’s significant accounting policies from those that were disclosed in the 2025 10-K, except as noted below.

Principles of Consolidation

The unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany balances and transactions have been eliminated.

Management’s Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant accounting estimates made by the Company include trade promotion and discount accruals; useful lives of property, plant and equipment; valuation of long-lived assets including assets held for sale; valuation of deferred tax assets; valuation of inventory and related provision; incremental

borrowing rate used to determine lease right-of-use assets and lease liabilities; assessment of contract-based factors, asset-based factors, entity-based factors and market-based factors to determine the lease term impacting right-of-use assets and lease liabilities; the probability of vesting and valuation of the fair value of stock options and performance stock units (“PSUs”) used to determine share-based compensation expense; the valuation and remeasurement of the fair value of warrant liability for the Delayed Draw Term Loan Warrants; the probability of vesting and the issuance date valuation of the BG Warrants; the valuation and remeasurement of the fair value of embedded derivatives; the number of underlying shares expected to vest, or for which vesting is probable, for equity-classified warrants, and liabilities and loss contingency accruals in connection with claims, lawsuits and administrative proceedings. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results could differ from those estimates and such differences may be material to the Company’s consolidated financial statements.

Reclassification of Prior Period Presentation

A prior period amount in the Company’s unaudited condensed consolidated balance sheet has been reclassified to be consistent with the current period presentation. This reclassification had no effect on the reported results of operations.

Correction of Previously Issued Interim Unaudited Condensed Consolidated Financial Statements

During the fourth quarter and full year 2025 financial close procedures, the Company identified errors in its previously issued interim unaudited condensed consolidated financial statements for the first three quarters of 2025 relating to (i) inventory valuation and (ii) debt issuance costs, as described in further detail below. The Company determined that the errors identified below were immaterial to its previously issued interim unaudited condensed consolidated financial statements for the three and six months ended June 28, 2025 and has corrected these errors in the accompanying interim unaudited condensed consolidated financial statements for the three and six months ended June 28, 2025 in accordance with Accounting Standards Codification (“ASC”) 250, “Accounting Changes and Error Corrections.” The Company has also corrected impacted amounts within the notes to the unaudited condensed consolidated financial statements, as applicable.

Inventory Valuation

Due to errors in the Company’s excess and obsolete inventory analysis, inventory was overstated and cost of goods sold was understated in the three and six months ended June 28, 2025.

Debt Issuance Costs

In connection with the Company’s 2025 balance sheet debt restructuring activities, namely, entry into the Loan and Security Agreement in May 2025 and the debt exchange offer which was completed in October 2025 (the “Exchange Offer”), the Company incurred significant transaction expenses (collectively, the “debt issuance costs”) related to professional services provided by various third-party advisors, consultants and professionals. Following the closing of the Exchange Offer in October 2025, the Company, in consultation with its external technical accounting advisors, determined that the Exchange Offer qualified as a “troubled debt restructuring” (“TDR”) in accordance with ASC 470-60, “Debt—Troubled Debt Restructurings by Debtors.” TDR accounting guidelines specify that debt issuance costs must be expensed and included in selling, general and administrative (“SG&A”) expenses in the periods in which they are incurred, rather than being capitalized as prepaid expenses and other current assets. The Company further determined in the fourth quarter of 2025 that TDR related accounting standards should have been applied in the three and six months ended June 28, 2025 as creditor concessions were expected prior to the completion of the Exchange Offer, notwithstanding the fact that the Exchange Offer was not completed until the fourth quarter of 2025. In the three and six months ended

June 28, 2025, the Company initially and incorrectly recorded the Exchange Offer debt issuance costs as prepaid expenses and other current assets on its balance sheet instead of expensing them as incurred as part of selling, general and administrative expenses.

The following tables reflect the effects of these error corrections to the previously issued interim unaudited condensed consolidated financial statements for the three and six months ended June 28, 2025, which are presented as comparative in this Quarterly Report on Form 10-Q for the three and six months ended June 27, 2026 (in thousands):


Condensed Consolidated Statement of Operations (unaudited)
	Three Months Ended June 28, 2025
	As Previously Reported		Inventory Valuation		Debt Issuance Costs		As Corrected
Cost of goods sold	$	66,367	$	671	$	—	$	67,038
Gross profit	$	8,591	$	(671)	$	—	$	7,920
Selling, general and administrative expenses	$	37,696	$	—	$	1,932	$	39,628
Total operating expenses	$	43,503	$	—	$	1,932	$	45,435
Loss from operations	$	(34,912)	$	(671)	$	(1,932)	$	(37,515)
Loss before taxes	$	(29,183)	$	(671)	$	(1,932)	$	(31,786)
Net loss	$	(29,242)	$	(671)	$	(1,932)	$	(31,845)
Net loss per share available to common stockholders—basic and diluted	$	(0.38)	$	(0.01)	$	(0.03)	$	(0.42)


Condensed Consolidated Statement of Operations (unaudited)
	Six Months Ended June 28, 2025
	As Previously Reported		Inventory Valuation		Debt Issuance Costs		As Corrected
Cost of goods sold	$	136,163	$	6,531	$	—	$	142,694
Gross profit	$	7,526	$	(6,531)	$	—	$	995
Selling, general and administrative expenses	$	85,368	$	—	$	4,242	$	89,610
Total operating expenses	$	98,637	$	—	$	4,242	$	102,879
Loss from operations	$	(91,111)	$	(6,531)	$	(4,242)	$	(101,884)
Loss before taxes	$	(82,088)	$	(6,531)	$	(4,242)	$	(92,861)
Net loss	$	(82,158)	$	(6,531)	$	(4,242)	$	(92,931)
Net loss per share available to common stockholders—basic and diluted	$	(1.08)	$	(0.08)	$	(0.06)	$	(1.22)


Condensed Consolidated Statement of Comprehensive Loss (unaudited)
	Three Months Ended June 28, 2025
	As Previously Reported		Inventory Valuation		Debt Issuance Costs		As Corrected
Net loss	$	(29,242)	$	(671)	$	(1,932)	$	(31,845)
Comprehensive loss	$	(31,710)	$	(671)	$	(1,932)	$	(34,313)


Condensed Consolidated Statement of Comprehensive Loss (unaudited)
	Six Months Ended June 28, 2025
	As Previously Reported		Inventory Valuation		Debt Issuance Costs		As Corrected
Net loss	$	(82,158)	$	(6,531)	$	(4,242)	$	(92,931)
Comprehensive loss	$	(85,666)	$	(6,531)	$	(4,242)	$	(96,439)


Condensed Consolidated Statement of Cash Flows (unaudited)
	Six Months Ended June 28, 2025
	As Previously Reported		Inventory Valuation		Debt Issuance Costs		As Corrected
Net loss	$	(82,158)	$	(6,531)	$	(4,242)	$	(92,931)
Inventories	$	4,709	$	6,531	$	—	$	11,240
Prepaid expenses and other current assets	$	(8,473)	$	—	$	5,623	$	(2,850)
Net cash used in operating activities	$	(59,355)	$	—	$	1,381	$	(57,974)

Debt issuance costs	$	(5,117)	$	—	$	(1,381)	$	(6,498)
Net cash provided by financing activities	$	33,640	$	—	$	(1,381)	$	32,259

2030 Notes Conversions and Gain on Debt Extinguishment

The Company accounts for conversions of the 7.00% Convertible Senior Secured Second Lien PIK Toggle Notes due 2030 (the “2030 Notes”) issued pursuant to an indenture and security agreement dated as of October 15, 2025 (as supplemented, the “2030 Notes Indenture”) in accordance with accounting for convertible debt with a bifurcated conversion option whereby each conversion is accounted for as a debt extinguishment in accordance with ASC 470, “Debt” (“ASC 470”), and ASC 815, “Derivatives and Hedging” (“ASC 815”). Accordingly, at each conversion settlement date, the Company records the fair value of the shares issued and reduces, on a pro rata basis, the carrying value of the 2030 Notes, the related debt discount and the remeasurement value of certain embedded derivatives contained in the 2030 Notes that require bifurcation (the “2030 Notes Embedded Derivative”), respectively, as of the settlement date. An extinguishment gain or loss is recognized on the settlement date equal to the difference between (i) the fair value of the shares issued and (ii) the sum of the pro rata carrying amounts of the respective 2030 Notes, the related debt discount and the remeasurement value of the 2030 Notes Embedded Derivative extinguished. The extinguishment gain or loss recognized is included in Other income (expense), net, in the Company’s unaudited condensed consolidated statements of operations. See Note 5 and Note 9.

Equity-Classified Warrants Issued as Customer Consideration

The Company may issue warrants or other share-based instruments to customers or parties that purchase the Company’s products from its customers in connection with sales and distribution arrangements. When such instruments are not issued in exchange for a distinct good or service, the Company accounts for the instruments as consideration payable to a customer in accordance with ASC 606, “Revenue From Contracts With Customers” (“ASC 606”), and ASC 718, “Compensation - Stock Compensation” (“ASC 718”), and records the related amount as a reduction of the transaction price and, therefore, revenue. The Company measures and classifies such instruments at grant-date fair value in accordance with ASC 718. Warrants that are indexed to the Company’s common stock or contain only market, service or performance conditions, and that otherwise qualify for equity classification under ASC 718, are recorded in equity. The Company evaluates whether equity-classified warrants are required to be presented outside permanent equity under ASC 480, “Distinguishing Liabilities From Equity” (“ASC 480”). Warrants that qualify for equity classification and are not required to be presented outside permanent equity are recorded in additional paid-in capital and are not subsequently

remeasured. If an equity-classified warrant is issued before the related revenue is recognized and the Company expects to recover the consideration through future purchases by the customer under the related arrangement, the grant-date fair value is initially recorded as a prepaid asset and amortized as a reduction of revenue as the related revenues are generated. For equity-classified warrants with service or performance conditions that affect vesting, the Company estimates the number of underlying shares expected to vest, or for which vesting is probable, and updates that estimate until the equity-classified warrants vest, or are forfeited, with changes reflected as adjustments to the transaction price. During the three months ended June 27, 2026, the Company issued equity-classified warrants to Big Geyser, Inc. (“Big Geyser”). See Note 10 .

Share-Based Compensation

For details of the Company's share-based compensation policy related to various types of equity grants, see Note 2, Summary of Significant Account Policies, to the Notes to Consolidated Financial Statements included in the 2025 10-K.

The Company’s performance-based units (MIP PSUs) are considered granted as of the date when the Company’s board of directors establishes relevant performance goals to be set based on metrics to be established upon recommendation from the Company’s human capital management and compensation committee. The MIP PSUs will be measured at the grant date fair value, which equals the Company’s stock price on the grant date. The Company will recognize compensation cost related to the MIP PSUs from the service inception date (which is the grant date) over the requisite service for the performance period only if it is considered probable that the performance condition will be satisfied. See No te 11.

New Accounting Pronouncements

In November 2024, the FASB issued ASU 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses” (“ASU 2024-03”), in order to improve the disclosures about a public business entity’s expenses. The amendments in ASU 2024-03 apply to all public business entities and are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, with early adoption is permitted. The amendments can be applied either prospectively or retrospectively. The Company is currently assessing adoption timing, the method of adoption, and the effect that the amendments will have on the Company’s financial statement disclosures.

On December 8, 2025, the FASB issued ASU 2025-11, “Interim Reporting (Topic 270),” which is intended to improve the navigability of the guidance in ASC 270, “Disclosure Requirements” (“ASC 270”) and clarify when it applies. Under the amendments, an entity is subject to ASC 270 if it provides “interim financial statements and notes in accordance with GAAP.” The ASU also addresses the form and content of such financial statements, adds lists to ASC 270 of the interim disclosures required by all other Codification topics, and establishes a principle under which an entity must “disclose events since the end of the last annual reporting period that have a material impact on the entity.” For public companies, the amendments in ASU 2025-11 are effective for interim reporting periods within annual reporting periods beginning after December 15, 2027. The Company is currently assessing adoption timing, the method of adoption, and the effect that the amendments will have on the Company’s financial statement disclosures.

Recently Adopted Accounting Pronouncements

On July 30, 2025, the FASB issued ASU 2025-05, “Measurement of Credit Losses for Accounts Receivable and Contract Assets,” which amends ASC 326-20 “Financial Instruments—Credit Losses: Measured at Amortized Cost,” to provide a practical expedient (for all entities) related to the estimation of expected credit losses for current accounts receivable and current contract assets that arise from transactions accounted for under ASC 606, “Revenue From Contracts With Customers.” ASU 2025-05 is effective for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods, with early adoption permitted. The Company adopted the amendments in ASU 2025-05 on January 1, 2026 on a prospective basis. The amendments in ASU 2025-05 did not have a material impact on the Company’s financial position, results of operations or cash flows.

In November 2024, the FASB issued ASU 2024-04, “—Debt—Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments” (“ASU 2024-04”) to improve the relevance and consistency in the application of induced conversion guidance in Subtopic 470-20, “Debt—Debt with Conversion and Other Options.” The amendments in ASU 2024-04 clarify the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion.

The amendments in ASU 2024-04 affect entities that settle convertible debt instruments for which the conversion privileges were changed to induce conversion. The amendments in ASU 2024-04 are effective for all entities for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. Early adoption is permitted for all entities that have adopted the amendments in ASU 2020-06. The amendments in ASU 2024-04 permit an entity to apply the new guidance on either a prospective or a retrospective basis. The Company adopted ASU 2024-04 on January 1, 2026 on a prospective basis. The adoption of ASU 2024-04 did not have a material impact on the Company’s financial position, results of operations or cash flows.

On December 17, 2025, the FASB issued ASU 2025-12, “Codification Improvements” (“ASU 2025-12”), which addresses suggestions received from stakeholders on the Codification and makes other incremental improvements to GAAP. This evergreen project facilitates Codification updates for a broad range of topics arising from technical corrections, the unintended application of the Codification, clarifications, and other minor improvements. The Company adopted ASU 2025-12 beginning January 1, 2026. The amendments in ASU 2025-12 did not have a material impact on the Company’s financial position, results of operations or cash flows.

Introduction	6 Months Ended
Introduction	Jun. 27, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Introduction	Introduction The Company Beyond Meat, Inc., a Delaware corporation (including its subsidiaries unless the context otherwise requires, the “Company”), is a leading plant-based meat company offering a portfolio of revolutionary plant-based meats and other innovative plant-based food and beverage products. The Company seeks to deliver the power of plants to consumers through its plant-based meat products, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating the Company’s plant-based meat products, and adjacent products that deliver taste and macronutrients from plants and plant-based ingredients. The Company’s brand promise, “Eat What You Love,” represents a strong belief that there is a better way to feed our future and that the positive choices we all make, no matter how small, can have a great impact on our personal health and the health of our planet. By shifting from animal-based protein to plant-based protein, we can positively impact four growing global issues: human health, climate change, constraints on natural resources and animal welfare.

Debt - Schedule of Convertible Senior Notes Due 2030 (Details) - USD ($) $ in Thousands		3 Months Ended	6 Months Ended
	May 01, 2026	Jun. 27, 2026	Jun. 27, 2026	Jun. 28, 2025	Dec. 31, 2025	Oct. 30, 2025	Oct. 15, 2025
Debt Instrument [Line Items]
Debt discount—Delayed draw term loan warrants		$ 323,796	$ 323,796		$ 415,740
Paid-in-kind interest			6,315	$ 0
2030 Notes, net \| Level 2
Debt Instrument [Line Items]
Amount		114,266	114,266		166,267
2030 Notes, net \| Convertible Debt
Debt Instrument [Line Items]
Principal Amount		151,288	151,288		209,721
Undiscounted Cash Flows		72,981	72,981		124,427
Unamortized Derivative Discount		(15,564)	(15,564)		(25,745)
Debt discount—Delayed draw term loan warrants		208,705	208,705		$ 308,403	$ 1,004	$ 208,717
Settlement of note conversions			68,800
Paid-in-kind interest	$ 10,400
Payment in kind, interest rate	9.50%						9.50%
Reduction in unamortized debt issuance costs		$ 7,200	$ 8,000
Embedded derivative, effective interest rate, percentage		1.70%	1.70%		1.60%

Share-Based Compensation - Schedule of RSU Activity (Details) - USD ($) $ / shares in Units, $ in Thousands				3 Months Ended	6 Months Ended
	Oct. 31, 2025	Oct. 30, 2025	Oct. 15, 2025	Jun. 27, 2026	Jun. 27, 2026
Weighted Average Grant Date Fair Value Per Unit
Common stock, issued (in shares)	317,834,446	1,684,270	316,150,176
Convertible Senior Notes Due 2030
Weighted Average Grant Date Fair Value Per Unit
Common stock, issued (in shares)				52,092,284	57,408,142
Convertible Senior Notes Due 2030 \| Convertible Debt
Weighted Average Grant Date Fair Value Per Unit
Exchange principal amount			$ 196,217	$ 62,600	$ 68,800
Common stock, issued (in shares)					57,408,142
2018 Plan
Number of Units
Granted (in shares)					7,176,019
Weighted Average Grant Date Fair Value Per Unit
Shares withheld to cover taxes (in shares)					3,234,470
Restricted Stock Units (RSUs)
Number of Units
Unvested, beginning balance (in shares)					35,344,345
Granted (in shares)					8,416,517
Vested (in shares)					(1,029,982)
Canceled/Forfeited (in shares)					(704,258)
Unvested, ending balance (in shares)				42,026,622	42,026,622
Weighted Average Grant Date Fair Value Per Unit
Unvested, beginning balance (in dollars per share)					$ 1.27
Granted (in dollars per share)					0.48
Vested (in dollars per share)					3.92
Canceled/Forfeited (in dollars per share)					1.68
Unvested, ending balance (in dollars per share)				$ 1.04	$ 1.04
Shares withheld to cover taxes (in shares)					2,870,960
Restricted Stock Units (RSUs) \| 2018 Plan
Number of Units
Granted (in shares)					4,264,723
Restricted Stock Units (RSUs) \| 2026 Employment Inducement Equity Incentive Plan
Number of Units
Granted (in shares)					330,094

Net Income (Loss) Per Share Available to Common Stockholders - Schedule of Reconciliation of Net Income (Loss) Per Share Available to Common Stockholders Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 27, 2026	Jun. 28, 2025	Jun. 27, 2026	Jun. 28, 2025
Numerator:
Net income (loss) available to common stockholders—basic	$ 16,404	$ (31,845)	$ (12,078)	$ (92,931)
Add: Dilutive effect of 2030 Notes, net	(52,933)	0	0	0
Net loss available to common stockholders—diluted	$ (36,529)	$ (31,845)	$ (12,078)	$ (92,931)
Denominator:
Weighted average common shares outstanding — basic (in shares)	501,304,934	76,491,594	476,742,903	76,348,524
2030 Notes, if converted (in shares)	90,563,957	0	0	0
Weighted average common shares outstanding—diluted (in shares)	591,868,891	76,491,594	476,742,903	76,348,524
Net income (loss) per share
Net income (loss) per share available to common stockholders—basic (in dollars per share)	$ 0.03	$ (0.42)	$ (0.03)	$ (1.22)
Net loss per share available to common stockholders—diluted (in dollars per share)	$ (0.06)	$ (0.42)	$ (0.03)	$ (1.22)

Fair Value of Financial Instruments - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 27, 2026	Jun. 28, 2025	Jun. 27, 2026	Jun. 28, 2025	Dec. 31, 2025	Oct. 15, 2025
Fair Value Disclosures [Abstract]
Remeasurement of delayed draw term loan warrant liability	$ 76	$ 0	$ (1,224)	$ 0
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
2030 Notes Embedded Derivative liability at fair value	$ 14,596		$ 14,596		$ 39,152
Total common stock reserved for future issuance (in shares)	180,709,132		180,709,132		183,354,433
Anti-Dilution Increases, MIP PSU Awards, Maximum Payout
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Total common stock reserved for future issuance (in shares)	2,911,527		2,911,527
Convertible Senior Notes Due 2030
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Total common stock reserved for future issuance (in shares)	86,660,407		86,660,407		120,000,000
Convertible Debt
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
2030 Notes Embedded Derivative liability at fair value	$ 14,600		$ 14,600		$ 39,200	$ 26,900
Convertible Debt \| Convertible Senior Notes Due 2030
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Amortization of debt issuance costs	1,000		2,200
Reduction in carrying value of debt discount			8,000
Reduction in unamortized debt issuance costs	$ 7,200		$ 8,000
Convertible Debt \| Convertible Senior Notes Due 2027
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Amortization of debt issuance costs		$ 1,000		$ 2,000

Inventories

6 Months Ended

Jun. 27, 2026

Inventory Disclosure [Abstract]

Inventories

Major classes of inventory were as follows (in thousands):


	June 27, 2026		December 31, 2025

Raw materials and packaging	$	25,352	$	32,569
Work in process	10,743		17,743
Finished goods	27,032		33,720
Total	$	63,127	$	84,032

The Company records a provision for excess and obsolete inventories in cost of goods sold in its unaudited condensed consolidated statements of operations.

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Jun. 27, 2026
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Fair Value of Financial Instruments (Tables)

6 Months Ended

Jun. 27, 2026

Fair Value Disclosures [Abstract]

Schedule of Assumptions Used for Valuation of Warrants

The following were the assumptions used in the Black-Scholes option-pricing model to mark-to-market the fair value of the total delayed draw term loan warrant liability as of June 26, 2026, the last trading day of the period:


Risk-free interest rate			4.11%
Average expected term (years)			4.0
Expected volatility			113.10%
Dividend yield			—
Exercise price			$1.95

The following table sets forth selected inputs to the binomial lattice valuation model used to value the 2030 Notes Embedded Derivative as of the respective dates indicated:


Inputs	June 27, 2026	December 31, 2025
Term (years)	4.3	4.8
Continuous risk free rate	4.07%	3.68%
Volatility	40.0%	40.0%
Stock price on valuation date	$0.66	$0.82
Discount rate (continuous)	24.51%	19.71%

Schedule of Changes in Fair Value of Warrants Liability

The following table sets forth a summary of the changes in the fair value of the total delayed draw term loan warrant liability for the periods indicated (in thousands):


	Three Months Ended				Six Months Ended
	June 27, 2026		June 28, 2025		June 27, 2026		June 28, 2025
Beginning balance	$	3,766	$	—	$	5,066	$	—
Fair value of delayed draw term loan warrants issued during the period	—		7,983		—		7,983
Fair value of contingently issued delayed draw term loan warrants	—		12,160		—		12,160
Remeasurement of delayed draw term loan warrants liability	76		—		(1,224)		—
Ending balance	$	3,842	$	20,143	$	3,842	$	20,143

The following table sets forth a summary of activity of the 2030 Notes Embedded Derivative liability for the periods indicated. (in thousands):


	Three Month Ended		Six Months Ended
	June 27, 2026		June 27, 2026
Beginning balance, at fair value	$	26,137	$	39,152
Pro rata reduction of liability due to partial conversions	(15,379)		(16,503)
Change in fair value from remeasurement	3,838		(8,053)
Ending balance as of June 27, 2026, at fair value	$	14,596	$	14,596

Summary of Significant Accounting Policies - Narrative (Details)	Oct. 15, 2025
Convertible Senior Notes Due 2030 \| Convertible Debt
Class of Warrant or Right [Line Items]
Interest, stated rate (in percent)	7.00%

Stockholders’ Equity (Deficit) (Tables)

6 Months Ended

Jun. 27, 2026

Equity [Abstract]

Schedule of Common Stock Reserved for Future Issuance

Common stock reserved for future issuance consisted of the following:


	June 27, 2026	December 31, 2025

Equity incentive compensation awards granted and outstanding	56,308,520	39,464,342
Shares available for issuance under the Amended and Restated 2018 Equity Incentive Plan(1)(2)(3)	10,024,113	10,310,481
Shares available for issuance under the 2026 Employment Inducement Equity Incentive Plan	9,433,685	—
Shares available for issuance under the 2018 Employee Stock Purchase Plan	4,557,105	4,020,975
Shares reserved for potential issuance under the 2030 Notes(4)	86,660,407	120,000,000
Shares reserved for potential issuance under the Delayed Draw Term Loan Warrants	9,558,635	9,558,635
Shares reserved for potential issuance under the BG Warrant—Tranche 1	2,500,000	—
Shares reserved for potential issuance under the BG Warrant—Tranche 2	1,666,667	—
Total common stock reserved for future issuance	180,709,132	183,354,433

_________________

(1) Shares available for issuance under the Amended and Restated 2018 Equity Incentive Plan includes 70,946 and 145,660 shares at June 27, 2026 and December 31, 2025, respectively, that may be issued pursuant to 2024 PSUs if 200% of the applicable performance targets are achieved. See Note 11.

(2) Shares available for issuance under the Amended and Restated 2018 Equity Incentive Plan includes 10,154,868 shares at June 27, 2026 including 9,198,298 MIP shares and 956,570 antidilution shares at June 27, 2026, that may be issued pursuant to PSUs (at “maximum” performance) to certain employees (the “MIP PSUs”) granted in 2026 if 150% of the applicable performance target is achieved.

(3) Shares available for issuance under the Amended and Restated 2018 Equity Incentive Plan at June 27, 2026 after deducting 20,309,683 shares that are reserved for issuance under MIP PSU awards to certain key employees, including 1,913,097 shares reserved pursuant to Anti-Dilution Increases in respect of the MIP PSU awards in the six months ended June 27, 2026, at maximum payout.

(4) As of June 27, 2026 and December 31, 2025, up to approximately 86,660,407 and 120,000,000 additional shares, respectively, may be issuable upon conversion of the 2030 Notes at the base conversion rate (prior to giving effect to any make-whole payments payable upon such conversion), in addition to issuances of common stock in connection with the

payment of interest in the form of common stock, mandatory equitizations and issuances with respect to additional 2030 Notes issued as payment-in-kind interest, that, in each case, may be resold in the public market.

Summary of Significant Accounting Policies - Schedule of Condensed Consolidated Statement of Operations (unaudited) and Prior Period Adjustments (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 27, 2026	Mar. 28, 2026	Jun. 28, 2025	Mar. 29, 2025	Jun. 27, 2026	Jun. 28, 2025
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Cost of goods sold	$ 62,959		$ 67,038		$ 119,180	$ 142,694
Gross profit	5,873		7,920		7,858	995
Selling, general and administrative expenses	32,490		39,628		70,359	89,610
Total operating expenses	36,679		45,435		79,768	102,879
Loss from operations	(30,806)		(37,515)		(71,910)	(101,884)
Loss before taxes	16,420		(31,786)		(12,046)	(92,861)
Net Income (Loss)	$ 16,404	$ (28,482)	$ (31,845)	$ (61,087)	$ (12,078)	$ (92,931)
Net income (loss) per share available to common stockholders—basic (in dollars per share)	$ 0.03		$ (0.42)		$ (0.03)	$ (1.22)
Net loss per share available to common stockholders—diluted (in dollars per share)	$ (0.06)		$ (0.42)		$ (0.03)	$ (1.22)
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Cost of goods sold			$ 66,367			$ 136,163
Gross profit			8,591			7,526
Selling, general and administrative expenses			37,696			85,368
Total operating expenses			43,503			98,637
Loss from operations			(34,912)			(91,111)
Loss before taxes			(29,183)			(82,088)
Net Income (Loss)			$ (29,242)			$ (82,158)
Net income (loss) per share available to common stockholders—basic (in dollars per share)			$ (0.38)			$ (1.08)
Net loss per share available to common stockholders—diluted (in dollars per share)			$ (0.38)			$ (1.08)
Inventory Valuation
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Cost of goods sold			$ 671			$ 6,531
Gross profit			(671)			(6,531)
Selling, general and administrative expenses			0			0
Total operating expenses			0			0
Loss from operations			(671)			(6,531)
Loss before taxes			(671)			(6,531)
Net Income (Loss)			$ (671)			$ (6,531)
Net income (loss) per share available to common stockholders—basic (in dollars per share)			$ (0.01)			$ (0.08)
Net loss per share available to common stockholders—diluted (in dollars per share)			$ (0.01)			$ (0.08)
Debt Issuance Costs
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Cost of goods sold			$ 0			$ 0
Gross profit			0			0
Selling, general and administrative expenses			1,932			4,242
Total operating expenses			1,932			4,242
Loss from operations			(1,932)			(4,242)
Loss before taxes			(1,932)			(4,242)
Net Income (Loss)			$ (1,932)			$ (4,242)
Net income (loss) per share available to common stockholders—basic (in dollars per share)			$ (0.03)			$ (0.06)
Net loss per share available to common stockholders—diluted (in dollars per share)			$ (0.03)			$ (0.06)

Net Income (Loss) Per Share Available to Common Stockholders (Tables)

6 Months Ended

Jun. 27, 2026

Earnings Per Share [Abstract]

Schedule of Calculation of Net Income (Loss) per Share Available to Common Stockholders Basic and Diluted

The numerators and denominators for the calculation of net income (loss) per share available to common stockholders—basic and diluted are as follows (in thousands, except share and per share data):


	Three Months Ended				Six Months Ended
	June 27, 2026		June 28, 2025		June 27, 2026		June 28, 2025
Numerator:

Net income (loss) available to common stockholders—basic	$	16,404	$	(31,845)	$	(12,078)	$	(92,931)
Add: Dilutive effect of 2030 Notes, net(1)	(52,933)		—		—		—

Net loss available to common stockholders—diluted	$	(36,529)	$	(31,845)	$	(12,078)	$	(92,931)










Denominator:

Weighted average common shares outstanding—basic	501,304,934		76,491,594		476,742,903		76,348,524







Effect of dilutive shares:
2030 Notes, if converted(1)	90,563,957		—		—		—


Weighted average common shares outstanding—diluted	591,868,891		76,491,594		476,742,903		76,348,524


Net income (loss) per share
Net income (loss) per share available to common stockholders—basic	$	0.03	$	(0.42)	$	(0.03)	$	(1.22)
Net loss per share available to common stockholders—diluted	$	(0.06)	$	(0.42)	$	(0.03)	$	(1.22)

____________

(1) For the three months ended June 27, 2026, net loss per share available to common stockholders—basic, and net loss available to common stockholders—diluted, excludes gain on debt extinguishment, remeasurement of derivative liability and interest expense, associated with the 2030 Notes during the period, as evaluated under the if-converted method. Under the if-converted method, net income is adjusted to reflect the assumption that the 2030 Notes were converted at the beginning of the period or date of issuance, if issued during the period.

Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss Per Share Available to Common Stockholders

The following outstanding shares of common stock equivalents were excluded from the computation of net loss per share available to common stockholders—diluted for the periods presented because the impact of including them would have been antidilutive:


	Three Months Ended		Six Months Ended
	June 27, 2026	June 28, 2025	June 27, 2026	June 28, 2025
Options to purchase common stock(1)	4,640,161	4,100,689	4,640,161	4,100,689
RSUs(1)	42,026,622	1,612,253	42,026,622	1,612,253
PSUs(1)	10,225,814	145,660	10,225,814	145,660
2027 Notes(2)	—	8,234,230	—	8,234,230
2030 Notes (if converted)	—	—	80,696,458	—
Delayed Draw Term Loan Warrants	9,558,635	3,823,454	9,558,635	3,823,454
BG Warrants	4,166,667	—	4,166,667	—
Total	65,977,738	13,815,597	146,674,196	13,815,597

____________

(1) As the Company recorded a net loss (on a diluted basis) in the six month months ended June 27, 2026, outstanding common stock equivalents for stock options, RSUs and PSUs were excluded, as their impact would be antidilutive.

(2) 2027 Notes are no longer convertible into shares of common stock in the three and six months ended June 27, 2026. In the three and six months ended June 28, 2025, as the Company recorded a net loss (on a diluted basis), inclusion of shares from the conversion premium or spread on the 2027 Notes would be anti-dilutive.

Share-Based Compensation (Tables)

6 Months Ended

Jun. 27, 2026

Share-Based Payment Arrangement [Abstract]

Schedule of Shares Available for Grant

The following table summarizes the shares available for issuance under the Amended and Restated 2018 Equity Incentive Plan:


						Shares Available for Issuance
Shares available for issuance at December 31, 2025(1)						10,310,481
Authorized						7,176,019
Granted						(11,106,936)
Shares withheld to cover taxes						3,234,470
Forfeited(2)						976,394
Shares available for issuance at June 27, 2026(3)						10,590,428

____________

(1) Shares available for issuance under the Amended and Restated 2018 Equity Incentive Plan includes 70,946 and 145,660 shares at June 27, 2026 and December 31, 2025, respectively, that may be issued pursuant to 2024 PSUs, if 200% of the applicable performance target is achieved.

(2) Includes forfeiture of 74,714 shares reserved for issuance for a potential 200% achievement of the Tranche 2 2024 PSUs. See Performance Stock Units—2024 PSUs below.

(3) Shares available for issuance under the Amended and Restated 2018 Equity Incentive Plan at June 27, 2026 after deducting 20,309,683 shares that are reserved for issuance under MIP PSU awards to certain key employees in 2025 (MIP PSUs), including 1,913,097 shares reserved for issuance pursuant to Anti-Dilution Increases in respect of the MIP PSUs, in the six months ended June 27, 2026, at maximum payout. Includes 70,946 shares reserved for issuance pursuant to 2024 PSUs if 200% of the applicable performance target is achieved.

The following table summarizes the shares available for issuance under the Inducement Plan:


						Shares Available for Issuance
Shares available for issuance at December 31, 2025						—
Authorized						10,000,000
Granted						(566,315)
Forfeited						—
Shares available for issuance at June 27, 2026						9,433,685

The following valuation assumptions were used in the Monte Carlo simulation for the 2024 PSUs granted on March 1, 2024:


Assumption						As of March 1, 2024
Expected term (years)						2.8
Expected volatility						78.7%
Average correlation						21.4%
Risk-free interest rate						4.36%
Dividend yield						0%
Measurement date stock price						$9.77

Schedule of Stock Options

Following are the assumptions used in the Black-Scholes valuation model for options granted under the Amended and Restated Equity Incentive Plan and the 2026 Inducement Plan during the periods shown below:

Three Months Ended

Six Months Ended

June 27, 2026

June 28, 2025

June 27, 2026

June 28, 2025

Risk-free interest rate

4.0%

N/A

4.0%

N/A

Average expected term (years)

4.0

N/A

4.0

N/A

Expected volatility

113.9%

N/A

113.9%

N/A

Dividend yield

N/A

Schedule of Stock Option Activity

The following table summarizes the Company’s stock option activity during the six months ended June 27, 2026 under the Amended and Restated 2018 Equity Incentive Plan and the 2026 Inducement Plan:


	Number of Stock Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)	Aggregate Intrinsic Value (in thousands)(1)
Outstanding at December 31, 2025	3,974,337	$	25.24	5.3	$	—
Granted(2)	790,900	$	0.83	—	$	—
Exercised	—	$	—	—	$	—
Canceled/Forfeited	(125,076)	$	6.80	—	$	—
Outstanding at June 27, 2026	4,640,161	$	21.58	5.9	$	—
Vested and exercisable at June 27, 2026	3,384,913	$	27.73	4.8	$	—
Vested and expected to vest at June 27, 2026	4,485,683	$	22.19	5.8	$	—

____________

(1) Aggregate intrinsic value is calculated as the difference between the value of common stock on the transaction date and the exercise price multiplied by the number of shares issuable under the stock option. Aggregate intrinsic value of shares outstanding at the beginning and end of the reporting period is calculated as the difference between the value of common stock on the beginning and end dates, respectively, and the exercise price multiplied by the number of shares outstanding.

(2) Includes 236,221 options granted under the 2026 Inducement Plan.

Schedule of RSU activity

The following table summarizes the Company’s RSU activity during the six months ended June 27, 2026 under the Amended and Restated 2018 Equity Incentive Plan and the 2026 Inducement Plan:


	Number of Units	Weighted Average Grant Date Fair Value Per Unit
Unvested at December 31, 2025	35,344,345	$	1.27
Granted(1)	8,416,517	$	0.48
Vested(2)	(1,029,982)	$	3.92
Canceled/Forfeited	(704,258)	$	1.68
Unvested at June 27, 2026	42,026,622	$	1.04

____________

(1) Includes 4,264,723 RSUs granted pursuant to Anti-Dilution Increases resulting from the conversion of $68.8 million in aggregate principal amount of the 2030 Notes into 57,408,142 shares of the Company’s common stock. Also includes 330,094 RSUs granted pursuant to the 2026 Inducement Plan.

(2) Includes 363,510 shares of common stock that were withheld to cover taxes on the release of vested RSUs and became available for future issuance pursuant to the Amended and Restated 2018 Equity Incentive Plan.

The following table summarizes the Company’s 2024 PSU activity during the six months ended June 27, 2026:


	Number of Units	Weighted Average Grant Date Fair Value Per Unit
Unvested at December 31, 2025	145,660	$	14.88
Granted	—	$	—
Vested	—	$	—
Canceled/Forfeited	(74,714)	$	14.50
Unvested at June 27, 2026	70,946	$	15.27

Schedule of Share-Based Payment Arrangement, Performance Shares, Outstanding Activity


	Number of Units	Grant Date Fair Value Per Unit		Performance Period
Tranche I	80,307	$	13.49	January 1, 2024 - December 31, 2024
Tranche II	74,714	$	14.50	January 1, 2024 - December 31, 2025
Tranche III	70,946	$	15.27	January 1, 2024 - December 31, 2026

The shares subject to each performance period (the “Target PSUs”) vest on the last day of the respective performance period in an amount equal to the applicable percentage set forth below for the Relative TSR Performance for such performance period, so long as the applicable executive remains a service provider through such date:


Relative TSR Performance(1)						Percentage Applicable to the Relative TSR Performance
Less than 30th percentile						0%
30th percentile						50%
50th percentile						100%
80th percentile and above						200%

____________

(1)Straight-line interpolation shall determine the Percentage Applicable to the Relative TSR Performance when Relative TSR Performance is between the 30th and 50th percentiles or between the 50th and 80th percentiles.

Share-Based Payment Arrangement, Performance Shares, Activity

The following table summarizes the Company’s MIP PSU activity during the six months ended June 27, 2026:


	Number of Units	Weighted Average Grant Date Fair Value Per Unit
Unvested at December 31, 2025	—	$	—
Granted	10,154,868	$	—
Vested	—	$	—
Canceled/Forfeited	—	$	—
Unvested at June 27, 2026	10,154,868	$	—

Related Party Transactions (Details) - USD ($)	3 Months Ended		6 Months Ended
Related Party Transactions (Details) - USD ($)	Jun. 27, 2026	Jun. 28, 2025	Jun. 27, 2026	Jun. 28, 2025	May 04, 2026
Related Party Transaction [Line Items]
Net revenues	$ 68,832,000	$ 74,958,000	$ 127,038,000	$ 143,689,000
Base salary					$ 130,000
Target annual bonus percentage					10.00%
Consulting fees	150,000		150,000
Related Party
Related Party Transaction [Line Items]
Net revenues	$ 0	$ 0	$ 0	$ 0

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Cash and Cash Equivalents and Restricted Cash

6 Months Ended

Jun. 27, 2026

Cash and Cash Equivalents [Abstract]

Cash and Cash Equivalents and Restricted Cash

Cash, Cash Equivalents and Restricted Cash

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the unaudited condensed consolidated balance sheets that sum to the total of the same amounts shown in the unaudited condensed consolidated statements of cash flows (in thousands):


	June 27, 2026		December 31, 2025		June 28, 2025		December 31, 2024
Cash and cash equivalents	$	171,369	$	203,890	$	103,497	$	131,913
Restricted cash, current	5,516		4,350		1,172		1,041
Restricted cash, non-current	9,250		9,291		12,600		12,600
Total cash, cash equivalents and restricted cash	$	186,135	$	217,531	$	117,269	$	145,554

Restricted cash includes cash held as collateral for stand-alone letter of credit agreements related to normal business transactions. The agreements require the Company to maintain specified amounts of cash as collateral in segregated accounts to support the letters of credit issued thereunder. As of June 27, 2026, the Company had $14.8 million in restricted cash, which was comprised of $12.6 million to secure the letter of credit delivered to the Company’s landlord as security for the performance of the Company’s obligations under its

Campus Lease, $1.2 million to secure the letter of credit associated with a third party contract manufacturer in Europe and $1.0 million to secure the letter of credit associated with the Company’s sales agreement with Roquette to purchase pea protein. See Note 1 2.

Inventories (Tables)

6 Months Ended

Jun. 27, 2026

Inventory Disclosure [Abstract]

Schedule of Major Classes of Inventory

Major classes of inventory were as follows (in thousands):


	June 27, 2026		December 31, 2025

Raw materials and packaging	$	25,352	$	32,569
Work in process	10,743		17,743
Finished goods	27,032		33,720
Total	$	63,127	$	84,032

Summary of Significant Accounting Policies - Schedule of Condensed Consolidated Statement of Comprehensive Loss (unaudited) and Prior Period Adjustments (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 27, 2026	Mar. 28, 2026	Jun. 28, 2025	Mar. 29, 2025	Jun. 27, 2026	Jun. 28, 2025
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)	$ 16,404	$ (28,482)	$ (31,845)	$ (61,087)	$ (12,078)	$ (92,931)
Comprehensive loss	$ 19,084		(34,313)		$ (9,015)	(96,439)
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)			(29,242)			(82,158)
Comprehensive loss			(31,710)			(85,666)
Inventory Valuation
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)			(671)			(6,531)
Comprehensive loss			(671)			(6,531)
Debt Issuance Costs
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)			(1,932)			(4,242)
Comprehensive loss			$ (1,932)			$ (4,242)

- Definition

Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.

+ References + Details

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480070/505-10-S50-6

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482705/350-40-65-4

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (e)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479719/606-10-65-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-7

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479168/946-830-55-10

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-4

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-21

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-14

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(k)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-4

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 480
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 480
-SubTopic 10
-Name Accounting Standards Codification
-Section S45
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 480
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3A
-Subparagraph (24)(d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 9
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-9

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 17
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480336/718-10-65-17

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-6

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 27: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482765/220-10-50-6

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-3

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 36: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-8

Reference 37: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-9

Reference 38: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 39: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-11

Reference 40: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 41: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 42: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479105/946-220-45-7

Reference 43: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 44: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(9))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 45: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(1)(d))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 46: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 47: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 48: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B

Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-28

Reference 50: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A

Reference 51: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B

Reference 52: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481538/470-20-65-4

Reference 53: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

+ Details

Revenue Recognition - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 27, 2026	Jun. 28, 2025	Jun. 27, 2026	Jun. 28, 2025	Dec. 31, 2025
Disaggregation of Revenue [Line Items]
Liability for estimated sales discounts	$ 5.7		$ 5.7		$ 6.2
Distributor One \| Revenue from Contract with Customer Benchmark \| Customer Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk (in percent)	14.00%	14.00%	12.00%	14.00%
Distributor Two \| Revenue from Contract with Customer Benchmark \| Customer Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk (in percent)		10.00%

- Definition

For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.

+ References + Details

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

+ Details

Revenue Recognition (Tables)

6 Months Ended

Jun. 27, 2026

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

The following table presents the Company’s net revenues by channel (in thousands):


	Three Months Ended				Six Months Ended
	June 27, 2026		June 28, 2025		June 27, 2026		June 28, 2025

U.S.:
Retail(1)	$	29,637	$	32,909	$	56,191	$	64,269
Foodservice	8,005		11,055		14,624		20,468
U.S. net revenues	37,642		43,964		70,815		84,737
International:
Retail	18,479		15,867		32,188		28,549
Foodservice	12,711		15,127		24,035		30,403
International net revenues	31,190		30,994		56,223		58,952
Net revenues	$	68,832	$	74,958	$	127,038	$	143,689

_________________

(1) Includes net revenues from the DTC Channel.

Debt - Schedule of Convertible Senior Notes Due 2027 (Details) - USD ($) $ in Thousands	Jun. 27, 2026	Dec. 31, 2025	Oct. 16, 2025	Mar. 05, 2021
Debt Instrument [Line Items]
Debt discount—Delayed draw term loan warrants	$ 323,796	$ 415,740
Convertible Senior Notes Due 2027 \| Level 2
Debt Instrument [Line Items]
Amount	6,098	6,098
Convertible Debt
Debt Instrument [Line Items]
Unamortized Issuance Costs				$ 23,600
Convertible Debt \| Convertible Senior Notes Due 2027
Debt Instrument [Line Items]
Principal amount	29,459	29,459	$ 35,397
Unamortized Issuance Costs	0	0
Debt discount—Delayed draw term loan warrants	$ 29,459	$ 29,459

- Definition

Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-10

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-11

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-11

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E

+ Details

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.9-06)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(16))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22)(a)(4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22)(a)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22)(a)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480657/210-10-S50-9

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22)(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22)(a)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A

Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4

Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3

Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(f))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 18: http://www.xbrl.org/2003/role/exampleRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 55
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482949/835-30-55-8

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 20: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B

Reference 21: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C

Reference 22: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E

Reference 23: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69F
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 26: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 36: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 37: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 38: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 39: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 40: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 41: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482925/835-30-45-2

Reference 42: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482900/835-30-50-1

+ Details

- Definition

Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.

+ References

+ Details

Share-Based Compensation - Narrative (Details) $ in Thousands							3 Months Ended		6 Months Ended		12 Months Ended
	Jan. 01, 2026 shares	Oct. 31, 2025 shares	Oct. 30, 2025 performancePeriod shares	Oct. 15, 2025 USD ($) shares	Feb. 04, 2025	Mar. 01, 2024 USD ($)	Jun. 27, 2026 USD ($) tranche shares	Jun. 28, 2025 USD ($)	Jun. 27, 2026 USD ($) performancePeriod tranche shares	Jun. 28, 2025 USD ($)	Dec. 31, 2025 shares	Mar. 30, 2026 shares	Sep. 27, 2025 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, outstanding (in shares)							515,793,219		515,793,219		453,688,312
Common stock, issued (in shares)		317,834,446	1,684,270	316,150,176
Stock options outstanding (in shares)							4,640,161		4,640,161		3,974,337
Total common stock reserved for future issuance (in shares)							180,709,132		180,709,132		183,354,433
Shares issued (in shares)									19,857,699		18,807,587
Payments of minimum withholding taxes on net share settlement of equity awards \| $									$ 3,019	$ 312
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)									8,416,517
Shares issuable (in shares)							42,026,622		42,026,622		35,344,345
Share-based compensation expense \| $							$ 6,200	$ 2,600	$ 11,700	$ 6,200
Unrecognized compensation expense, period of recognition									10 months 24 days
Incremental share-based compensation expense \| $							4,700		$ 8,400
Payments of minimum withholding taxes on net share settlement of equity awards \| $									$ 2,700
Shares withheld to cover taxes (in shares)									2,870,960
Unrecognized share-based compensation expense \| $							$ 37,000		$ 37,000
Restricted Stock Units (RSUs) \| Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period											2 years
Restricted Stock Units (RSUs) \| Continuing Employees, Option Two \| Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage										50.00%
Vesting period											1 year
Restricted Stock Units (RSUs) \| Director
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period									1 year
Restricted Stock Units (RSUs) \| Share-Based Payment Arrangement, Tranche One \| Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage											50.00%
Restricted Stock Units (RSUs) \| Share-Based Payment Arrangement, Tranche One \| Continuing Employees, Option One \| Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage									25.00%	25.00%
Vesting period											1 year
Restricted Stock Units (RSUs) \| Share-Based Payment Arrangement, Tranche One \| Continuing Employees, Option Two \| Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period											1 year
Restricted Stock Units (RSUs) \| Share-Based Payment Arrangement, Tranche Two \| Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage											50.00%
Restricted Stock Units (RSUs) \| Share-Based Payment Arrangement, Tranche Two \| Continuing Employees, Option One \| Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period										3 years
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)									0
Shares issuable (in shares)							70,946		70,946		145,660
Vesting percentage									200.00%
Share-based compensation expense \| $							$ 100	200	$ 200	$ 500
Unrecognized compensation expense \| $							$ 200		$ 200
Unrecognized compensation expense, period of recognition									6 months
Total grant fair value \| $						$ 3,300
Number of performance period \| performancePeriod									3
Period for determination of vesting after end of performance period									60 days
Number of tranche \| tranche							3		3
Total expense \| $									$ 1,100
Performance Shares \| Monte-Carlo
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield						0.00%
Performance Shares \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage									0.00%
Performance Shares \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage									200.00%
Performance Shares \| Share-Based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)									80,307
Vesting period									1 year
Award requisite service period (in months)									10 months
Performance Shares \| Share-Based Payment Arrangement, Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)									74,714
Vesting period									2 years
Award requisite service period (in months)									22 months
Performance Shares \| Share-Based Payment Arrangement, Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)									70,946
Vesting period									3 years
Award requisite service period (in months)									34 months
Performance Shares \| Less than 30th percentile
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage					0.00%				0.00%
Performance Shares, Reserved For Issuance Under Unvested PSUs Outstanding If Performance Target Achieved
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total common stock reserved for future issuance (in shares)							70,946		70,946		145,660
Performance Shares, Reserved For Issuance Under MIP PSUs At Maximum Performance
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total common stock reserved for future issuance (in shares)							18,396,586		18,396,586		27,998,591
Vesting percentage									150.00%
Performance Shares, Reserved For Issuance Pursuant To Anti-Dilution Increases
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total common stock reserved for future issuance (in shares)							956,570		956,570		126
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense \| $							$ 1,000	$ 1,500	$ 2,000	$ 3,500
Unrecognized compensation expense \| $							3,600		$ 3,600
Unrecognized compensation expense, period of recognition									9 months 18 days
Employee Stock Option \| Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense \| $							$ 200		$ 200
Additional period									5 years
Employee Stock Option \| Share-Based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage									25.00%
Vesting period									1 year
Employee Stock Option \| Share-Based Payment Arrangement, Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period									3 years
MIP PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Authorized (in shares)			27,998,717
Granted (in shares)									10,154,868
Shares issuable (in shares)							10,154,868		10,154,868		0
Share-Based Payment Arrangements, Number Of Annual Performance Periods \| performancePeriod			2
Convertible Senior Notes Due 2030
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, issued (in shares)							52,092,284		57,408,142
Total common stock reserved for future issuance (in shares)							86,660,407		86,660,407		120,000,000
Convertible Senior Notes Due 2030 \| Convertible Debt
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, issued (in shares)									57,408,142
Exchange principal amount \| $				$ 196,217			$ 62,600		$ 68,800
2018 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Authorized (in shares)	96,359,368												27,349,482
Fully-diluted shares outstanding (in percent)		0.125
Common stock, outstanding (in shares)		69,009,600
Additional conversion shares (in percent)		0.125
Fully-diluted shares outstanding, annual increase (in percent)		3.00%
Granted (in shares)									7,176,019
Total common stock reserved for future issuance (in shares)							10,024,113		10,024,113		10,310,481
Vesting percentage									150.00%
Shares available for grant (in shares)							10,590,428		10,590,428		10,310,481
Shares withheld to cover taxes (in shares)									3,234,470
Authorized (in shares)									7,176,019
2018 Plan \| Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)									4,264,723
2018 Plan \| Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total common stock reserved for future issuance (in shares)							20,309,683		20,309,683
Vesting percentage									200.00%
2018 Plan \| Performance Shares, Reserved For Issuance Under Unvested PSUs Outstanding If Performance Target Achieved
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total common stock reserved for future issuance (in shares)							70,946		70,946		145,660
2018 Plan \| Performance Shares, Reserved For Issuance Pursuant To Anti-Dilution Increases
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total common stock reserved for future issuance (in shares)							1,913,097		1,913,097
Shares available for issuance under the 2026 Employment Inducement Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total common stock reserved for future issuance (in shares)							9,433,685		9,433,685		0	10,000,000
Shares available for grant (in shares)							9,433,685		9,433,685		0
Authorized (in shares)									10,000,000
Shares available for issuance under the 2026 Employment Inducement Equity Incentive Plan \| Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)									330,094
2018 ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total common stock reserved for future issuance (in shares)							4,557,105		4,557,105		4,020,975
2018 ESPP \| Employee Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Authorized (in shares)	4,557,105
Authorized (in shares)	536,130

Subsequent Events	6 Months Ended
Subsequent Events	Jun. 27, 2026
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events Fifth Amendment to Campus Lease On July 31, 2026, the Company entered into the Fifth Amendment to Lease with HC Hornet Way, LLC, a Delaware limited liability company (the “Landlord”), amending that certain Lease dated January 14, 2021, as amended by that certain First Amendment to Lease dated as of September 17, 2024, that certain Second Amendment to Lease dated as of May 9, 2025, that certain Third Amendment to Lease dated as of July 16, 2025, and that certain Fourth Amendment to Lease dated as of October 7, 2025 (collectively, the “Campus Lease”), pursuant to which the Company currently leases approximately 220,519 rentable square feet in a portion of a building located at 888 N. Douglas Street, El Segundo, California. The Fifth Amendment to Lease provides for, among other things, the surrender of approximately 101,612 rentable square feet of the existing premises (the “Surrendered Premises”), a mutual release of claims arising out of, based upon, or relating to any act, omission, event, matter or thing with respect to the Surrendered Premises (subject to specified exceptions, including claims arising from a breach of the Fifth Amendment to Lease), and the continued leasing of approximately 118,907 rentable square feet of the existing premises (the “Remaining Premises”). Approximately 54,749 rentable square feet of the Remaining Premises is currently subleased by the Company to Varda Space Industries, Inc. (the “Subtenant”), subject to increase to approximately 55,109 rentable square feet, under a sublease agreement dated July 22, 2025, as amended. The consideration for the surrender, the release of claims, and certain other terms in the Fifth Amendment to Lease includes, among other things: (a) payment by the Company to the Landlord of $14.0 million, as additional base rent (the “Compromise Rent”), payable in forty-eight (48) monthly installments of approximately $291,667 during the periods February 1, 2027 through April 30, 2027 and August 1, 2028 through April 30, 2032, which installments are included in, and are not in addition to, the monthly base rent amounts for the Remaining Premises set forth in the rent schedule attached to the Fifth Amendment to Lease; (b) performance by the Company, at its sole cost and expense, of specified repair, restoration and removal obligations with respect to the Surrendered Premises and adjacent areas, estimated to cost approximately $2.8 million, including broker fees, which obligations must be completed by August 31, 2026, except for certain items for which a later completion date is specified in the Fifth Amendment to Lease; and (c) payment by the Company of base rent and additional rent attributable to the Surrendered Premises through the date on which the Lease terminates with respect to the Surrendered Premises (the “Surrender Termination Date”), which is expected to occur no later than July 31, 2027, subject to a rent credit to the Company in certain circumstances if the Surrender Termination Date occurs prior to that date. The Fifth Amendment to Lease also amends the Campus Lease to replace the provisions governing reduction of the letter of credit securing the Company’s obligations under the Campus Lease. Under the amended provisions, the stated amount of the letter of credit will remain at $12,500,000 until the outstanding balance of the Compromise Rent first falls below that amount, which is anticipated to occur on or after October 1, 2028. Thereafter, so long as the Company is not in default under the Campus Lease and has not failed to pay any rent when due, the Company may from time to time—but not more than once in any calendar month, and at its own expense—cause the issuing bank to deliver an amendment reducing the stated amount of the letter of credit to the then-outstanding balance of the Compromise Rent. Each such reduction is subject to the Landlord’s written consent, which the Landlord is required to give if no such default or payment failure exists and the amendment satisfies specified conditions. Following payment of the Compromise Rent in full, the Company may cause the stated amount of the letter of credit to be reduced to zero. Effective the day following the Surrender Termination Date, the Company’s proportionate share of expenses and charges under the Lease will be reduced from 56.45% to 30.44%. The obligations of the Landlord and the Company under the Fifth Amendment to Lease were conditioned on the execution and delivery of a lease of the Surrendered Premises between the Landlord and a new tenant, which condition has been satisfied. The Company is evaluating the accounting impact of the Fifth Amendment to Lease, including the effect on its lease liabilities, right-of-use assets, prepaid lease costs and leasehold improvements, which may include an impairment of such assets, and related disclosures. The impairment, if any, could be material to the Company’s consolidated financial statements. The Company is unable to estimate such an impairment, if any, as of the date of this report. First Amendment to Sublease On July 23, 2025, the Company entered into a Sublease Agreement (the “Sublease”) with Varda Space Industries, Inc., a Delaware corporation (“Subtenant”), pursuant to which the Company subleases to Subtenant approximately 54,749 rentable square feet, consisting of approximately 16,967 rentable square feet of improved space (the “Improved Space”) and approximately 37,782 rentable square feet of unimproved space (the “Unimproved Space” and, collectively with the Improved Space, the “Subleased Premises”), in a portion of a building located at 888 N. Douglas Street, El Segundo, California, leased by the Company pursuant to the Campus Lease. The Sublease was made effective as of July 22, 2025, subject to receipt of Master Landlord’s consent to the Sublease, which consent was granted on October 7, 2025. In connection with the surrender of the Surrendered Premises pursuant to the Fifth Amendment to Lease, the Company entered into that certain First Amendment to Sublease, dated as of July 31, 2026 (the “First Amendment to Sublease”), with Subtenant. The First Amendment to Sublease provides for, among other things: (a) the extinguishment of Subtenant’s rights in and to the Surrendered Premises, including the amendment of the definitions of “Subleased Premises” and “Site Plan” under the Sublease; (b) the transfer of approximately 360 rentable square feet from the Surrendered Premises to the Subleased Premises, increasing the Subleased Premises from approximately 54,749 to approximately 55,109 rentable square feet; (c) the construction by the Company, at its sole cost and expense and by August 31, 2026, of demising walls and an opening to an existing exterior door for emergency exit, and the relocation by the Company, at its sole cost and expense, of the electrical room serving the Subleased Premises; (d) a revised schedule of base rent for the Improved Space, commencing at $52,026 per month and escalating by 3% annually, subject to the rent abatement provided under the Sublease; and (e) an increase in Subtenant’s proportionate share of operating expenses and other charges under the Sublease, which will be 46.35% from and after the termination of the Campus Lease with respect to the Surrendered Premises. The matters described in clauses (a), (b), (d) and (e) take effect upon completion of the work described in clause (c) and delivery of the approximately 360 rentable square feet to Subtenant. The effectiveness of the First Amendment to Sublease was conditioned on the Company and Landlord entering into the Fifth Amendment to Lease, which condition has been satisfied. The effectiveness of the First Amendment to Sublease was also conditioned on the consent of Landlord, which consent was granted pursuant to that certain First Amendment to Consent to Sublease, dated as of July 31, 2026, among the Company, Landlord and Subtenant (the “First Amendment to Consent”). The Company is evaluating the accounting impact of the First Amendment to Sublease in connection with the Fifth Amendment to Lease discussed above. First Amendment to Consent The First Amendment to Consent amends that certain Consent to Sublease, executed as of October 7, 2025, among the Company, Landlord and Subtenant (the “Original Consent”), and provides for, among other things: (a) Landlord’s consent to the First Amendment to Sublease; and (b) conforming amendments to certain defined terms used in the Original Consent, including the amendment of the definition of “Sublet Space” to refer to approximately 55,109 rentable square feet. Related Party Agreements On June 29, 2026, the Company’s subsidiary, Beyond Meat BV, entered into an employment agreement with Adriaan Figee pursuant to which he will serve as General Manager, EMEA effective as of July 1, 2026. The Company is party to various contracts with certain Zandbergen entities relating to distribution, manufacturing, cold storage and real estate in EMEA. Mr. Figee previously served in various C-suite roles for certain Zandbergen entities. Although Mr. Figee has resigned these positions, certain of his immediate family members are owners, officers and/or directors of these entities as described below. Employment Agreement On June 29, 2026, Beyond Meat BV entered into an employment agreement with Mr. Figee, effective July 1, 2026, to serve as General Manager, EMEA. The agreement provides for an annual base salary of €325,000, eligibility for a discretionary annual incentive of up to 60% of base salary, and customary benefits and allowances. Supply Agreement The Company and The New Plant B.V. (“TNP”) are parties to that certain Beyond Meat International Manufacturing and Supply Agreement dated February 4, 2020, as amended July 27, 2023 (the “Supply Agreement”), pursuant to which TNP provides contract manufacturing for certain of the Company’s products in Europe. Beheer- en Beleggingsmaatschappij Zandbergen B.V. (“BZ”), TNP’s parent company, is a party to the Supply Agreement solely with respect to certain provisions related to exclusivity, conflicts, IP, non-solicitation and indemnification. Charlotte Zandbergen, the spouse of Mr. Figee, is an owner, officer and director of TNP and BZ. In addition, Joris Zandbergen, Mr. Figee’s brother-in-law, is an officer and director of TNP and BZ, and Anthonius (Ton) Zandbergen and Barbara Zandbergen, Mr. Figee’s father-in-law and sister-in-law, respectively, are officers and directors of BZ. Distribution Agreement The Company and Vleesgroothandel Gebrs. Zandbergen B.V. (“Zandbergen”) are parties to that certain Distribution Agreement dated June 23, 2021, as amended January 31, 2023, and further amended June 22, 2026, pursuant to which Zandbergen serves as the Company’s non-exclusive distributor of certain retail and foodservice products in certain territories. Charlotte Zandbergen, the spouse of Mr. Figee, is an owner, officer and director of Zandbergen. In addition, Anthonius (Ton) Zandbergen, Joris Zandbergen and Barbara Zandbergen, Mr. Figee’s father-in-law, brother-in-law and sister-in-law, respectively, are officers and directors of Zandbergen. Cold Storage The Company and Frigomundo Coldstore B.V. (“Frigomundo”) are parties to a cold storage price list pursuant to which the Company procures storage of certain frozen products manufactured by TNP and which sets forth warehousing and cold storage service rates for Beyond Meat inventory stored at Frigomundo facilities. Charlotte Zandbergen, the spouse of Mr. Figee, is an owner of Frigomundo. Anthonius (Ton) Zandbergen and Joris Zandbergen, Mr. Figee’s father-in-law and brother-in-law, respectively, are officers of Frigomundo. Beheer- en Beleggingsmaatschappij Zandbergen B.V. is a director of Frigomundo (see “Distribution Agreement” above). Warehouse Lease Agreement The Company and Enschede Property Fund BV, as successor to G.S.A. B.V. (“EPF”), are parties to that certain Warehouse Lease Agreement dated February 1, 2024, pursuant to which the Company leases a warehousing and storage facility near its manufacturing facility in Enschede, The Netherlands. Freek Figee, Guus Figee and Cas Figee, children of Mr. Figee, are each an indirect owner of EPF. In addition, Mr. Figee, Charlotte Zandbergen, Joris Zandbergen, Willem van Duin, Barbara Zandbergen and Inge Zandbergen, Mr. Figee’s spouse, brothers-in-law and sisters-in-law, respectively, are owners, officers and/or directors of EPF. Consulting Agreement The Company and Rijndijk Beheer BV (Moonlighters BV), on behalf of Mr. Figee, as the owner thereof, are parties to that certain Consulting Agreement dated April 8, 2026, pursuant to which Mr. Figee provided certain consulting services to the Company. In the three and six months ended June 27, 2026, the Company paid Mr. Figee $150,000 in connection with such services. The Consulting Agreement terminated effective as of June 30, 2026 in connection with Mr. Figee’s employment by Beyond Meat BV.

Introduction (Details)	6 Months Ended
Introduction (Details)	Jun. 27, 2026 globalIssue
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of growing global issues	4

Stockholders’ Equity (Deficit) - Narrative (Details) $ / shares in Units, $ in Thousands				3 Months Ended	6 Months Ended
	Oct. 31, 2025 shares	Oct. 30, 2025 shares	Oct. 15, 2025 USD ($) shares	Jun. 27, 2026 USD ($) $ / shares shares	Jun. 27, 2026 USD ($) $ / shares shares	Jun. 22, 2026 agreement $ / shares shares	Dec. 31, 2025 $ / shares shares	Dec. 22, 2025 $ / shares	Dec. 21, 2025 $ / shares	May 07, 2025 $ / shares shares
Class of Stock [Line Items]
Common stock, authorized (in shares)				3,000,000,000	3,000,000,000		3,000,000,000
Common stock, par value (in dollars per share) \| $ / shares				$ 0.0001	$ 0.0001		$ 0.0001
Common stock, outstanding (in shares)				515,793,219	515,793,219		453,688,312
Common stock, issued (in shares)				515,793,219	515,793,219		453,688,312
Preferred stock, authorized (in shares)				500,000	500,000		500,000
Preferred stock, par value (in dollars per share) \| $ / shares				$ 0.0001	$ 0.0001		$ 0.0001
Preferred stock, outstanding (in shares)				0	0		0
Preferred stock, issued (in shares)				0	0		0
Class of warrant or right, number of securities called by warrants or rights (in shares)										9,558,635
Class of warrant or right, exercise price of warrants or rights (in usd per share) \| $ / shares								$ 1.95	$ 3.26	$ 3.26
Issuance of equity classified warrants to purchase common stock \| $				$ 1,228
Common stock, issued (in shares)	317,834,446	1,684,270	316,150,176
Convertible Senior Notes Due 2030
Class of Stock [Line Items]
Common stock, issued (in shares)				52,092,284	57,408,142
Convertible Senior Notes Due 2030 \| Convertible Debt
Class of Stock [Line Items]
Common stock, issued (in shares)					57,408,142
Exchange principal amount \| $			$ 196,217	$ 62,600	$ 68,800
Additional Paid-in Capital
Class of Stock [Line Items]
Issuance of equity classified warrants to purchase common stock \| $				$ 1,228
2018 Plan
Class of Stock [Line Items]
Common stock, outstanding (in shares)	69,009,600
Granted (in shares)					7,176,019
Big Geyser, Inc \| BG Warrants
Class of Stock [Line Items]
Common stock, par value (in dollars per share) \| $ / shares						$ 0.0001
Number of warrant agreements \| agreement						2
Class of warrant or right, number of securities called by warrants or rights (in shares)						4,166,667
Big Geyser, Inc \| Shares reserved for potential issuance under the BG Warrant—Tranche 1
Class of Stock [Line Items]
Class of warrant or right, number of securities called by warrants or rights (in shares)						2,500,000
Class of warrant or right, exercise price of warrants or rights (in usd per share) \| $ / shares						$ 0.60
Average expected term (years)						18 months
Big Geyser, Inc \| BG Tranche 2 Warrant
Class of Stock [Line Items]
Class of warrant or right, number of securities called by warrants or rights (in shares)						1,666,667
Class of warrant or right, exercise price of warrants or rights (in usd per share) \| $ / shares						$ 0.001

Fair Value of Financial Instruments - Schedule of Changes in Fair Value of Warrants Liability (Details) - Warrant - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 27, 2026	Jun. 28, 2025	Jun. 27, 2026	Jun. 28, 2025
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 3,766	$ 0	$ 5,066	$ 0
Fair value of delayed draw term loan warrants issued during the period	0	7,983	0	7,983
Fair value of contingently issued delayed draw term loan warrants	0	12,160	0	12,160
Remeasurement of delayed draw term loan warrants liability	76	0	(1,224)	0
Ending balance	$ 3,842	$ 20,143	$ 3,842	$ 20,143

Stockholders’ Equity (Deficit)

6 Months Ended

Jun. 27, 2026

Equity [Abstract]

Stockholders’ Equity (Deficit)

As of June 27, 2026, the Company’s shares consisted of 3,000,000,000 authorized shares of common stock, par value $0.0001 per share, of which 515,793,219 shares of common stock were issued and outstanding, and 500,000 authorized shares of preferred stock, par value $0.0001 per share, of which no shares were issued and outstanding.

As of December 31, 2025, the Company’s shares consisted of 3,000,000,000 authorized shares of common stock, par value $0.0001 per share, of which 453,688,312 shares were issued and outstanding, and 500,000 authorized shares of preferred stock, par value $0.0001 per share, of which no shares were issued and outstanding.

The Company has not declared or paid any dividends, or authorized or made any distribution upon or with respect to any class or series of its capital stock.

Common Stock

Common stock reserved for future issuance consisted of the following:


	June 27, 2026	December 31, 2025

Equity incentive compensation awards granted and outstanding	56,308,520	39,464,342
Shares available for issuance under the Amended and Restated 2018 Equity Incentive Plan(1)(2)(3)	10,024,113	10,310,481
Shares available for issuance under the 2026 Employment Inducement Equity Incentive Plan	9,433,685	—
Shares available for issuance under the 2018 Employee Stock Purchase Plan	4,557,105	4,020,975
Shares reserved for potential issuance under the 2030 Notes(4)	86,660,407	120,000,000
Shares reserved for potential issuance under the Delayed Draw Term Loan Warrants	9,558,635	9,558,635
Shares reserved for potential issuance under the BG Warrant—Tranche 1	2,500,000	—
Shares reserved for potential issuance under the BG Warrant—Tranche 2	1,666,667	—
Total common stock reserved for future issuance	180,709,132	183,354,433

_________________

Warrants

Delayed Draw Term Loan Warrants

On May 7, 2025, in connection with the entry into the Loan and Security Agreement, the Company and the Lenders entered into the Delayed Draw Term Loan Warrant Agreement setting forth the rights and obligations of the Company and the Lenders. See Note 5 and Note 9.

Big Geyser Warrants

On April 15, 2026, Beyond Meat, Inc. (the “Company”) entered into a distribution agreement (the “Distribution Agreement”) with Big Geyser, Inc. (“Big Geyser”), pursuant to which Big Geyser will sell, distribute, market and assist in the promotion of the Company’s products.

On June 22, 2026, in connection with the Distribution Agreement, the Company and Big Geyser entered into two separate warrant agreements (each as further described below) setting forth the rights and obligations of the Company and Big Geyser in connection with warrants representing Big Geyser’s right to purchase up to, in the aggregate, 4,166,667 shares of the Company’s common stock, par value $0.0001 per share.

Tranche 1 Warrant Agreement

The first warrant (the “BG Tranche 1 Warrant”) entitles Big Geyser to purchase up to an aggregate of 2,500,000 shares of common stock at an exercise price of $0.60 per share. The BG Tranche 1 Warrant is exercisable by Big Geyser, in whole or in part, at any time, or from time to time, prior to the expiration of the warrant agreement governing the BG Tranche 1 Warrant (the “BG Tranche 1 Warrant Agreement”), by tendering to the Company at its principal office a notice of exercise. Promptly upon receipt of such exercise notice and the payment of the exercise price, and in no event later than two (2) business days thereafter, the Company will issue to Big Geyser the whole number of shares of common stock purchased plus an amount in cash representing any fractional share of common stock otherwise due upon such exercise.

The BG Tranche 1 Warrant will be exercisable by payment in cash from time to time until or prior to 5:00 p.m. (Eastern Time) on the eighteen-month anniversary of the initial issuance of the BG Tranche 1 Warrant. The BG Tranche 1 Warrant is subject to adjustment from time to time in accordance with the provisions of the BG Tranche 1 Warrant Agreement, including a weighted average adjustment for certain below-market issuances of equity or equity-linked securities, subject to exceptions set forth in the BG Tranche 1 Warrant Agreement. The BG Tranche 1 Warrant may not be transferred or assigned to any person other than Permitted Transferees (as defined in the BG Tranche 1 Warrant Agreement) without the prior written consent of the Company.

The Company determined that the BG Tranche 1 Warrant met the definition of an equity-classified award and is presented in permanent equity as part of Additional paid in capital in the Company’s unaudited condensed consolidated statement of stockholder’s equity (deficit) as of June 27, 2026. The Company also determined that the BG Tranche 1 Warrant represents share-based consideration payable to a customer and is not in exchange for a distinct good or service. Accordingly, the BG Tranche 1 Warrant was measured at grant-date fair value and accounted for as a reduction of revenue. The BG Tranche 1 Warrant does not contain vesting conditions and, as a result, the Company recognized the grant-date fair value of the BG Tranche 1 Warrant as a prepaid asset upon issuance and included in Other non-current assets, net, in its unaudited condensed consolidated balance sheet, which will be amortized as a reduction of revenue as the related sales to Big Geyser occur over the expected contract term. The grant-date fair value of the BG Tranche 1 Warrant was $1.2 million and was recorded in Additional paid-in capital in the Company’s unaudited condensed consolidated statement of stockholders’ equity (deficit) as of June 27, 2026.

Tranche 2 Warrant Agreement

The second warrant (the “BG Tranche 2 Warrant” and, together with the BG Tranche 1 Warrant, the “BG Warrants”) entitles Big Geyser to purchase up to an aggregate of 1,666,667 shares of common stock at an exercise price of $0.001 per share. The BG Tranche 2 Warrant is subject to certain performance-based vesting conditions based on the cumulative number of cases of the Company’s beverage products sold by Big Geyser into retail, convenience, foodservice and other outlets in the New York metropolitan area as described in the BG Tranche 2 Warrant Agreement (as defined below).

The BG Tranche 2 Warrant, if vested, is exercisable by Big Geyser, in whole or in part, at any time, or from time to time, prior to the expiration of the warrant agreement governing the BG Tranche 2 Warrant (the “BG Tranche 2 Warrant Agreement” and, together with the BG Tranche 1 Warrant Agreement, the “BG Warrant Agreements”), by tendering to the Company at its principal office a notice of exercise. Promptly upon receipt of such exercise notice and the payment of the exercise price, and in no event later than two (2) business days thereafter, the Company will issue to Big Geyser the whole number of shares of common stock purchased plus an amount in cash representing any fractional share of common stock otherwise due upon such exercise.

The BG Tranche 2 Warrant, if vested, will be exercisable by payment in cash or by way of “Net-Share Settlement” (as defined in the BG Tranche 2 Warrant Agreement) from time to time until or prior to 5:00 p.m. (Eastern Time) on the 20th business day following the expiration of the Distribution Agreement. The BG Tranche 2 Warrant is subject to adjustment from time to time in accordance with the provisions of the BG Tranche 2 Warrant Agreement, including a weighted average adjustment for certain below-market issuances of equity or equity-linked securities, subject to exceptions set forth in the BG Tranche 2 Warrant Agreement. The BG Tranche 2 Warrant may not be transferred or assigned to any person other than Permitted Transferees (as defined in the BG Tranche 2 Warrant Agreement) without the prior written consent of the Company.

As of June 27, 2026, none of the vesting conditions of the BG Tranche 2 Warrant were met, and they were not probable of being met. See Note 2.

2030 Notes Conversions

In the six months ended June 27, 2026, pursuant to the 2030 Notes Indenture, the Company issued an aggregate of 57,408,142 Conversion Shares to certain holders of the 2030 Notes upon the conversion by such holders of $68.8 million in aggregate principal amount of 2030 Notes into shares of the Company’s common stock, which resulted in Anti-Dilution Increases totaling 7,176,019 shares including shares reserved for Anti-Dilution Increases in respect of the MIP PSU awards.

- Definition

The entire disclosure for equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 20
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479951/505-20-S50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 20
-Name Accounting Standards Codification
-Section S25
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479982/505-20-S25-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480070/505-10-S50-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S45
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 20
-Name Accounting Standards Codification
-Section S50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479951/505-20-S50-2

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 20
-Name Accounting Standards Codification
-Section S25
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479982/505-20-S25-2

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.C)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481520/505-30-50-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 20
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 1.D.2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479921/505-20-S99-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 20
-Name Accounting Standards Codification
-Section S50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479951/505-20-S50-3

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 855
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 1.B.3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480148/855-10-S99-1

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 20
-Name Accounting Standards Codification
-Section S25
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479982/505-20-S25-3

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/505/tableOfContent

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 11
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480237/815-40-50-5

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477968/946-235-50-2

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 505
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478448/946-505-50-6

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480237/815-40-50-6

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-13

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-14

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 16
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-16

+ Details

Cash and Cash Equivalents and Restricted Cash - Schedule of Reconciliation of Cash and Cash Equivalents, Restricted Cash (Details) - USD ($) $ in Thousands	Jun. 27, 2026	Dec. 31, 2025	Jun. 28, 2025	Dec. 31, 2024
Cash and Cash Equivalents [Abstract]
Cash and cash equivalents	$ 171,369	$ 203,890	$ 103,497	$ 131,913
Restricted cash, current	5,516	4,350	1,172	1,041
Restricted cash, non-current	9,250	9,291	12,600	12,600
Total cash, cash equivalents and restricted cash	$ 186,135	$ 217,531	$ 117,269	$ 145,554

Property, Plant and Equipment - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 27, 2026	Jun. 28, 2025	Jun. 27, 2026	Jun. 28, 2025	Dec. 31, 2025
Property, Plant, and Equipment [Line Items]
Depreciation and amortization	$ 6,700	$ 8,300	$ 13,549	$ 15,682
Accelerated depreciation related to the idled assets	1,600		2,100	3,200
Assets held for sale	8,700		8,700		$ 9,400
Location, Statement of Income, Balance [Axis]: us-gaap:CostOfGoodsAndServicesSold
Property, Plant, and Equipment [Line Items]
Depreciation and amortization	4,000	6,100	7,800	12,000
Accelerated depreciation related to the idled assets	1,600	1,700	2,100	2,300
Location, Statement of Income, Balance [Axis]: us-gaap:ResearchAndDevelopmentExpense
Property, Plant, and Equipment [Line Items]
Depreciation and amortization	2,000	2,100	4,200	3,400
Accelerated depreciation related to the idled assets			900	900
Location, Statement of Income, Balance [Axis]: us-gaap:SellingGeneralAndAdministrativeExpense
Property, Plant, and Equipment [Line Items]
Depreciation and amortization	$ 700	$ 100	$ 1,500	$ 300

- Definition

The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Subparagraph (b)
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-28

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-1

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482665/350-30-50-2

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-1

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482558/350-40-50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476148/220-40-50-12

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 49
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-49

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476148/220-40-50-6

+ Details

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 905
-SubTopic 360
-Name Accounting Standards Codification
-Section 25
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478704/905-360-25-4

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 05
-Paragraph 3
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482338/360-10-05-3

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 30
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482222/360-10-30-2

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 05
-Paragraph 3
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482338/360-10-05-3

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-1

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 05
-Paragraph 3
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482338/360-10-05-3

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 05
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482338/360-10-05-3

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-1

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482558/350-40-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 842
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A

+ Details

Leases - Schedule of Sublease Income (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 27, 2026	Jun. 28, 2025	Jun. 27, 2026	Jun. 28, 2025
Leases [Abstract]
Sublease income	$ 311	$ 0	$ 608	$ 0

Inventories (Details) - USD ($) $ in Thousands	Jun. 27, 2026	Dec. 31, 2025
Inventory Disclosure [Abstract]
Raw materials and packaging	$ 25,352	$ 32,569
Work in process	10,743	17,743
Finished goods	27,032	33,720
Total	$ 63,127	$ 84,032

Fair Value of Financial Instruments - Fair Value Measurements, Recurring and Nonrecurring (Details) - Valuation Technique, Binomial Pricing Model	Jun. 27, 2026 $ / shares yr	Dec. 31, 2025 $ / shares yr
Term (years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative asset (liability) net, measurement input \| yr	4.3	4.8
Risk-free interest rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative asset (liability) net, measurement input	0.0407	0.0368
Expected volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative asset (liability) net, measurement input	0.400	0.400
Stock price on valuation date
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative asset (liability) net, measurement input \| $ / shares	0.66	0.82
Discount rate (continuous)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative asset (liability) net, measurement input	0.2451	0.1971

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

Debt

6 Months Ended

Jun. 27, 2026

Debt Disclosure [Abstract]

Debt

The following is a summary of debt balances as of June 27, 2026 and December 31, 2025 (in thousands):


	June 27, 2026		December 31, 2025

2027 Notes	$	29,459	$	29,459
2030 Notes	224,269		334,148
Debt discount—2030 Notes issue date embedded derivatives, net(1)	(15,564)		(25,745)
Delayed draw term loans(2)	110,884		104,569
Debt issuance costs—Delayed draw term loans	(6,718)		(7,181)
Debt discount—Delayed draw term loan warrants	(18,534)		(19,510)

Total debt outstanding	$	323,796	$	415,740
Less: current portion of long-term debt	(29,459)		—
Long-term debt	$	294,337	$	415,740

_________

(1) 2030 Notes Embedded Derivative was valued using the binomial lattice valuation model and recorded as debt discount. Amount shown is net of amortization from the issue date discount and pro rata reductions from conversions. See Note 2 and Note 5.

(2) Includes accrued PIK interest of $10.9 million and $4.6 million as of June 27, 2026 and December 31, 2025, respectively.

2027 Notes

On March 5, 2021, the Company issued $1.0 billion aggregate principal amount of 2027 Notes in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). On March 12, 2021, the initial purchasers of the 2027 Notes exercised their option to purchase an additional $150.0 million aggregate principal amount of 2027 Notes, and such additional 2027 Notes were issued on March 16, 2021.

The 2027 Notes will mature on March 15, 2027, unless earlier repurchased, redeemed or converted. The 2027 Notes were issued pursuant to, and are governed by, an indenture, dated as of March 5, 2021 (the “2027 Notes Indenture”), between the Company and U.S. Bank National Association, as trustee (the “2027 Notes Trustee”).

The 2027 Notes do not bear regular interest, and the principal amount of the 2027 Notes do not accrete. For additional details regarding the terms of the 2027 Notes, including redemption, fundamental change and events of default provisions, see Note 9, Debt, to the Notes to Consolidated Financial Statements included in the 2025 10-K.

In the event of the Company’s liquidation, dissolution or winding up, holders of the Company’s common stock will be entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all of the Company’s debts and other liabilities and the satisfaction of any liquidation preference granted to the holders of any then-outstanding shares of preferred stock.

Holders of the Company’s common stock have no preemptive, conversion, subscription or other rights, and there are no redemption or sinking fund provisions applicable to the Company’s common stock. The rights, preferences and privileges of the holders of the Company’s common stock are subject to and may be adversely affected by the rights of the holders of shares of any series of preferred stock that the Company may designate in the future.

If an Event of Default (as defined in the 2027 Notes Indenture) involving bankruptcy, insolvency or reorganization events with respect to the Company (and not solely with respect to a significant subsidiary of the Company) occurs, then the principal amount of, and any accrued and unpaid special interest and additional interest on, all of the 2027 Notes then outstanding will immediately become due and payable without any further action or notice by any person. If any other Event of Default occurs and is continuing, then, the 2027 Notes Trustee, by notice to the Company, or noteholders of at least 25% of the aggregate principal amount of 2027 Notes then outstanding, may declare the principal amount of, and any accrued and unpaid special interest and additional interest on, all of the 2027 Notes then outstanding to become due and payable immediately. However, notwithstanding the foregoing, the Company may elect, at its option, that the sole remedy for an Event of Default relating to certain failures by the Company to comply with certain reporting covenants in the 2027 Notes Indenture consists exclusively of the right of the noteholders to receive special interest on the 2027 Notes for up to 365 days at a specified rate per annum not exceeding 0.50% on the principal amount of the Notes.

The total amount of debt issuance costs of $23.6 million was recorded as a reduction to 2027 Notes in the Company’s unaudited condensed consolidated balance sheet and was being amortized as interest expense over the term of the 2027 Notes using the effective interest method. In the three and six months ended June 28, 2025, the Company recognized $1.0 million and $2.0 million, respectively, in interest expense related to the amortization of the debt issuance costs related to the 2027 Notes. The annualized effective interest rate was 0.34% in the three and six months ended June 28, 2025. In October 2025, concurrently with the completion of the Exchange Offer, the remaining unamortized debt issuance costs associated with the 2027 Notes in the amount of $5.4 million was offset against the gain on debt restructuring.

Exchange Offer and Consent Solicitation

On September 29, 2025, the Company commenced the Exchange Offer to exchange any and all of its 2027 Notes issued pursuant to the 2027 Notes Indenture, for a pro rata portion of (i) up to $202.5 million in aggregate principal amount of the 2030 Notes and (ii) up to 326,190,370 shares of the Company’s common stock (the “New Shares”). Simultaneously with the Exchange Offer, the Company solicited consents (the “Consent Solicitation”) from holders of the 2027 Notes to adopt certain proposed amendments to the 2027 Notes Indenture.

Early Settlement of the Exchange Offer

On October 15, 2025, the Company completed the early settlement of the exchange of the 2027 Notes that were validly tendered on or before the early tender deadline of 5:00 p.m., New York City time, on October 10, 2025 (the “Early Tender Date”) in the Exchange Offer. Pursuant to the early settlement of the Exchange Offer, $1,114,603,000 in aggregate principal amount of the 2027 Notes were validly tendered, accepted for exchange by the Company and subsequently canceled (“Early Tendered Notes”). The Early Tendered Notes represented 96.92% of the aggregate principal amount of the previously outstanding 2027 Notes. Following the cancellation of the Early Tendered Notes, $35,397,000 in aggregate principal amount of the 2027 Notes remained outstanding. On the Early Settlement Date, the Company issued (i) $196,217,000 in aggregate principal amount of 2030 Notes and (ii) 316,150,176 New Shares, in exchange for the Early Tendered Notes. In addition, the Company issued an additional $12.5 million in aggregate principal amount of 2030 Notes as payment to certain holders of 2027 Notes that had entered into a transaction support agreement with the Company relating to the Exchange Offer (the “SteerCo Premium”), for a total of $208,717,000 in aggregate principal amount of 2030 Notes. The Company also completed the Consent Solicitation and entered into a supplemental indenture (the

“Supplemental Indenture”) to the 2027 Notes Indenture with the 2027 Notes Trustee. The Supplemental Indenture eliminated substantially all of the restrictive covenants in the 2027 Notes Indenture as well as certain events of default and related provisions applicable to the 2027 Notes.

Final Settlement of the Exchange Offer

On October 30, 2025, (the “Final Settlement Date”) the Company completed the final settlement of the exchange of the 2027 Notes that were validly tendered in the Exchange Offer and not validly withdrawn following the Early Tender Date in connection with the Exchange Offer. Pursuant to the final settlement of the Exchange Offer, an additional $5,938,000 in aggregate principal amount of the 2027 Notes were validly tendered (“Additional Tendered Notes”), accepted for exchange by the Company and subsequently canceled. In connection with the final settlement of the Exchange Offer, on the Final Settlement Date, the Company issued (i) $1,004,000 in aggregate principal amount of 2030 Notes and (ii) 1,684,270 New Shares, in exchange for the Additional Tendered Notes.

Following the Final Settlement Date, a total of (i) $209,721,000 in aggregate principal amount of 2030 Notes (inclusive of $12.5 million in aggregate principal amount of 2030 Notes as payment of the SteerCo Premium) and (ii) 317,834,446 New Shares were issued by the Company in connection with the Exchange Offer. The Additional Tendered Notes and the Early Tendered Notes together represented 97.44% of the previously outstanding aggregate principal amount of the 2027 Notes. As of June 27, 2026 and December 31, 2025, $29,459,000 in aggregate principal amount of the 2027 Notes remained outstanding as further discussed below.

2030 Notes Indenture

The 2030 Notes were issued pursuant to an indenture and security agreement dated as of October 15, 2025 (as supplemented, the “2030 Notes Indenture”), by and between the Company and Wilmington Trust, National Association, as trustee (in such capacity, the “Trustee”) and collateral agent (in such capacity, the “Collateral Agent”).

The 2030 Notes are secured, second lien obligations of the Company. The 2030 Notes will mature on October 15, 2030, unless earlier redeemed, converted, equitized or repurchased in accordance with the terms of the 2030 Notes. The 2030 Notes bear interest at a rate of 7.00% per annum from the Early Settlement Date, which interest may be paid in cash or, subject to certain limitations, in shares of common stock. At the option of the Company, interest on the 2030 Notes may be accrued and compounded in whole or in part for any interest period as “payment-in-kind” (“PIK”) interest at a rate of 9.50% per annum from the Early Settlement Date. The Company used the PIK option as discussed below under Gain on Debt Restructuring. On January 12, 2026, the Company and Beyond Meat EU B.V., the Company’s wholly owned subsidiary (“Beyond Meat BV”), entered into a First Supplemental Indenture (the “First Supplemental Indenture”) with the Collateral Agent. The First Supplemental Indenture modified the 2030 Notes Indenture to provide for the guarantee of the 2030 Notes by Beyond Meat BV, which are secured on a second-priority basis by the Company’s assets and the assets of Beyond Meat BV, subject to certain exceptions.

The conversion rate for the 2030 Notes was initially set to a number of shares of common stock per $1,000 principal amount of 2030 Notes equal to the lesser of (i) 1,029.2716 and (ii) an amount calculated based on a 10% premium to a reference price determined over an observation period consisting of 20 consecutive trading days immediately following the Early Settlement Date, (excluding any trading days on which there is a Market Disruption Event, as defined in the 2030 Notes Indenture) with such conversion rate subject to customary adjustments. The conversion rate will be increased for conversions occurring prior to October 15, 2028, to reflect a “make-whole” premium, payable in the form of shares of common stock, to compensate holders for interest that would have been payable to such date. On November 14, 2025, the initial conversion rate for the 2030 Notes was established as 572.7784 shares of the Company’s common stock per $1,000 principal amount of the 2030 Notes, which represents a conversion price of approximately $1.7459 per share of common stock.

The Company is permitted to satisfy its obligations under the 2030 Notes with any settlement method it is otherwise permitted to elect, including by physical settlement of shares of common stock. The 2030 Notes are convertible at any time prior to the close of business on the second trading day immediately preceding the maturity date.

The 2030 Notes Indenture includes incurrence based negative covenants and financial covenants, including a minimum liquidity covenant of $15.0 million tested quarterly, restrictions on the amount of 2027 Notes that may remain outstanding prior to maturity, and a cap of $60.0 million on cash used to repay the 2027 Notes at maturity, subject to increase from equity raises. For a detailed description of the 2030 Notes Indenture covenants, see Note 9, Debt, to the Notes to Consolidated Financial Statements included in the 2025 10-K. As of June 27, 2026 and December 31, 2025, the Company was in compliance with the covenants under the 2030 Notes.

If certain corporate events constituting a make-whole fundamental change occur (which shall include, among other things, the acquisition by any person or group of more than 50% of the outstanding common stock of the Company or a delisting of the Company’s common stock), the Company shall offer to repurchase all of the outstanding 2030 Notes for cash at a repurchase price equal to 100% of the aggregate principal amount of the 2030 Notes then outstanding plus accrued and unpaid interest. If a fundamental change occurs, then the Company will in certain circumstances increase the conversion rate for the 2030 Notes for a specified period of time on the terms set forth in the 2030 Notes Indenture.

2030 Notes Embedded Derivative

The 2030 Notes contain certain embedded derivatives that require bifurcation and separate accounting from the debt host pursuant to ASC 815. For the Company's accounting policy regarding evaluation of convertible debt and warrants for embedded derivatives requiring bifurcation under ASC 815, including the valuation methodology per ASC 820, “Fair Value Measurement,” and the financial statement presentation of the 2030 Notes Embedded Derivative, see Note 2, Summary of Significant Accounting Policies, to the Notes to Consolidated Financial Statements included in the 2025 10-K. See Note 5.

Intercreditor Agreement

In connection with the issuance of the 2030 Notes and the entry into the 2030 Notes Indenture, the Company entered into an Intercreditor Agreement, dated as of October 15, 2025 (as amended, the “Intercreditor Agreement”), among Unprocessed Foods LLC, an affiliate of the Ahimsa Foundation (“Unprocessed Foods”), the lender under the Company’s Loan and Security Agreement, dated as of May 7, 2025 (as amended, the “Loan and Security Agreement”), as the first lien representative and the first lien collateral agent for the first lien claimholders, Wilmington Trust, National Association, as the initial second lien collateral agent for the initial second lien claimholders and as the initial second lien representative for the initial second lien claimholders, and the Company, as a grantor, which, among other things, provides for the relative priorities of the security interests in the assets securing the 2030 Notes, the loans pursuant to the Loan and Security Agreement and certain of the Company’s additional debt, and certain other matters relating to the administration of security interests. The terms of the Intercreditor Agreement expressly subordinate, in right of payment and in liens, the obligations under the 2030 Notes to the obligations under the Loan and Security Agreement.

Voting Agreements and Cancellation of Tendered 2027 Notes

In connection with the Exchange Offer, participating holders of 2027 Notes entered into voting agreements with the Company agreeing to vote shares received in the Exchange Offer in favor of certain stockholder proposals through the earlier of (i) the date following the date of the Company’s annual meeting in 2026, (ii) the date certain stockholder proposals are approved and (iii) June 19, 2026. The Company caused the tendered 2027 Notes, representing 97.44% of the previously outstanding 2027 Notes, to be delivered to the 2027 Notes

Trustee for cancellation. For additional details regarding the voting agreements, see Note 9, Debt, to the Notes to Consolidated Financial Statements included in the 2025 10-K.

Fair Values of the Notes

The carrying amount of the liability for the 2030 Notes as of June 27, 2026 and December 31, 2025 was $208.7 million and $308.4 million, respectively, net of debt discount, which represents the issuance date principal amount plus the undiscounted future cash flows using the PIK election, including any amounts contingently payable, and amounts reduced, on a pro rata basis, from partial conversion settlements completed during the period, offset by amortization of the debt discount, discussed below, included in 2030 Notes, net, under Long-term liabilities in the Company’s unaudited condensed consolidated balance sheets. See Note 2.

The following is a summary of the 2027 Notes as of June 27, 2026, included in Current liabilities in the Company’s unaudited condensed consolidated balance sheet (in thousands):


	Principal Amount		Unamortized Issuance Costs		Net Carrying Amount		Fair Value
							Amount		Leveling
2027 Notes	$	29,459	$	—	$	29,459	$	6,098	Level 2

The following is a summary of the 2027 Notes as of December 31, 2025, included in Long-term liabilities in the Company’s unaudited condensed consolidated balance sheet (in thousands):


	Principal Amount		Unamortized Issuance Costs		Net Carrying Amount		Fair Value
							Amount		Leveling
2027 Notes	$	29,459	$	—	$	29,459	$	6,098	Level 2

The 2027 Notes are carried at face value on the Company’s unaudited condensed consolidated balance sheets. The 2027 Notes are quoted on the Intercontinental Exchange and are classified as Level 2 financial instruments. The estimated fair value of the 2027 Notes was determined based on the actual bid price of the 2027 Notes on June 1, 2026 the last business day in the six months ended June 27, 2026 when the 2027 Notes were traded.

The following is a summary of the 2030 Notes as of June 27, 2026 (in thousands):


	Principal Amount(1)		Undiscounted Cash Flows(2)		Unamortized Derivative Discount(3)		Net Carrying Amount		Fair Value
									Amount		Leveling
2030 Notes, net	$	151,288	$	72,981	$	(15,564)	$	208,705	$	114,266	Level 2

__________

(1) Represents the net principal amount remaining after $68.8 million of 2030 Note conversions settled during the six months ended June 27, 2026. See Note 2. On May 1, 2026, the aggregate remaining principal amount of the 2030 Notes was increased by approximately $10.4 million in interest payment in the form of PIK interest at a rate of 9.5% for the period from October 15, 2025 to May 1, 2026, pursuant to the terms of the 2030 Notes Indenture.

(2) Represents the remaining undiscounted future cash flows using the PIK election, including any amounts contingently payable.

(3) Represents the remaining unamortized debt discount in the 2030 Notes. The discount was reduced by $8.0 million for conversions settled during the six months ended June 27, 2026. See Note 2. The remaining discount is being amortized to interest expense at an effective interest rate of 1.7% per annum over the term of the 2030 Notes.

The following is a summary of the 2030 Notes as of December 31, 2025 (in thousands):


	Principal Amount		Undiscounted Cash Flows(1)		Unamortized Derivative Discount(2)		Carrying Amount		Fair Value
									Amount		Leveling
2030 Notes, net	$	209,721	$	124,427	$	(25,745)	$	308,403	$	166,267	Level 2

__________

(1) Represents the undiscounted future cash flows using the PIK election, including any amounts contingently payable, recognized on the restructuring date in accordance with TDR accounting discussed in Note 2.

(2) Represents the unamortized embedded derivatives in the 2030 Notes, recorded as a single derivative, bifurcated from the host and recorded as a discount in accordance with ASC 815. The 2030 Notes Embedded Derivative discount is being amortized to interest expense at an effective interest rate of 1.6% per annum over the term of the 2030 Notes.

The 2030 Notes are quoted on the Intercontinental Exchange and are classified as Level 2 financial instruments. The estimated fair value of the 2030 Notes was determined based on the actual bid price of the 2030 Notes on May 4, 2026, the last business day in the six months ended June 27, 2026 when the 2030 Notes were traded.

As of June 27, 2026, the remaining lives of the 2027 Notes and 2030 Notes were approximately 0.7 years and 4.3 years, respectively.

2030 Note Conversions and Gain on Debt Extinguishment

In the three and six months ended June 27, 2026, pursuant to the 2030 Notes Indenture, the Company issued 52,092,284 and 57,408,142 Conversion Shares to certain holders of the 2030 Notes upon the conversion by such holders of $62.6 million and $68.8 million, respectively, in aggregate principal amount of 2030 Notes into shares of the Company’s common stock. This resulted in the pro rata reduction of $100.0 million and $109.9 million, respectively, of the 2030 Notes carrying value, the pro rata reduction of $7.2 million and $8.0 million, respectively, of the debt discount, and the pro rata reduction of $15.4 million and $16.5 million, respectively, of the 2030 Notes Embedded Derivative at fair value on the settlement dates. In the three and six months ended June 27, 2026, the Company recognized a gain on debt extinguishment of $57.7 million and $63.8 million, respectively, from these conversions. See Note 2.

In the six months ended June 27, 2026, an aggregate of 4,264,723 anti-dilution RSUs were granted to the recipients of the MIP awards and an aggregate of 2,911,527 shares were reserved for Anti-Dilution Increases with respect to MIP PSU awards, at maximum payout, associated with these 2030 Note conversions.

Loan and Security Agreement

On May 7, 2025, the Company, as borrower, entered into the Loan and Security Agreement with Unprocessed Foods, the other lenders party thereto (together with Unprocessed Foods, the “Lenders”) and certain of the Company’s subsidiaries party thereto from time to time, as guarantors, pursuant to which the Lenders agreed to provide for a senior secured delayed draw term loan facility (the “Delayed Draw Term Loan Facility” and the loans thereunder, the “Delayed Draw Term Loans”) in an aggregate principal amount of $100.0 million. Beyond Meat BV has guaranteed the Company’s obligations under the Loan and Security Agreement. The Delayed Draw Term Loans are secured by a first-priority lien and security interest in substantially all of the assets, subject to certain exceptions, of the Company and Beyond Meat BV.

The Delayed Draw Term Loans mature on February 7, 2030 (the “Initial Maturity Date”), which date may be extended by the Company, with the relevant Lenders’ consent, to no later than May 7, 2035. Borrowings accrue interest at a rate per annum of 12.0% with accrued but unpaid interest compounded on a quarterly basis and PIK interest by adding the amount of such accrued interest to the principal amount of the outstanding Delayed

Draw Term Loans. As of June 27, 2026 and December 31, 2025, the effective interest on the Delayed Draw Term Loans was 19.4% and 13.8%, respectively. For additional details regarding the terms of the Loan and Security Agreement, including interest rate, use of proceeds restrictions and covenant provisions, see Note 9, Debt, to the Notes to the Consolidated Financial Statements included in the 2025 10-K.

The Loan and Security Agreement includes financial covenants requiring the Company to maintain liquidity of $15.0 million, caps on cash interest payments and caps on cash used to repay the 2027 Notes at maturity, among other restrictive covenants.

On June 26, 2025 and September 18, 2025, at the Company’s request, Unprocessed Foods, as the sole Lender at such time, made Delayed Draw Term Loans to the Company in the principal amounts of $40.0 million and $60.0 million, respectively. The Company plans to use the proceeds from such Delayed Draw Term Loans for general corporate purposes.

The total amount of debt issuance costs related to the Delayed Draw Term Loan Facility was $7.3 million, which is being amortized to interest expense over the term of the loan using the effective interest rate method. As of June 27, 2026, the Company had drawn the entire $100.0 million and had no amount available under the Delayed Draw Term Loan Facility.

In the three and six months ended June 27, 2026, the Company recorded accrued unpaid interest of $3.4 million and $6.8 million, respectively, in PIK interest expense related to the Delayed Draw Term Loans and $0.5 million and $1.0 million, respectively in interest expense from the amortization of the debt discount resulting from the Delayed Draw Term Loan Warrants (as defined below).

Embedded Derivatives in Delayed Draw Term Loans

The Delayed Draw Term Loans contain certain embedded derivatives that require bifurcation and separate accounting from the debt host pursuant to ASC 815, including separate valuations of fair value for those derivatives both at the issuance date and all reporting periods thereafter until the derivatives expire, are canceled or the debt is no longer outstanding. The issuance date fair value of the derivatives is recorded as a debt discount and amortized, while the changes to the fair value of those derivatives after the issuance date are marked to market and recognized in the consolidated statements of operations. The Company assessed the fair value of these derivatives and determined that both the issuance date fair value and the subsequent changes to fair value as of June 27, 2026 and December 31, 2025, were immaterial, subject to subsequent reassessment.

Amendment to the Loan and Security Agreement

On October 15, 2025, the Company also entered into a First Amendment to the Loan and Security Agreement (the “First Amendment to LSA”), with Unprocessed Foods, which amends the Loan and Security Agreement, among the Company, as the borrower, Unprocessed Foods, as a lender, and the other lenders from time to time party thereto. Pursuant to the First Amendment to LSA, the Loan and Security Agreement was amended to, among other things, add cross defaults to the Loan and Security Agreement related to events of default under other debt secured by a second priority security interest and certain secured debt for borrowed money. The amendment was deemed to be a debt modification pursuant to ASC 470, with no material amounts being recorded in the Company’s consolidated financial statements in connection with a modification for the year ended December 31, 2025.

As of June 27, 2026 and December 31, 2025, the Company was in compliance with the covenants of the Loan and Security Agreement.

Delayed Draw Term Loan Warrant Agreement

On May 7, 2025, in connection with the entry into the Loan and Security Agreement, the Company and the Lenders entered into a warrant agreement (the “Delayed Draw Term Loan Warrant Agreement”) setting forth the rights and obligations of the Company and the Lenders, as holders, in connection with warrants (the Delayed Draw Term Loan Warrants”) representing the Lenders’ right to purchase up to, in the aggregate, 9,558,635 shares of common stock (the “Maximum Warrant Share Amount”), at an initial exercise price of $3.26 per share calculated based on the terms of the Delayed Draw Term Loan Warrant Agreement. The Loan and Security Agreement provides that at each funding date of any Delayed Draw Term Loan, the Company would execute and deliver to the applicable Lenders Delayed Draw Term Loan Warrants representing the pro rata portion of the Maximum Warrant Share Amount based on the amount of Delayed Draw Term Loan provided by such Lender on the date thereof.

The Delayed Draw Term Loan Warrants are exercisable by the holder thereof, in whole or in part, at any time, or from time to time, prior to the expiration of the Delayed Draw Term Loan Warrant Agreement by tendering to the Company at its principal office a notice of exercise. Promptly upon receipt of such exercise notice and the payment of the exercise price, and in no event later than two business days thereafter, the Company will issue to such holder the whole number of shares of common stock purchased plus an amount in cash representing any fractional share of common stock otherwise due upon such exercise.

The Delayed Draw Term Loan Warrants will be exercisable by payment in cash from time to time until June 26, 2030. The Delayed Draw Term Loan Warrants are subject to adjustment from time to time in accordance with the provisions of the Delayed Draw Term Loan Warrant Agreement, including a weighted average adjustment for certain below-market issuances of equity or equity-linked securities, subject to exceptions set forth in the Delayed Draw Term Loan Warrant Agreement. Subject to compliance with applicable federal and state securities laws, the Delayed Draw Term Loan Warrant Agreement and all rights thereunder are transferable by the Holder subject to the terms of the Delayed Draw Term Loan Warrant Agreement.

The Company agreed in the Delayed Draw Term Loan Warrant Agreement to provide certain customary registration rights with respect to the resale of shares of common stock underlying the Delayed Draw Term Loan Warrants. As the Company is no longer eligible to use Form S-3 registration statements, the Company is required to use its commercially reasonable efforts to register for resale on a registration statement on Form S-1 the shares of common stock underlying the Delayed Draw Term Loan Warrants outstanding. For additional details regarding the Delayed Draw Term Loan Warrant Agreement terms, see Note 9, Debt, to the Notes to Consolidated Financial Statements included in the 2025 10-K.

Pursuant to the terms of the Delayed Draw Term Loan Warrant Agreement, the exercise price of the Delayed Draw Term Loan Warrants is subject to a weighted average adjustment for certain below-market issuances of equity or equity-linked securities, subject to exceptions. On December 22, 2025, the Company adjusted the exercise price for the Delayed Draw Term Loan Warrants from $3.26 to $1.95 in order to fully account for any and all potential past or future adjustments relating to the exchange of the 2027 Notes for $209,721,000 in principal amount of 2030 Notes and 317,834,446 shares of common stock that was completed on October 30, 2025, the payment of interest on the 2030 Notes in the form of common stock or in the form of payment-in-kind interest, as well as certain mandatory conversions, equitizations and make-whole payments that could result in additional issuances of common stock thereunder, if any. There was no corresponding adjustment to the number of shares of common stock underlying the Delayed Draw Term Loan Warrants. On June 27, 2026 and December 31, 2025, the Company remeasured the fair value of the total warrant liability marking it to market. See Note 5.

The debt discount arising from the Delayed Draw Term Loan Warrant liability is amortized to interest expense over the life of the Delayed Draw Term Loan Warrant Agreement. In the three and six months ended June 27, 2026, the Company recorded $0.5 million and $1.0 million, respectively, in interest expense related to

the amortization of the debt discount resulting from the Delayed Draw Term Loan Warrants. Total unamortized debt issuance costs related to the Delayed Draw Term Loans were $6.7 million and $7.2 million as of June 27, 2026 and December 31, 2025, respectively.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(16))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480657/210-10-S50-8

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(19)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22)(a)(4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22)(a)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22)(a)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(19))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480657/210-10-S50-9

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481544/470-10-50-6

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481544/470-10-50-6

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 470
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/470/tableOfContent

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482925/835-30-45-2

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

+ Details

Cover Page - shares	6 Months Ended
Cover Page - shares	Jun. 27, 2026	Aug. 05, 2026
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 27, 2026
Document Transition Report	false
Entity File Number	001-38879
Entity Registrant Name	BEYOND MEAT, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-4087597
Entity Address, Address Line One	888 N Douglas Street
Entity Address, Address Line Two	Suite 100
Entity Address, City or Town	El Segundo
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	90245
City Area Code	866
Local Phone Number	756-4112
Title of 12(b) Security	Common Stock, $0.0001 par value
Trading Symbol	BYND
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		515,818,978
Entity Central Index Key	0001655210
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2026
Document Fiscal Period Focus	Q2
Amendment Flag	false

Fair Value of Financial Instruments - Schedule of Changes in Fair Value of Warrants Liability (Details) - Black-Scholes	Jun. 26, 2026 $ / shares
Risk-free interest rate
Fair Value, Option, Quantitative Disclosures [Line Items]
Measurement input	0.0411
Average expected term (years)
Fair Value, Option, Quantitative Disclosures [Line Items]
Average expected term (years)	4 years
Expected volatility
Fair Value, Option, Quantitative Disclosures [Line Items]
Measurement input	1.1310
Dividend yield
Fair Value, Option, Quantitative Disclosures [Line Items]
Measurement input	0
Exercise price
Fair Value, Option, Quantitative Disclosures [Line Items]
Measurement input	1.95

Commitments and Contingencies	6 Months Ended
Commitments and Contingencies	Jun. 27, 2026
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Leases We paid $1.6 million and $8.3 million in rent prepayments and payments towards construction costs of the Campus Headquarters in the six months ended June 27, 2026 and year ended December 31, 2025, respectively. The Company’s lease commitments, including its Campus Headquarters lease, related amendments, sublease arrangements, and letter of credit, are described in Note 6. Big Geyser For details about the Company’s Distribution Agreement with Big Geyser and issuance of the BG Warrants in connection therewith, see Note 10. China Investment and Lease Agreement In 2020, the Company and its subsidiary, Beyond Meat (Jiaxing) Food Co., Ltd. (“BYND JX”), entered into an investment agreement with the Administrative Committee (the “JX Committee”) of the Jiaxing Economic & Technological Development Zone (the “JXEDZ”) pursuant to which, among other things, BYND JX agreed to make certain investments in the JXEDZ in two phases of development, and the Company agreed to guarantee certain repayment obligations of BYND JX under such agreement. During Phase 1, the Company agreed to invest $10.0 million as the registered capital of BYND JX in the JXEDZ through intercompany investment in BYND JX. and BYND JX agreed to lease a facility in the JXEDZ for a minimum of  two years. In connection with such agreement, BYND JX entered into a factory leasing contract with a JXEDZ company, pursuant to which BYND JX agreed to lease and renovate a facility in the JXEDZ and lease it for a minimum of  two years. In 2022, the lease was amended to extend the term for an additional five years without rent escalation. On February 24, 2025, as part of the Company’s global operations review initiated in 2023 (the “Global Operations Review”), the Company’s board of directors approved a plan to suspend the Company’s operational activities in China, which ceased as of the end of 2025. As of June 27, 2026, the Company continued to use this facility in its process of winding down the operational activities in China and has notified the landlord of its intention to terminate the lease at the end of August 2026. In the fourth quarter of 2021, BYND JX leased an approximately 12,000 square foot facility in Shanghai, China, for a period of eight years, which was used as a local research and development facility. In connection with the cessation of operational activities in China, BYND JX and the landlord agreed to terminate the lease early effective as of May 20, 2025. As of June 27, 2026, the Company had invested $22.5 million as the registered capital of BYND JX that included $0.5 million to fund the cessation of its operational activities in China, and advanced $20.0 million to BYND JX. During the six months ended June 27, 2026, the Company determined that the cessation of the Company’s operational activities in China was substantially complete. As a result, the Company reclassified approximately $0.9 million of cumulative foreign currency translation losses related to BYND JX from Accumulated other comprehensive loss to Other (expense) income, net in the Company’s unaudited condensed consolidated statement of operations. The Planet Partnership In 2021, the Company entered into the Planet Partnership, LLC (“TPP”), a joint venture with PepsiCo, Inc., to develop, produce and market innovative snack and beverage products made from plant-based protein. In the three months ended June 27, 2026 and June 28, 2025, the Company recognized its share of the net losses in TPP in the amount of $16,000 and $59,000, respectively. In the six months ended June 27, 2026 and June 28, 2025, the Company recognized its share of the net losses in TPP in the amount of $32,000 and $70,000, respectively. As of June 27, 2026 and December 31, 2025, the Company had contributed its share of the investment in TPP in the amount of $27.6 million. See Note 1 5. Purchase Commitments On March 28, 2026, the Company and Roquette entered into a Sales Agreement (the “Sales Agreement”) pursuant to which Roquette will provide the Company with pea protein. The Sales Agreement expires on December 31, 2027, subject to extension or early termination under certain circumstances. The Sales Agreement provides for pea protein to be supplied by Roquette in each of 2026 and 2027, on a purchase order basis per specified minimum annual base quantities, subject to periodic adjustment based on the Company’s binding forecasted requirements throughout the term. The Company is not required to purchase and Roquette is not required to deliver pea protein in amounts in excess of such specified minimum annual quantities. The total annual amount purchased each year by the Company must be at least the minimum amount specified in the Sales Agreement, which totals in the aggregate approximately $23.5 million (subject to annual inflationary and exchange rate adjustments) over the term of the Sales Agreement. If the Company does not purchase the applicable minimum annual quantities, it will be required to pay Roquette liquidated damages calculated as a percentage of the amount the Company would have been required to pay for the unpurchased volumes in the relevant year, subject to roll over of a portion of unpurchased volumes from year to year. The Sales Agreement requires the Company to procure a $1.0 million standby letter of credit to secure its payment obligations thereunder and also provides for the Company and Roquette to indemnify one another in certain circumstances. The Company procured a $1.0 million standby letter of credit to secure its payment obligations under the Sales Agreement which is included in Restricted cash, non-current as of June 27, 2026. As of June 27, 2026, pursuant to the Sales Agreement, the Company committed to purchase pea protein inventory totaling $18.6 million as of June 27, 2026, of which $6.9 million is expected to be purchased in 2026 and $11.7 million in 2027. Litigation In connection with the matters described below, the Company has accrued for loss contingencies where it believes that losses are probable and estimable. No loss contingency is recorded for matters where such losses are either not probable or reasonably estimable (or both). Although it is reasonably possible that actual losses could be in excess of the Company’s accrual, the Company is unable to estimate a reasonably possible loss or range of loss in excess of its accrual, due to various reasons, including, among others, that: (i) the proceedings are in early stages or no claims have been asserted, (ii) specific damages have not been sought in all of these matters, (iii) damages, if asserted, are considered unsupported and/or exaggerated, (iv) there is uncertainty as to the outcome of pending appeals, motions or settlements, (v) there are significant factual issues to be resolved, and/or (vi) there are novel legal issues or unsettled legal theories presented. It is not possible to predict the ultimate outcome of all pending legal proceedings, and some of the matters discussed below seek or may seek potentially large and/or indeterminate amounts. Any such loss or excess loss could have a material effect on the Company’s results of operations or cash flows or on the Company’s financial condition. In addition to the matters described below, the Company is involved in various other legal proceedings, claims and litigation arising in the ordinary course of business. Based on the facts currently available, the Company does not believe that the disposition of such other matters that are pending or asserted will have a material effect on its financial statements. Aliments BVeggie, Inc. In November 2023, Aliments BVeggie, Inc. (“BVeggie”) filed and served legal proceedings against the Company before the Superior Court of Quebec’s District of Montreal. BVeggie alleges, among other things that: (i) in 2019, the Company and BVeggie entered into a co-manufacturing agreement, by which BVeggie would produce and deliver products for the benefit of the Company, in exchange for a tolling fee to be paid per pound of product produced and delivered to the Company; (ii) the Company would have made false and misleading statements regarding the volume of purchase orders it would provide BVeggie; (iii) BVeggie invested significant sums to adapt its facilities for the intended production; (iv) the Company fell short of its undertakings and promises; and (v) in March 2023, the Company illegally terminated the business relationship. BVeggie intends to claim damages in the total amount of 129,841,920 CAD, in compensation for its investments, lost profits and the repairs needed to be made to its facility post-termination of the business relationship and removal of the Company’s equipment. The Company intends to vigorously defend against these claims. On December 7, 2023, the Company filed a motion for declinatory exception to stay the proceedings pending before the Superior Court of Quebec, District of Montreal, and refer the dispute to arbitration in California. A hearing on the motion for declinatory exception occurred on April 25, 2024. By judgment dated May 9, 2024, the Superior Court of Quebec granted the motion for declinatory exception filed by the Company and declared that the courts sitting in Los Angeles County, in the State of California, are in a better position to decide the dispute. BVeggie appealed the court’s decision on June 7, 2024, and the Company filed a cross-appeal on June 18, 2024. The appeals were heard on October 30, 2025 and by judgment rendered on November 21, 2025, the Court of Appeal has decided to grant the Company’s motion for declinatory exception and to defer the dispute to arbitration in California. BVeggie had 60 days from the day of the judgment to file a motion for leave to appeal before the Supreme Court of Canada. Said delay has now elapsed and the judgment of the Court of Appeal is now final. In June 2024 and in parallel to the litigation mentioned above, BVeggie filed and served legal proceedings against the Company before the Superior Court of Quebec’s District of Montreal, asking that an agreement between the parties by which BVeggie was to purchase certain machinery from the Company, in the amount of $5.1 million, be voided. This litigation was suspended pending the outcome of the aforementioned appeals. As a consequence of the judgment rendered by the Court of Appeal, all of the aforementioned actions filed by BVeggie against the Company in Quebec are suspended indefinitely, until the JAMS arbitration tribunal has clarified its jurisdiction, via a final judgment. Consumer Class Actions Regarding Protein Claims From May 31, 2022 through January 13, 2023, multiple putative class action lawsuits were filed against the Company in various federal and state courts alleging that the labeling and marketing of certain of the Company’s products is false and/or misleading under federal and/or various states’ laws. Specifically, each of these lawsuits allege one or more of the following theories of liability: (i) that the labels and related marketing of the challenged products misstate the quantitative amount of protein that is provided by each serving of the product; (ii) that the labels and related marketing of the challenged products misstate the percent daily value of protein that is provided by each serving of the product; and (iii) that the Company has represented that the challenged products are “all-natural,” “organic,” or contain no “synthetic” ingredients when they in fact contain methylcellulose, an allegedly synthetic ingredient. The named plaintiffs of each complaint seek to represent classes of nationwide and/or state-specific consumers, and seek on behalf of the putative classes damages, restitution, and injunctive relief, among other relief. Additional complaints asserting these theories of liability are possible. Some lawsuits previously filed were voluntarily withdrawn or dismissed without prejudice, though they may be refiled. On November 14, 2022, the Company filed a motion with the Judicial Panel on Multidistrict Litigation to transfer and consolidate all pending class actions. No party opposed the motion, and the Panel held oral argument on the motion on January 26, 2023. The Panel granted the motion on February 1, 2023, consolidating the pending class action lawsuits and transferring them to Judge Sara Ellis in the Northern District of Illinois for pre-trial proceedings, In re: Beyond Meat, Inc. Protein Content Marketing and Sales Practices Litigation, No. 1:23-cv-00669 (N.D. Ill.) (the “MDL”). On March 3, 2023, the MDL court held the initial status conference. The MDL court granted plaintiffs’ motion to appoint interim class counsel. On May 3, 2023, plaintiffs filed an amended consolidated complaint. The Company’s motion to dismiss was filed on June 5, 2023, and plaintiffs filed a brief in opposition on July 5, 2023. The Company’s reply in support of the motion to dismiss was filed on July 21, 2023. On February 22, 2024, the MDL court issued an order granting in part and denying in part the Company’s motion to dismiss. On March 5, 2024, the parties filed a joint status report noting they had agreed to engage in mediation. On April 24, 2024, the parties engaged in mediation before the Honorable Wayne R. Andersen (Ret.) but did not reach agreement. Negotiations continued and the parties entered into a confidential binding settlement term sheet on May 6, 2024. On July 8, 2024, the parties entered into a class action settlement agreement, pursuant to which the Company agreed to contribute $7.5 million to a settlement fund in full satisfaction of all settlement costs and attorneys’ fees. On August 5, 2024, the parties filed a motion for preliminary approval of the settlement agreement. The MDL court granted the motion for preliminary approval on August 14, 2024. On January 23, 2025, upon reviewing submissions from the court-appointed settlement administrator and the plaintiffs acting on behalf of the class, and after holding a final settlement hearing, the court issued a minute order approving the class action settlement and indicating a final approval order will be entered. On March 24, 2025, the court issued the final approval order. Final approval resolves the claims of all persons (individuals and/or entities) who purchased any Beyond Meat product (as defined in the settlement agreement) for household use and not for resale or distribution, from May 31, 2018 to August 14, 2024. The Company paid $250,000 to the settlement fund in August 2024. The final effective date of the settlement agreement was April 24, 2025. The Company recorded $7.5 million in SG&A expenses in its condensed consolidated statement of operations and paid $250,000 in the year ended December 31, 2024, and included $7.25 million in Accrued litigation settlement costs in the Company’s condensed consolidated balance sheets as of March 29, 2025 and December 31, 2024. The Company’s final payment of $7.25 million was paid into escrow by May 14, 2025. The court appointed settlement administrator is in the process of finalizing distributions to the class. The active lawsuits, each of which was consolidated and transferred to the MDL and is subject to the class action settlement agreement, are: •Roberts v. Beyond Meat, Inc., No. 1:22-cv-02861 (N.D. Ill.) (filed May 31, 2022) •Cascio v. Beyond Meat, Inc., No. 1:22-cv-04018 (E.D.N.Y.) (filed July 8, 2022) •Miller v. Beyond Meat, Inc., No. 1:22-cv-06336 (S.D.N.Y.) (filed July 26, 2022) •Garcia v. Beyond Meat, Inc., No. 4:22-cv-00297 (S.D. Iowa) (filed September 9, 2022) •Borovoy v. Beyond Meat, Inc., No. 1:22-cv-06302 (N.D. Ill.) (filed September 30, 2022 in DuPage Co., Ill.; removed on Nov. 10, 2022) •Zakinov v Beyond Meat, Inc., No. 4:23-cv-00144 (S.D. Tex.) (filed January 13, 2023) Arbitration with Former Co-Manufacturer In March 2024, a former co-manufacturer (“Manufacturer”) brought an action against the Company in a confidential arbitration proceeding. The Company had entered into an agreement with the Manufacturer, under which the Manufacturer was responsible for producing products on behalf of the Company. The Company terminated the agreement in November 2023 due to the Manufacturer’s failure to produce food in compliance with applicable laws, as required by the agreement. The Manufacturer alleged that the Company terminated the agreement without a contractual basis to do so and that it was owed past and future payments under the agreement. The Manufacturer claimed total damages of at least approximately $73.0 million. In October 2024, the Company filed amended counterclaims against the Manufacturer for breach of contract, breach of the duty of good faith and fair dealing, fraudulent inducement, false promise, concealment, and intentional misrepresentation, and negligent misrepresentation. On September 15, 2025, the arbitrator issued an interim award (the “Interim Award”) and found that the Company had a valid basis to terminate the agreement with the Manufacturer. On September 25, 2025, the Manufacturer filed a request with the arbitrator to re-open the arbitration hearing. On September 29, 2025, the Company opposed this request. On October 20, 2025, the arbitrator denied the Manufacturer’s request. Shortly thereafter, the parties engaged in fees briefing. On December 10, 2025, the arbitrator issued the final award, and on December 18, 2025, the arbitrator corrected scrivener’s and other typographical errors in the final award (the “Final Award”). Certain details of the Interim Award and Final Award are confidential. The Final Award is similar to the Interim Award, but the Interim Award does not address attorneys’ fees, costs and interests. In the Final Award, the arbitrator awarded the Company: (i) $349,493 for its breach of contract claim in out of pocket costs, (ii) $7,183,782 for its negligent misrepresentation claim, which is inclusive of the $349,493 in contract damages awarded for the Company’s breach of contract claim, (iii) $6,246,693 for its attorneys’ fees; and (iv) $550,640 for its costs. In total, the arbitrator awarded the Company $13,981,115 (the “Total Award”). On January 30, 2026, the Company filed a petition to confirm the Final Award and enter judgment in the Superior Court of the State of California for the County of Los Angeles. On February 13, 2026, the Manufacturer filed an ex parte application to extend its deadline to oppose the Company’s petition and set a briefing schedule on its forthcoming petition to vacate the Final Award. The Company opposed the ex parte application. On February 17, 2026, the court granted the Manufacturer’s ex parte application and scheduled the hearing on both the Company’s petition to confirm the Final Award and enter judgment and the Manufacturer’s forthcoming petition to vacate for May 1, 2026. On March 13, 2026, the Manufacturer opposed the Company’s petition and filed a petition to vacate the Final Award. The Company’s reply in support of its petition and opposition to the Manufacturer’s petition to vacate was due on April 3, 2026. Because the parties were negotiating and finalizing a settlement agreement, they requested all deadlines be extended by two months. On April 24, 2026, the parties reached a full and final settlement in the amount of $11.0 million which was due and payable to the Company within 60 days. In June 2026, the Company received $4.0 million of the settlement amount. The remaining $7.1 million, which includes approximately $0.1 million of interest, was received by the Company on July 10, 2026. The Company recognized $11.0 million as a reduction of SG&A expenses in its unaudited condensed consolidated statements of operations for the three and six months ended June 27, 2026, and recorded $7.1 million in Prepaid expenses and other current assets, on its unaudited condensed consolidated balance sheet as of June 27, 2026. Trademark Infringement Litigation On April 28, 2022, a trademark infringement complaint for injunctive and other relief was filed against Beyond Meat in the United States District Court for the Middle District of Florida, Orlando Division, captioned Sonate Corporation, d/b/a Vegadelphia Foods (“Sonate”) v. Dunkin’ Brands Group, Inc., Dunkin’ Brands, Inc. (collectively, “Dunkin’”) and Beyond Meat, Inc., et al., Case No. 6:22-cv-00812. A First Amended Complaint was filed on May 17, 2022 (the “FAC”). The FAC alleged that the Company and Dunkin’s use of the tagline “Great Taste Plant-Based,” infringed on Sonate’s registered trademark WHERE GREAT TASTE IS PLANT-BASED® (“Sonate’s trademark”). Additionally, Sonate alleged that the Company’s use of the tagline “Plant-Based Great Taste” in connection with its own sales of products also infringed on Sonate’s trademark. The FAC sought injunctive relief and a monetary award for corrective advertising, a reasonable royalty award, damages representing Sonate’s lost sales and the Company’s profits generated by the alleged likelihood of confusion, interest, costs, expenses and attorneys’ fees. On June 24, 2022, both the Company and Dunkin’ filed their answers to the FAC and a motion to change venue. On March 24, 2023, the court issued an order granting Dunkin’ and the Company’s motion to transfer venue and directed the clerk of the court to transfer the case to the District of Massachusetts, Boston Division for all further proceedings (Case No. 1:23-cv-10690-IT). The Company contended that Sonate would not be able to meet its burden of establishing a likelihood of confusion. Additionally, the Company asserted the fair use defense to Sonate’s allegations, namely that the Company’s use of “Plant-Based Great Taste” and “Great Taste Plant-Based” satisfy the requirements of the fair use doctrine (e.g., they are only used descriptively), precluding liability. Mediation was held on September 18, 2024, at which time Dunkin’ settled its involvement in the case. On November 20, 2024, Dunkin’ was dismissed from the case with prejudice, and the case continued as to the Company. On or about March 11, 2025, the Company filed a motion for summary judgment or adjudication and motions to strike some of Sonate’s expert reports and testimony. On or about March 9, 2024, Sonate filed a motion for summary judgment or adjudication and on or about March 11, 2024 filed motions to strike some of the Company’s expert reports and testimony. On October 29, 2025, the Court denied Sonate’s motion for summary judgment as to issues impacting liability and granted it with respect to a portion of damages relating to the sales made through Dunkin’ stores. The Company’s motion for summary judgment as to liability for either tagline was denied. As to damages, the Company’s motion for summary judgment was granted as to corrective advertising and reasonable royalty damages and denied in part as to lost profits from lost value. The Company’s motion to strike was granted as to Sonate’s expert report and testimony as to corrective advertising damages, reasonable royalty damages and lost value. A jury trial commenced on November 10, 2025 and concluded on November 24, 2025. The Company’s primary general liability insurer has been providing the Company’s defense under its primary policy, subject to a reservation of rights. On November 24, 2025, the jury returned its verdict finding that the Company was liable for trademark infringement and that the fair use defense did not apply. The jury awarded damages as follows: $23.5 million in actual damages and $15.4 million in disgorgement of the Company’s profits. The Company has filed two post-trial requests seeking to reduce or eliminate the amount awarded by the jury. Sonate has filed motions seeking prejudgment interest, an increase in the disgorgement award, and the prompt entry of a judgment. The parties have filed oppositions to the respective motions and await the Court’s decision on the post-verdict issues. Pursuant to ASC 450, the Company recorded a $38.9 million litigation-related accrual in operating expenses in its unaudited condensed consolidated statements of operations during the year ended December 31, 2025, which is subject to adjustment pending the Court’s final decision and pending any further appeal by the Company. Aljendan v. Beyond Meat, Inc. et al. On January 23, 2026, a class action complaint was filed against the Company and certain current officers in the United States District Court for the Central District of California, captioned Aljendan v. Beyond Meat, Inc., et al., Case No. 2:26-cv-00742 (the “Aljendan Action”). The complaint alleges, among other things, that the Company and the individual defendants made false and misleading statements or omissions regarding the book and market value of certain long-lived assets and the likelihood that the Company would have to record a material, non-cash impairment charge. The complaint seeks an order certifying the class; awarding compensatory damages, interest, costs, attorneys’ and expert fees; and granting other unspecified relief. The complaint alleges causes of action under Sections 10(b) and 20(a) of the Exchange Act, on behalf of a putative class of investors who purchased the Company’s common stock between February 27, 2025 and November 11, 2025, inclusive. On April 6, 2026, the Court appointed Brandon Mitchell Waldaias, Aaron Saran and Brandon Barclay as Co-Lead Plaintiffs and Pomerantz LLP and Wolf Haldenstein Adler Freeman & Herz LLP as Co-Lead Counsel. On June 1, 2026, the Co-Lead Plaintiffs filed an amended complaint. The amended complaint similarly alleges causes of action under Section 10(b) and 20(a) of the Exchange Act, on behalf of a putative class of investors who purchased the Company’s common stock between February 27, 2025 and March 31, 2026, inclusive. The amended complaint alleges, among other things, that the Company and the individual defendants made false and misleading statements or omissions concerning the value of the Company’s long-lived assets, inventory, and expenses associated with a note exchange transaction, as well as the adequacy of the Company’s internal control over financial reporting. On July 15, 2026, Defendants filed a motion to dismiss. The Co-Lead Plaintiffs’ opposition to the motion to dismiss is due on August 28, 2026. The Company intends to vigorously defend against these claims. Consolidated Derivative Action Following the Aljendan Action, on February 12, 2026, a derivative stockholder action was filed by a purported stockholder against certain current officers and current and former directors of the Company in the United States District Court for the Central District of California, captioned Azima v. Brown, et al., Case No. 2:26-cv-01525 (the “Azima Action”). The Azima Action alleges substantially similar facts as those alleged in the Aljendan Action. The complaint asserts claims for breach of fiduciary duty, unjust enrichment, abuse of control, gross mismanagement and waste of corporate assets. It also asserts claims under Section 14(a) of the Exchange Act against a subset of defendants and seeks contribution under Sections 10(b) and 21D of the Exchange Act from the individual defendants named in the Aljendan Action. The Company is named as a nominal defendant only. On April 13, 2026, the parties to the Azima Action filed a stipulation to stay the case through the resolution of the Aljendan Action. On June 1, 2026, the court granted the stipulation to stay the Azima Action. On May 15, 2026, another derivative action was filed by a purported stockholder against certain current officers and current and former directors of the Company in the United States District Court for the Central District of California, captioned Davis v. Brown, et al., Case No. 2:26-cv-05180 (the “Davis Action”). The Davis Action alleges substantially similar facts as those alleged in the Aljendan Action and the Azima Action. The complaint asserts claims under Sections 14(a) and 20(a) of the Exchange Act, breach of fiduciary duty, and unjust enrichment. The Company is named as a nominal defendant only. On May 27, 2026, the Davis Action was transferred to the same court as the Azima Action. On June 2, 2026, the plaintiff in the Azima Action, the plaintiff in the Davis Action, and the defendants in both actions filed a stipulation to consolidate the Azima Action and the Davis Action and appoint co-lead counsel. On June 10, 2026, the court granted the stipulation and consolidated the cases into one action captioned In re Beyond Meat, Inc. Stockholder Derivative Litigation, Case No. 2:26-cv-01525 (the “Consolidated Derivative Action”). The terms of the stipulated stay in the Azima Action apply to the Consolidated Derivative Action. On June 4, 2026, a third derivative action was filed by two purported stockholders against certain current officers and current and former directors of the Company in the United States District Court for the Central District of California, captioned Perrow v. Brown, et al., Case No. 2:26-cv-6086 (the “Perrow Action”). The Perrow Action alleges substantially similar facts as those alleged in the Aljendan Action, the Azima Acton, and the Davis Action. The complaint asserts claims under Section 20(a) of the Exchange Act, breach of fiduciary duty, abuse of control, unjust enrichment, gross mismanagement, and waste of corporate assets. It also asserts claims under Section 14(a) of the Exchange Act against a subset of defendants and seeks contribution under Sections 10(b) and 21D of the Exchange Act from the individual defendants named in the Aljendan Action. The Company is named as a nominal defendant only. On July 2, 2026, the plaintiffs in the Consolidated Derivative Action filed a notice of related case regarding the Perrow Action, which stated that the plaintiffs in the Perrow Action do not object to the consolidation of the Perrow Action into the Consolidated Derivative Action. The Consolidated Derivative Action and the Perrow Action are at a preliminary stage. The Company intends to vigorously defend against these claims.

Subsequent Events (Details)		1 Months Ended	3 Months Ended		6 Months Ended
Subsequent Events (Details)	Jul. 23, 2026 USD ($)	Jul. 31, 2026 USD ($) ft² installment	Jun. 27, 2026 USD ($)	Jun. 28, 2025 USD ($)	Jun. 27, 2026 USD ($)	Jun. 28, 2025 USD ($)	Aug. 01, 2027	Jul. 31, 2027	Jun. 29, 2026 EUR (€)	Mar. 28, 2026 USD ($)	Oct. 07, 2025 ft²	Jul. 23, 2025 ft²
Subsequent Event [Line Items]
Future minimum lease payments \| $			$ 5,568,000		$ 5,568,000
Operating lease cost: \| $			685,000	$ 1,897,000	1,437,000	$ 6,448,000
Standby letter of credit \| $										$ 1,000,000.0
Consulting fees \| $			$ 150,000		$ 150,000
Subsequent Event
Subsequent Event [Line Items]
Annual base salary \| €									€ 325,000
Base salary and customary benefits and allowances (as a percent)									60.00%
HC Hornet Way, LLC \| Subsequent Event
Subsequent Event [Line Items]
Current leases rentable area		220,519
Number of square feet surrendered in lease agreement		101,612
Rentable area		118,907
Future minimum lease payments \| $		$ 14,000,000.0
Number of installments \| installment		48
Monthly installments rent paid \| $		$ 291,667
Operating lease cost: \| $		2,800,000
Standby letter of credit \| $		$ 12,500,000
HC Hornet Way, LLC \| Subsequent Event \| Forecast
Subsequent Event [Line Items]
Proportionate share percentage of expenses and charges							30.44%	56.45%
Varda Space Industries, Inc.
Subsequent Event [Line Items]
Net rentable area												54,749
Area available for sublease											55,109
Varda Space Industries, Inc. \| Subleased Premises, Improved Space
Subsequent Event [Line Items]
Net rentable area												16,967
Varda Space Industries, Inc. \| Subleased Premises, Unimproved Space
Subsequent Event [Line Items]
Net rentable area												37,782
Varda Space Industries, Inc. \| Subsequent Event
Subsequent Event [Line Items]
Rentable area		54,749
Increase space in rentable area		55,109
Net rentable area		55,109
Increase in net rentable area		360
Rent abatement escalated percentage		3.00%
Subtenant's proportionate share of operating expenses and other charges		46.35%
Varda Space Industries, Inc. \| Subsequent Event \| Subleased Premises, Improved Space
Subsequent Event [Line Items]
Monthly installments rent paid \| $	$ 52,026

Fair Value of Financial Instruments - Schedule of Activity 2030 Notes Embedded Derivative Liability (Details) - Derivative Financial Instruments, Liabilities - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 27, 2026	Jun. 27, 2026
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 26,137	$ 39,152
Pro rata reduction of liability due to partial conversions	(15,379)	(16,503)
Change in fair value from remeasurement	3,838	(8,053)
Ending balance	$ 14,596	$ 14,596

Segment Information

6 Months Ended

Jun. 27, 2026

Segment Reporting [Abstract]

Segment Information

The Company operates in one segment in the plant-based meat industry, offering a portfolio of revolutionary plant-based meats. The Company’s Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company, has been identified as the Chief Operating Decision Maker.

The following table presents the details of the significant segment expenses, segment net revenues, and the segment performance measure, net income (loss), in the periods indicated (in thousands):


	Three Months Ended				Six Months Ended
	June 27, 2026		June 28, 2025		June 27, 2026		June 28, 2025
Net revenues	$	68,832	$	74,958	$	127,038	$	143,689
Less:
Cost of goods sold	62,959		67,038		119,180		142,694
Research and development expenses	4,189		5,807		9,409		13,269
Selling expenses	6,790		6,741		13,117		13,712
Marketing expenses	9,426		8,061		15,054		20,150
General and administrative expenses	16,273		24,826		42,188		55,748
Interest expense	6,571		2,002		13,303		3,026
Remeasurement of delayed draw term loan warrant liability	76		—		(1,224)		—
Remeasurement of derivative liability	3,838		—		(8,053)		—
Gain on debt extinguishment	(57,729)		—		(63,789)		—
Equity in losses of unconsolidated joint venture	16		59		32		70
Other segment items, net(1)	19		(7,731)		(101)		(12,049)
Net income (loss)	$	16,404	$	(31,845)	$	(12,078)	$	(92,931)

___________

(1) Includes Other, net and Income tax (benefit) expense as reported in the Company’s unaudited condensed consolidated statements of operations. Other, net includes $1.5 million and $0.5 million in interest income in the three months ended June 27, 2026 and June 28, 2025, respectively, and $3.0 million and $1.4 million in interest income in the six months ended June 27, 2026 and June 28, 2025, respectively. Other, net also includes $(1.8) million and $7.5 million in foreign currency transaction (losses) gains in the three months ended June 27, 2026 and June 28, 2025, respectively, and $(3.1) million and $11.0 million in foreign currency transaction (losses) gains in the three months ended June 27, 2026 and June 28, 2025, respectively. See the accompanying unaudited condensed consolidated financial statements for the other financial information regarding the Company’s operating segment.

See the accompanying unaudited condensed consolidated financial statements for other financial information regarding the Company's operating segment.

- Definition

The entire disclosure for segment reporting.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 34
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-34

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-15

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 15: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 17: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 18: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 19: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 20: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 21: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 22: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/280/tableOfContent

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26

+ Details

Summary of Significant Accounting Policies - Schedule of Condensed Consolidated Statement of Cash Flows (unaudited) and Prior Period Adjustments (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 27, 2026	Mar. 28, 2026	Jun. 28, 2025	Mar. 29, 2025	Jun. 27, 2026	Jun. 28, 2025
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)	$ 16,404	$ (28,482)	$ (31,845)	$ (61,087)	$ (12,078)	$ (92,931)
Inventories					20,580	11,240
Prepaid expenses and other current assets					(8,540)	(2,850)
Net cash used in operating activities					(23,156)	(57,974)
Debt issuance costs					0	(6,498)
Net cash (used in) provided by financing activities					$ (6,613)	32,259
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)			(29,242)			(82,158)
Inventories						4,709
Prepaid expenses and other current assets						(8,473)
Net cash used in operating activities						(59,355)
Debt issuance costs						(5,117)
Net cash (used in) provided by financing activities						33,640
Inventory Valuation
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)			(671)			(6,531)
Inventories						6,531
Prepaid expenses and other current assets						0
Net cash used in operating activities						0
Debt issuance costs						0
Net cash (used in) provided by financing activities						0
Debt Issuance Costs
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income (loss)			$ (1,932)			(4,242)
Inventories						0
Prepaid expenses and other current assets						5,623
Net cash used in operating activities						1,381
Debt issuance costs						(1,381)
Net cash (used in) provided by financing activities						$ (1,381)

Cash and Cash Equivalents and Restricted Cash - Narrative (Details) $ in Millions	Jun. 27, 2026 USD ($)
Restricted Cash and Cash Equivalent Item [Line Items]
Restricted cash	$ 14.8
HC Hornet Way, LLC
Restricted Cash and Cash Equivalent Item [Line Items]
Cash collateral for borrowed securities	12.6
Third Party Manufacturer In Europe
Restricted Cash and Cash Equivalent Item [Line Items]
Cash collateral for borrowed securities	1.2
Roquette
Restricted Cash and Cash Equivalent Item [Line Items]
Cash collateral for borrowed securities	$ 1.0

- Definition

Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.

+ References + Details

Income Taxes	6 Months Ended
Income Taxes	Jun. 27, 2026
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes In each of the three and six months ended June 27, 2026 and June 28, 2025, the Company recorded no income tax expense in its unaudited condensed consolidated statements of operations. The Company has evaluated the available evidence supporting the realization of its deferred tax assets, including the amount and timing of future taxable income, and has determined that it is more likely than not that its net deferred tax assets will not be realized. Due to uncertainties surrounding the realization of the deferred tax assets, the Company maintains a full valuation allowance against substantially all deferred tax assets. If the Company determines that it will be able to realize some portion or all of its deferred tax assets, an adjustment to its valuation allowance on its deferred tax assets will be made and the adjustment would have the effect of increasing net income in the period such determination is made. As of June 27, 2026, the Company did not have any accrued interest or penalties related to uncertain tax positions. The Company’s policy is to recognize interest and penalties related to uncertain tax positions in income tax expense. The Company is subject to U.S. federal tax authority and U.S. state tax authority examinations for all years with respect to net operating loss and credit carryforwards.

- Definition

The entire disclosure for income tax.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 740
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477617/942-740-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 740
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478822/944-740-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 231
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482663/740-10-55-231

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 270
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477891/740-270-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.5.Q1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-13

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/740/tableOfContent

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-14

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-21

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 17
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-17

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482603/740-30-50-2

+ Details

Leases (Tables)

6 Months Ended

Jun. 27, 2026

Leases [Abstract]

Schedule of Sublease Income

The following table presents the Company’s sublease income (in thousands):


	Three Months Ended				Six Months Ended
	June 27, 2026		June 28, 2025		June 27, 2026		June 28, 2025

Sublease income	$	311	$	—	$	608	$	—

Schedule of Components of Lease

Lease costs for operating and finance leases were as follows (in thousands):


		Three Months Ended
	Statement of Operations Location	June 27, 2026		June 28, 2025
Operating lease cost:
Lease cost	Cost of goods sold	$	455	$	419
Lease cost	Research and development expenses	—		485
Lease cost	SG&A expenses	105		557
Variable lease cost(1)	Cost of goods sold	125		66

Variable lease cost(1)	SG&A expenses	—		370
Operating lease cost		685		1,897
Short- term lease cost:
Short-term lease cost	Cost of goods sold	60		118
Short-term lease cost	Research and development expenses	10		15
Short-term lease cost	SG&A expenses	40		109
Short-term lease cost		110		242
Finance lease cost:
Amortization of right-of use assets	Cost of goods sold	142		272
Amortization of right-of use assets	Research and development expenses	1,586		1,561
Amortization of right-of use assets	SG&A expenses	630		—
Interest on lease liabilities	Interest expense	1,656		1,016
Variable lease cost(1)	Cost of goods sold	3		16
Variable lease cost(1)	Research and development expenses	1		1
Variable lease cost(1)	SG&A expenses	2,543		585
Finance lease cost		6,561		3,451
Total lease cost		$	7,356	$	5,590

____________

(1) Variable lease cost primarily consists of common area maintenance, such as cleaning and repairs.


		Six Months Ended
	Statement of Operations Location	June 27, 2026		June 28, 2025
Operating lease cost:
Lease cost	Cost of goods sold	$	912	$	826
Lease cost	Research and development expenses	—		2,872
Lease cost	SG&A expenses	206		1,180
Variable lease cost(1)	Cost of goods sold	319		102

Variable lease cost(1)	SG&A expenses	—		1,468
Operating lease cost		1,437		6,448
Short- term lease cost:
Short-term lease cost	Cost of goods sold	120		195
Short-term lease cost	Research and development expenses	14		29
Short-term lease cost	SG&A expenses	103		245
Short-term lease cost		237		469
Finance lease cost:
Amortization of right-of use assets	Cost of goods sold	319		526
Amortization of right-of use assets	Research and development expenses	3,349		1,564
Amortization of right-of use assets	SG&A expenses	1,322		—
Interest on lease liabilities	Interest expense	3,336		1,056
Variable lease cost(1)	Cost of goods sold	4		28
Variable lease cost(1)	Research and development expenses	1		1
Variable lease cost(1)	SG&A expenses	3,160		585
Finance lease cost		11,491		3,760
Total lease cost		$	13,165	$	10,677

____________

(1) Variable lease cost primarily consists of common area maintenance, such as cleaning and repairs.

Weighted average remaining lease terms and weighted average discount rates were:


	June 27, 2026
	Operating Leases	Finance Leases
Weighted average remaining lease term (years)	3.4	12.2
Weighted average discount rate	4.7%	8.4%

Schedule of Future Maturities of Operating Lease Liabilities

The following is a schedule by year of the maturities of lease liabilities with original terms in excess of one year, as of June 27, 2026 (in thousands):


	June 27, 2026
	Operating Leases		Finance Leases
Remainder of 2026	$	1,204	$	5,475
2027	1,957		9,592
2028	946		9,173
2029	654		9,264
2030	513		9,519
Thereafter	294		86,046
Total undiscounted future minimum lease payments	5,568		129,069
Less imputed interest	(348)		(50,272)
Total discounted future minimum lease payments	$	5,220	$	78,797

Schedule of Future Maturities of Finance Lease Liabilities

The following is a schedule by year of the maturities of lease liabilities with original terms in excess of one year, as of June 27, 2026 (in thousands):


	June 27, 2026
	Operating Leases		Finance Leases
Remainder of 2026	$	1,204	$	5,475
2027	1,957		9,592
2028	946		9,173
2029	654		9,264
2030	513		9,519
Thereafter	294		86,046
Total undiscounted future minimum lease payments	5,568		129,069
Less imputed interest	(348)		(50,272)
Total discounted future minimum lease payments	$	5,220	$	78,797

Schedule of Supplemental Cash Flow Information

Supplemental cash flow information (in thousands):


	Three Months Ended				Six Months Ended
	June 27, 2026		June 28, 2025		June 27, 2026		June 28, 2025
Cash paid for amounts included in the measurement of operating lease liabilities	$	435	$	1,568	$	1,048	$	3,823
Cash paid for interest on finance lease liabilities	$	1,656	$	2,082	$	3,336	$	2,082

Fair Value of Financial Instruments

6 Months Ended

Jun. 27, 2026

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

There were no transfers of financial assets or liabilities into or out of Level 1, Level 2 or Level 3 in the three and six months ended June 27, 2026 and June 28, 2025.

Valuation of Delayed Draw Term Loan Warrant Liability

The Company remeasured the fair value of the total delayed draw term loan warrant liability as of June 27, 2026, marking it to market, and recognized an increase in fair value in the amount of $0.1 million for the three months ended June 27, 2026 in the Company’s unaudited condensed consolidated statements of operations in

Other income (expense), net. For the six months ended June 27, 2026, the Company recognized a $1.2 million reduction in fair value. The following were the assumptions used in the Black-Scholes option-pricing model to mark-to-market the fair value of the total delayed draw term loan warrant liability as of June 26, 2026, the last trading day of the period:


Risk-free interest rate			4.11%
Average expected term (years)			4.0
Expected volatility			113.10%
Dividend yield			—
Exercise price			$1.95

The following table sets forth a summary of the changes in the fair value of the total delayed draw term loan warrant liability for the periods indicated (in thousands):


	Three Months Ended				Six Months Ended
	June 27, 2026		June 28, 2025		June 27, 2026		June 28, 2025
Beginning balance	$	3,766	$	—	$	5,066	$	—
Fair value of delayed draw term loan warrants issued during the period	—		7,983		—		7,983
Fair value of contingently issued delayed draw term loan warrants	—		12,160		—		12,160
Remeasurement of delayed draw term loan warrants liability	76		—		(1,224)		—
Ending balance	$	3,842	$	20,143	$	3,842	$	20,143

Valuation of 2030 Notes Embedded Derivative

The Company determined that the conversion option embedded within the 2030 Notes required bifurcation as a derivative liability under ASC 815. The sensitivity of the fair value calculation to these methods, assumptions and estimates included could create materially different results under different conditions or using different assumptions. The mandatory conversion feature along with the make whole interest, the mandatory equitization feature along with the make whole interest and the holder’s optional conversion feature with the make whole interest require bifurcation and therefore, these embedded derivatives were bifurcated, along with the conversion option, from the debt host as a single, compound derivative liability.

The Company uses a binomial lattice valuation model in order to estimate the fair value of the 2030 Notes Embedded Derivative at inception, on each subsequent conversion date and period end dates. The fair value of the 2030 Notes Embedded Derivative at the issuance date was $26.9 million, recorded as a debt discount to the 2030 Notes and is being amortized to interest expense over the term of the debt. The debt discount carrying value is also reduced, on a pro rata basis, on each 2030 Notes conversion settlement date further discussed under the heading 2030 Notes Conversions and Gain on Debt Extinguishment (see Note 9). For the three and six months ended June 27, 2026, the Company recognized $1.0 million and $2.2 million, respectively, in interest expense related to the amortization of this discount, and a reduction of the carrying value of the debt discount of $8.0 million related to settled conversions to equity.

The following table sets forth a summary of activity of the 2030 Notes Embedded Derivative liability for the periods indicated. (in thousands):


	Three Month Ended		Six Months Ended
	June 27, 2026		June 27, 2026
Beginning balance, at fair value	$	26,137	$	39,152
Pro rata reduction of liability due to partial conversions	(15,379)		(16,503)
Change in fair value from remeasurement	3,838		(8,053)
Ending balance as of June 27, 2026, at fair value	$	14,596	$	14,596

There was no 2030 Notes Embedded Derivative liability outstanding for the three and six months ended June 28, 2025.

As of June 27, 2026 and December 31, 2025, the 2030 Notes Embedded Derivative liability was $14.6 million and $39.2 million, respectively, shown above. See Note 9.

Due to the use of a qualitative adjustment for estimating volatility, the binomial lattice valuation used is considered Level 3 in the valuation hierarchy.

The following table sets forth selected inputs to the binomial lattice valuation model used to value the 2030 Notes Embedded Derivative as of the respective dates indicated:


Inputs	June 27, 2026	December 31, 2025
Term (years)	4.3	4.8
Continuous risk free rate	4.07%	3.68%
Volatility	40.0%	40.0%
Stock price on valuation date	$0.66	$0.82
Discount rate (continuous)	24.51%	19.71%

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 107
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482078/820-10-55-107

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 100
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482078/820-10-55-100

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 940
-SubTopic 820
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478119/940-820-50-1

+ Details

Stockholders’ Equity (Deficit) - Schedule of Common Stock Reserved for Future Issuance (Details) - shares	6 Months Ended
	Jun. 27, 2026	Mar. 30, 2026	Dec. 31, 2025
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total common stock reserved for future issuance (in shares)	180,709,132		183,354,433
Convertible Senior Notes Due 2030
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total common stock reserved for future issuance (in shares)	86,660,407		120,000,000
Shares reserved for potential issuance under the Delayed Draw Term Loan Warrants
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total common stock reserved for future issuance (in shares)	9,558,635		9,558,635
Shares reserved for potential issuance under the BG Warrant—Tranche 1
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total common stock reserved for future issuance (in shares)	2,500,000		0
Shares reserved for potential issuance under the BG Warrant—Tranche 2
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total common stock reserved for future issuance (in shares)	1,666,667		0
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	200.00%
Performance Shares, Reserved For Issuance Under MIP PSUs Including Anti-Dilution Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total common stock reserved for future issuance (in shares)	10,154,868
Performance Shares, Reserved For Issuance Under MIP PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total common stock reserved for future issuance (in shares)	9,198,298
Performance Shares, Reserved For Issuance Pursuant To Anti-Dilution Increases
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total common stock reserved for future issuance (in shares)	956,570		126
Performance Shares, Reserved For Issuance Under Unvested PSUs Outstanding If Performance Target Achieved
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total common stock reserved for future issuance (in shares)	70,946		145,660
Equity incentive compensation awards granted and outstanding
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total common stock reserved for future issuance (in shares)	56,308,520		39,464,342
Shares available for issuance under the 2018 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total common stock reserved for future issuance (in shares)	10,024,113		10,310,481
Vesting percentage	150.00%
Shares available for issuance under the 2018 Equity Incentive Plan \| Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total common stock reserved for future issuance (in shares)	20,309,683
Vesting percentage	200.00%
Shares available for issuance under the 2018 Equity Incentive Plan \| Performance Shares, Reserved For Issuance Pursuant To Anti-Dilution Increases
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total common stock reserved for future issuance (in shares)	1,913,097
Shares available for issuance under the 2018 Equity Incentive Plan \| Performance Shares, Reserved For Issuance Under Unvested PSUs Outstanding If Performance Target Achieved
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total common stock reserved for future issuance (in shares)	70,946		145,660
Shares available for issuance under the 2026 Employment Inducement Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total common stock reserved for future issuance (in shares)	9,433,685	10,000,000	0
Shares available for issuance under the 2018 Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total common stock reserved for future issuance (in shares)	4,557,105		4,020,975

Leases - Narrative (Details)	Jun. 27, 2026	Dec. 31, 2021
Lessee, Lease, Description [Line Items]
Lease, initial term (in years)		8 years
Minimum
Lessee, Lease, Description [Line Items]
Lease, initial term (in years)	2 years
Maximum
Lessee, Lease, Description [Line Items]
Lease, initial term (in years)	16 years

Share-Based Compensation - Schedule of Shares Available for Grant (Details) - shares	6 Months Ended	12 Months Ended
	Jun. 27, 2026	Dec. 31, 2025	Mar. 30, 2026
Shares Available for Issuance
Total common stock reserved for future issuance (in shares)	180,709,132	183,354,433
Performance Shares
Shares Available for Issuance
Shares issuable (in shares)	70,946	145,660
Vesting percentage	200.00%
Performance Shares \| Maximum
Shares Available for Issuance
Vesting percentage	200.00%
Performance Shares, Reserved For Issuance Pursuant To Anti-Dilution Increases
Shares Available for Issuance
Total common stock reserved for future issuance (in shares)	956,570	126
Performance Shares, Reserved For Issuance Under Unvested PSUs Outstanding If Performance Target Achieved
Shares Available for Issuance
Total common stock reserved for future issuance (in shares)	70,946	145,660
2018 Plan
Shares Available for Issuance
Beginning balance (in shares)	10,310,481
Authorized (in shares)	7,176,019
Granted (in shares)	(11,106,936)
Shares withheld to cover taxes (in shares)	3,234,470
Forfeited (in shares)	976,394
Ending balance (in shares)	10,590,428	10,310,481
Vesting percentage	150.00%
Total common stock reserved for future issuance (in shares)	10,024,113	10,310,481
2018 Plan \| Performance Shares
Shares Available for Issuance
Vesting percentage	200.00%
Total common stock reserved for future issuance (in shares)	20,309,683
2018 Plan \| Performance Shares \| Share-Based Payment Arrangement, Tranche One
Shares Available for Issuance
Forfeited (in shares)	74,714
2018 Plan \| Performance Shares, Reserved For Issuance Pursuant To Anti-Dilution Increases
Shares Available for Issuance
Total common stock reserved for future issuance (in shares)	1,913,097
2018 Plan \| Performance Shares, Reserved For Issuance Under Unvested PSUs Outstanding If Performance Target Achieved
Shares Available for Issuance
Total common stock reserved for future issuance (in shares)	70,946	145,660
Shares available for issuance under the 2026 Employment Inducement Equity Incentive Plan
Shares Available for Issuance
Beginning balance (in shares)	0
Authorized (in shares)	10,000,000
Granted (in shares)	(566,315)
Forfeited (in shares)	0
Ending balance (in shares)	9,433,685	0
Total common stock reserved for future issuance (in shares)	9,433,685	0	10,000,000

Leases - Schedule of Components of Lease (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 27, 2026	Jun. 28, 2025	Jun. 27, 2026	Jun. 28, 2025
Lease Cost
Operating lease cost	$ 685	$ 1,897	$ 1,437	$ 6,448
Short-term lease cost	110	242	237	469
Interest on lease liabilities	1,656	1,016	3,336	1,056
Finance lease cost	6,561	3,451	11,491	3,760
Total lease cost	$ 7,356	5,590	$ 13,165	10,677
Operating Leases
Weighted average remaining lease term (years)	3 years 4 months 24 days		3 years 4 months 24 days
Weighted average discount rate	4.70%		4.70%
Finance Leases
Weighted average remaining lease term (years)	12 years 2 months 12 days		12 years 2 months 12 days
Weighted average discount rate	8.40%		8.40%
Location, Statement of Income, Balance [Axis]: us-gaap:CostOfGoodsAndServicesSold
Lease Cost
Lease cost	$ 455	419	$ 912	826
Variable lease cost	125	66	319	102
Short-term lease cost	60	118	120	195
Amortization of right-of use assets	142	272	319	526
Variable lease cost	3	16	4	28
Location, Statement of Income, Balance [Axis]: us-gaap:ResearchAndDevelopmentExpense
Lease Cost
Lease cost	0	485	0	2,872
Short-term lease cost	10	15	14	29
Amortization of right-of use assets	1,586	1,561	3,349	1,564
Variable lease cost	1	1	1	1
Location, Statement of Income, Balance [Axis]: us-gaap:SellingGeneralAndAdministrativeExpense
Lease Cost
Lease cost	105	557	206	1,180
Variable lease cost	0	370	0	1,468
Short-term lease cost	40	109	103	245
Amortization of right-of use assets	630	0	1,322	0
Variable lease cost	$ 2,543	$ 585	$ 3,160	$ 585

Leases - Schedule of Future Maturities of Operating Lease and Financial Lease Liabilities (Details) $ in Thousands	Jun. 27, 2026 USD ($)
Operating Leases
Remainder of 2026	$ 1,204
2027	1,957
2028	946
2029	654
2030	513
Thereafter	294
Total undiscounted future minimum lease payments	5,568
Less imputed interest	(348)
Total discounted future minimum lease payments	5,220
Finance Leases
Remainder of 2026	5,475
2027	9,592
2028	9,173
2029	9,264
2030	9,519
Thereafter	86,046
Total undiscounted future minimum lease payments	129,069
Less imputed interest	(50,272)
Total discounted future minimum lease payments	$ 78,797

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 27, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 171,369	$ 203,890
Restricted cash, current	5,516	4,350
Accounts receivable, net	25,725	26,060
Inventory	63,127	84,032
Prepaid expenses and other current assets	21,168	13,758
Assets held for sale	8,744	9,394
Total current assets	295,649	341,484
Restricted cash, non-current	9,250	9,291
Property, plant, and equipment, net	201,672	213,262
Operating lease right-of-use assets	4,613	5,661
Prepaid lease costs, non-current	42,503	40,931
Other non-current assets, net	4,675	2,595
Investment in unconsolidated joint venture	1,491	1,523
Total assets	559,853	614,747
Current liabilities:
Accounts payable	25,015	20,525
2027 Notes	29,459	0
Current portion of operating lease liabilities	2,162	2,132
Accrued expenses and other current liabilities	12,709	8,975
Accrued litigation expenses	38,900	38,900
Short-term finance lease liabilities	3,998	4,385
Total current liabilities	112,243	74,917
Long-term liabilities:
Delayed draw term loans, net	85,632	77,877
Delayed draw term loan warrants at fair value	3,843	5,066
Operating lease liabilities, net of current portion	3,058	4,059
Finance lease liabilities	74,799	76,590
2030 Notes Embedded Derivative liability at fair value	14,596	39,152
Other long-term liabilities	220	220
Total long-term liabilities	390,853	540,827
Commitments and contingencies (Note 12)
Stockholders’ deficit:
Preferred stock, par value $0.0001 per share — 500,000 shares authorized, none issued and outstanding	0	0
Common stock, par value $0.0001 per share — 3,000,000,000 shares authorized; 515,793,219 shares and 453,688,312 shares issued and outstanding at June 27, 2026 and December 31, 2025, respectively	52	45
Additional paid-in-capital	1,096,070	1,029,308
Accumulated deficit	(1,034,585)	(1,022,507)
Accumulated other comprehensive loss	(4,780)	(7,843)
Total stockholders’ equity (deficit)	56,757	(997)
Total liabilities and stockholders' equity (deficit)	559,853	614,747
2027 Notes
Long-term liabilities:
Notes, net	0	29,459
2030 Notes, net
Long-term liabilities:
Notes, net	$ 208,705	$ 308,404

Property, Plant and Equipment - Schedule of Property, Plant and Equipment (Details) - USD ($) $ in Thousands	Jun. 27, 2026	Dec. 31, 2025
Property, Plant, and Equipment [Line Items]
Finance leases	$ 124,555	$ 125,216
Total property, plant and equipment	311,664	315,240
Less: accumulated depreciation and amortization	109,992	101,978
Property, plant and equipment, net	201,672	213,262
Machinery and equipment
Property, Plant, and Equipment [Line Items]
Property, plant and equipment, gross	126,340	127,475
Leasehold improvements
Property, Plant, and Equipment [Line Items]
Property, plant and equipment, gross	16,322	16,885
Building
Property, Plant, and Equipment [Line Items]
Property, plant and equipment, gross	29,408	29,562
Software
Property, Plant, and Equipment [Line Items]
Property, plant and equipment, gross	2,654	2,688
Furniture and fixtures
Property, Plant, and Equipment [Line Items]
Property, plant and equipment, gross	899	900
Vehicles
Property, Plant, and Equipment [Line Items]
Property, plant and equipment, gross	595	595
Land
Property, Plant, and Equipment [Line Items]
Property, plant and equipment, gross	5,512	5,548
Assets not yet placed in service
Property, Plant, and Equipment [Line Items]
Property, plant and equipment, gross	$ 5,379	$ 6,371

Share-Based Compensation - Schedule of Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 27, 2026	Dec. 31, 2025
Number of Stock Options
Outstanding, beginning balance (in shares)	3,974,337
Granted (in shares)	790,900
Exercised (in shares)	0
Canceled/Forfeited (in shares)	(125,076)
Outstanding, ending balance (in shares)	4,640,161	3,974,337
Vested and exercisable (in shares)	3,384,913
Vested and expected to vest (in shares)	4,485,683
Weighted Average Exercise Price
Outstanding, beginning balance (in dollars per share)	$ 25.24
Granted (in dollars per share)	0.83
Exercised (in dollars per share)	0
Canceled/Forfeited (in dollars per share)	6.80
Outstanding, ending balance (in dollars per share)	21.58	$ 25.24
Vested and exercisable (in dollars per share)	27.73
Vested and expected to vest (in dollars per share)	$ 22.19
Weighted Average Remaining Contractual Life (Years)
Outstanding	5 years 10 months 24 days	5 years 3 months 18 days
Vested and exercisable	4 years 9 months 18 days
Vested and expected to vest	5 years 9 months 18 days
Aggregate Intrinsic Value
Outstanding, beginning balance	$ 0
Outstanding, ending balance	0	$ 0
Exercised	0
Vested and exercisable	0
Vested and expected to vest	$ 0
2026 Employment Inducement Equity Incentive Plan
Number of Stock Options
Granted (in shares)	236,221

Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 27, 2026	Jun. 28, 2025	Jun. 27, 2026	Jun. 28, 2025
Income Statement [Abstract]
Net revenues	$ 68,832,000	$ 74,958,000	$ 127,038,000	$ 143,689,000
Cost of goods sold	62,959,000	67,038,000	119,180,000	142,694,000
Gross profit	5,873,000	7,920,000	7,858,000	995,000
Operating expenses:
Research and development expenses	4,189,000	5,807,000	9,409,000	13,269,000
Selling, general and administrative expenses	32,490,000	39,628,000	70,359,000	89,610,000
Total operating expenses	36,679,000	45,435,000	79,768,000	102,879,000
Loss from operations	(30,806,000)	(37,515,000)	(71,910,000)	(101,884,000)
Other income (expense), net:
Interest expense	(6,571,000)	(2,002,000)	(13,303,000)	(3,026,000)
Remeasurement of delayed draw term loan warrant liability	(76,000)	0	1,224,000	0
Remeasurement of derivative liability	(3,838,000)	0	8,053,000	0
Gain on debt extinguishment	57,729,000	0	63,789,000	0
Other (expense) income, net	(18,000)	7,731,000	101,000	12,049,000
Total other income, net	47,226,000	5,729,000	59,864,000	9,023,000
Income (loss) before taxes	16,420,000	(31,786,000)	(12,046,000)	(92,861,000)
Income tax expense	0	0	0	0
Equity in losses of unconsolidated joint venture	16,000	59,000	32,000	70,000
Net income (loss)	$ 16,404,000	$ (31,845,000)	$ (12,078,000)	$ (92,931,000)
Net income (loss) per share available to common stockholders—basic (in dollars per share)	$ 0.03	$ (0.42)	$ (0.03)	$ (1.22)
Net loss per share available to common stockholders—diluted (in dollars per share)	$ (0.06)	$ (0.42)	$ (0.03)	$ (1.22)
Weighted average common shares outstanding — basic (in shares)	501,304,934	76,491,594	476,742,903	76,348,524
Weighted average common shares outstanding — diluted (in shares)	591,868,891	76,491,594	476,742,903	76,348,524

Property, Plant and Equipment

6 Months Ended

Jun. 27, 2026

Property, Plant, and Equipment [Abstract]

Property, Plant and Equipment

The Company records property, plant, and equipment at cost and includes finance lease assets in Property, plant and equipment, net in its unaudited condensed consolidated balance sheets. A summary of property, plant, and equipment, net as of June 27, 2026 and December 31, 2025, is as follows (in thousands):


	June 27, 2026		December 31, 2025

Machinery and equipment	$	126,340	$	127,475

Leasehold improvements	16,322		16,885
Building	29,408		29,562
Finance leases	124,555		125,216
Software	2,654		2,688
Furniture and fixtures	899		900
Vehicles	595		595
Land	5,512		5,548
Assets not yet placed in service	5,379		6,371
Total property, plant and equipment	$	311,664	$	315,240
Less: accumulated depreciation and amortization	109,992		101,978
Property, plant and equipment, net	$	201,672	$	213,262

Depreciation and amortization expense in the three months ended June 27, 2026 and June 28, 2025 was $6.7 million and $8.3 million, respectively. Depreciation and amortization expense in the three months ended June 27, 2026 included $1.6 million in accelerated depreciation related to the Company’s remaining leasehold improvement assets in China unrelated to the assets held for sale. Of the total depreciation and amortization expense in the three months ended June 27, 2026 and June 28, 2025, $4.0 million (including $1.6 million in accelerated depreciation related to the reassessment of useful lives of certain assets resulting from the cessation of the Company’s operational activities in China) and $6.1 million (including $1.7 million in accelerated depreciation related to the reassessment of useful lives of certain assets resulting from the cessation of the Company’s operational activities in China), respectively, were recorded in cost of goods sold, $2.0 million and $2.1 million, respectively were recorded in research and development expenses, and $0.7 million and $0.1 million, respectively, were recorded in SG&A expenses, in the Company’s unaudited condensed consolidated statement of operations.

Depreciation and amortization expense in the six months ended June 27, 2026 and June 28, 2025 was $13.5 million and $15.7 million, respectively. Depreciation and amortization expense in the six months ended June 27, 2026 and June 28, 2025 included $2.1 million and $3.2 million, respectively, in accelerated depreciation related to the reassessment of useful lives of certain assets resulting from the cessation of the Company’s operational activities in China. Of the total depreciation and amortization expense in the six months ended June 27, 2026 and June 28, 2025, $7.8 million (including $2.1 million in accelerated depreciation related to the reassessment of useful lives of certain assets resulting from the cessation of the Company’s operational activities in China) and $12.0 million (including $2.3 million in accelerated depreciation related to the reassessment of useful lives of certain assets resulting from the cessation of the Company’s operational activities in China), respectively, were recorded in cost of goods sold, $4.2 million (including $0.9 million in accelerated depreciation related to the reassessment of useful lives of certain assets resulting from the cessation of the Company’s operational activities in China) and $3.4 million (including $0.9 million in accelerated depreciation related to the reassessment of useful lives of certain assets resulting from the cessation of the Company’s operational activities in China), respectively, were recorded in research and

development expenses, and $1.5 million and $0.3 million, respectively, were recorded in SG&A expenses, in the Company’s unaudited condensed consolidated statement of operations.

As of June 27, 2026 and December 31, 2025, the Company had $8.7 million and $9.4 million in property, plant and equipment, respectively, classified as assets held for sale.

- Definition

The entire disclosure for property, plant, and equipment. Includes, but is not limited to, land and land improvement; building; machinery and equipment; furniture and fixture; and work of art, historical treasure, or similar asset classified as collection.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-3

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-3

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 360
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/360/tableOfContent

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482099/360-10-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482130/360-10-45-13

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 360
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.CC)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480091/360-10-S99-2

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-SubTopic 360
-Topic 958
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477798/958-360-50-6

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-SubTopic 360
-Topic 958
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477798/958-360-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-SubTopic 360
-Topic 958
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477798/958-360-50-7

+ Details

Commitments and Contingencies (Details) ft² in Thousands								1 Months Ended				3 Months Ended		6 Months Ended		12 Months Ended
Commitments and Contingencies (Details) ft² in Thousands	Jul. 10, 2026 USD ($)	Apr. 24, 2026 USD ($)	Dec. 18, 2025 USD ($)	Nov. 24, 2025 USD ($)	Nov. 21, 2025	May 14, 2025 USD ($)	Jul. 08, 2024 USD ($)	Jun. 27, 2026 USD ($)	Aug. 31, 2024 USD ($)	Mar. 31, 2024 USD ($)	Nov. 30, 2023 CAD ($)	Jun. 27, 2026 USD ($)	Jun. 28, 2025 USD ($)	Jun. 27, 2026 USD ($)	Jun. 28, 2025 USD ($)	Dec. 31, 2025 USD ($)	Dec. 31, 2024 USD ($)	Dec. 31, 2022	Dec. 31, 2020 USD ($) phase	Mar. 28, 2026 USD ($)	Jun. 29, 2024 USD ($)	Dec. 31, 2021 ft²
Loss Contingencies [Line Items]
Payments rent prepayment and construction costs														$ 1,600,000		$ 8,300,000
Number of phases of development \| phase																			2
Investment agreement, expected amount								$ 22,500,000				$ 22,500,000		22,500,000
Investment agreement, land use right period																		5 years
Lease, initial term (in years)																						8 years
Investment agreement, amount advanced								20,000,000.0				20,000,000.0		20,000,000.0
Other (expense) income, net												(18,000)	$ 7,731,000	101,000	$ 12,049,000
Equity in losses of unconsolidated joint venture												16,000	59,000	32,000	70,000
Investment in unconsolidated joint venture								1,491,000				1,491,000		1,491,000		1,523,000
Purchase obligation, annual minimum amount								18,600,000				18,600,000		18,600,000						$ 23,500,000
Purchase obligation mandatory letter of credit amount								1,000,000.0				1,000,000.0		1,000,000.0
Standby letter of credit																				$ 1,000,000.0
Purchase commitments, remainder of fiscal year								6,900,000				6,900,000		6,900,000
Purchase obligation, to be paid, year one								11,700,000				11,700,000		11,700,000
Prepaid expenses and other current assets								21,168,000				21,168,000		21,168,000		13,758,000
Accrued litigation expenses								38,900,000				38,900,000		38,900,000		38,900,000
Certain Machinery
Loss Contingencies [Line Items]
Property, plant and equipment, gross																					$ 5,100,000
BVeggie
Loss Contingencies [Line Items]
Damages sought, value											$ 129,841,920
Period for other party to file motion					60 days
Consumer Class Actions Regarding Protein Claims
Loss Contingencies [Line Items]
Loss contingency, accrual, payments							$ 7,500,000
Litigation settlement, amount						$ 7,250,000
Consumer Class Actions Regarding Protein Claims \| Pending Litigation
Loss Contingencies [Line Items]
Loss contingency, accrual, payments																	$ 7,500,000
Litigation settlement, amount									$ 250,000								250,000
Accrued litigation settlement													7,250,000		7,250,000		$ 7,250,000
Arbitration With Former Co-Manufacturer
Loss Contingencies [Line Items]
Damages sought, value										$ 73,000,000.0
Litigation settlement amount		$ 11,000,000.0	$ 13,981,115
Litigation settlement period		60 days
Proceeds from settlements								4,000,000.0
Reduction of SG&A expenses from litigation settlement												11,000,000.0		11,000,000.0
Prepaid expenses and other current assets								7,100,000				7,100,000		7,100,000
Arbitration With Former Co-Manufacturer \| Subsequent Event
Loss Contingencies [Line Items]
Proceeds from settlements	$ 7,100,000
Litigation settlement interest	$ 100,000
Arbitration With Former Co-Manufacturer \| Breach Of Contract, Out Of Pocket Costs
Loss Contingencies [Line Items]
Litigation settlement amount			349,493
Arbitration With Former Co-Manufacturer \| Negligent Misrepresentation Claim
Loss Contingencies [Line Items]
Litigation settlement amount			7,183,782
Arbitration With Former Co-Manufacturer \| Professional Attorney Fees
Loss Contingencies [Line Items]
Litigation settlement amount			6,246,693
Arbitration With Former Co-Manufacturer \| Loss Contingency, Additional Costs
Loss Contingencies [Line Items]
Litigation settlement amount			$ 550,640
Trademark Infringement Litigation \| Actual Damages
Loss Contingencies [Line Items]
Loss contingency, damages awarded, value				$ 23,500,000
Trademark Infringement Litigation \| Disgorgement Of Profits
Loss Contingencies [Line Items]
Loss contingency, damages awarded, value				$ 15,400,000
The Planet Partnership, LLC (“TPP”)
Loss Contingencies [Line Items]
Equity in losses of unconsolidated joint venture												16,000	$ 59,000	32,000	$ 70,000
Investment in unconsolidated joint venture								27,600,000				27,600,000		27,600,000		$ 27,600,000
Reclassification out of Accumulated Other Comprehensive Income
Loss Contingencies [Line Items]
Other (expense) income, net														900,000
Shanghai, China
Loss Contingencies [Line Items]
Number of square feet in lease agreement \| ft²																						12
China (Jiaxing)
Loss Contingencies [Line Items]
Investment agreement, expected amount								$ 500,000				$ 500,000		$ 500,000
JXEDZ
Loss Contingencies [Line Items]
Investment agreement, expected amount																			$ 10,000,000.0
Investment agreement, land use right period																			2 years

Segment Information - Narrative (Details)	6 Months Ended
Segment Information - Narrative (Details)	Jun. 27, 2026 segment
Segment Reporting [Abstract]
Number of operating segments	1
Number of reportable segments	1

Leases

6 Months Ended

Jun. 27, 2026

Leases [Abstract]

Leases

The Company has finance leases for its corporate headquarters, lab and innovation space in El Segundo, California (the "Campus Headquarters"), a warehousing facility in the Netherlands and for certain equipment used for research and development and operations. The Company also has operating leases including lease arrangements for the Company’s corporate offices (other than the Campus Headquarters), manufacturing facilities, warehouses, vehicles, and certain equipment. Such leases generally have original lease terms between 2 years and 16 years, and often include one or more options to extend. Some leases also include early termination options, which can be exercised under specific conditions. The Company includes options to extend the lease term if the options are reasonably certain of being exercised. The Company does not have residual value guarantees or material restrictive covenants associated with its leases.

For details of the Company's Campus Headquarters lease, including amendments thereto (which resulted in, among other things, a reclassification from an operating to a finance lease and a revised letter of credit reduction schedule), and the Company's subleases, see Note 5, Leases, to the Notes to Consolidated Financial Statements included in the 2025 10-K.

Subsequent to the three months ended June 27, 2026, the Company entered into a Fifth Amendment to Lease, dated as of July 31, 2026, (the “Fifth Amendment to Lease”) to the Campus Headquarters lease. The impact of the Fifth Amendment to Lease is not reflected in the tables below. See Note 1 7.

The Company subleases a portion of its Campus Headquarters to a third party. Sublease income is recognized on a straight-line basis and included in the Company’s unaudited condensed consolidated statements of operations as a credit to Research and development expenses. See Note 1 2.

The following table presents the Company’s sublease income (in thousands):


	Three Months Ended				Six Months Ended
	June 27, 2026		June 28, 2025		June 27, 2026		June 28, 2025

Sublease income	$	311	$	—	$	608	$	—

Subsequent to the three months ended June 28, 2026, in connection with the Fifth Amendment to Lease, the Company entered into a First Amendment to Sublease, dated as of July 31, 2026 (the “First Amendment to Sublease”), with the subtenant. The impact of the First Amendment to Sublease is not reflected in the tables below. See Note 17.

Lease costs for operating and finance leases were as follows (in thousands):


		Three Months Ended
	Statement of Operations Location	June 27, 2026		June 28, 2025
Operating lease cost:
Lease cost	Cost of goods sold	$	455	$	419
Lease cost	Research and development expenses	—		485
Lease cost	SG&A expenses	105		557
Variable lease cost(1)	Cost of goods sold	125		66

Variable lease cost(1)	SG&A expenses	—		370
Operating lease cost		685		1,897
Short- term lease cost:
Short-term lease cost	Cost of goods sold	60		118
Short-term lease cost	Research and development expenses	10		15
Short-term lease cost	SG&A expenses	40		109
Short-term lease cost		110		242
Finance lease cost:
Amortization of right-of use assets	Cost of goods sold	142		272
Amortization of right-of use assets	Research and development expenses	1,586		1,561
Amortization of right-of use assets	SG&A expenses	630		—
Interest on lease liabilities	Interest expense	1,656		1,016
Variable lease cost(1)	Cost of goods sold	3		16
Variable lease cost(1)	Research and development expenses	1		1
Variable lease cost(1)	SG&A expenses	2,543		585
Finance lease cost		6,561		3,451
Total lease cost		$	7,356	$	5,590

____________

(1) Variable lease cost primarily consists of common area maintenance, such as cleaning and repairs.


		Six Months Ended
	Statement of Operations Location	June 27, 2026		June 28, 2025
Operating lease cost:
Lease cost	Cost of goods sold	$	912	$	826
Lease cost	Research and development expenses	—		2,872
Lease cost	SG&A expenses	206		1,180
Variable lease cost(1)	Cost of goods sold	319		102

Variable lease cost(1)	SG&A expenses	—		1,468
Operating lease cost		1,437		6,448
Short- term lease cost:
Short-term lease cost	Cost of goods sold	120		195
Short-term lease cost	Research and development expenses	14		29
Short-term lease cost	SG&A expenses	103		245
Short-term lease cost		237		469
Finance lease cost:
Amortization of right-of use assets	Cost of goods sold	319		526
Amortization of right-of use assets	Research and development expenses	3,349		1,564
Amortization of right-of use assets	SG&A expenses	1,322		—
Interest on lease liabilities	Interest expense	3,336		1,056
Variable lease cost(1)	Cost of goods sold	4		28
Variable lease cost(1)	Research and development expenses	1		1
Variable lease cost(1)	SG&A expenses	3,160		585
Finance lease cost		11,491		3,760
Total lease cost		$	13,165	$	10,677

____________

(1) Variable lease cost primarily consists of common area maintenance, such as cleaning and repairs.

The following is a schedule by year of the maturities of lease liabilities with original terms in excess of one year, as of June 27, 2026 (in thousands):


	June 27, 2026
	Operating Leases		Finance Leases
Remainder of 2026	$	1,204	$	5,475
2027	1,957		9,592
2028	946		9,173
2029	654		9,264
2030	513		9,519
Thereafter	294		86,046
Total undiscounted future minimum lease payments	5,568		129,069
Less imputed interest	(348)		(50,272)
Total discounted future minimum lease payments	$	5,220	$	78,797

Weighted average remaining lease terms and weighted average discount rates were:


	June 27, 2026
	Operating Leases	Finance Leases
Weighted average remaining lease term (years)	3.4	12.2
Weighted average discount rate	4.7%	8.4%

Supplemental cash flow information (in thousands):


	Three Months Ended				Six Months Ended
	June 27, 2026		June 28, 2025		June 27, 2026		June 28, 2025
Cash paid for amounts included in the measurement of operating lease liabilities	$	435	$	1,568	$	1,048	$	3,823
Cash paid for interest on finance lease liabilities	$	1,656	$	2,082	$	3,336	$	2,082

Leases

The following table presents the Company’s sublease income (in thousands):


	Three Months Ended				Six Months Ended
	June 27, 2026		June 28, 2025		June 27, 2026		June 28, 2025

Sublease income	$	311	$	—	$	608	$	—

Lease costs for operating and finance leases were as follows (in thousands):


		Three Months Ended
	Statement of Operations Location	June 27, 2026		June 28, 2025
Operating lease cost:
Lease cost	Cost of goods sold	$	455	$	419
Lease cost	Research and development expenses	—		485
Lease cost	SG&A expenses	105		557
Variable lease cost(1)	Cost of goods sold	125		66

Variable lease cost(1)	SG&A expenses	—		370
Operating lease cost		685		1,897
Short- term lease cost:
Short-term lease cost	Cost of goods sold	60		118
Short-term lease cost	Research and development expenses	10		15
Short-term lease cost	SG&A expenses	40		109
Short-term lease cost		110		242
Finance lease cost:
Amortization of right-of use assets	Cost of goods sold	142		272
Amortization of right-of use assets	Research and development expenses	1,586		1,561
Amortization of right-of use assets	SG&A expenses	630		—
Interest on lease liabilities	Interest expense	1,656		1,016
Variable lease cost(1)	Cost of goods sold	3		16
Variable lease cost(1)	Research and development expenses	1		1
Variable lease cost(1)	SG&A expenses	2,543		585
Finance lease cost		6,561		3,451
Total lease cost		$	7,356	$	5,590

____________

(1) Variable lease cost primarily consists of common area maintenance, such as cleaning and repairs.


		Six Months Ended
	Statement of Operations Location	June 27, 2026		June 28, 2025
Operating lease cost:
Lease cost	Cost of goods sold	$	912	$	826
Lease cost	Research and development expenses	—		2,872
Lease cost	SG&A expenses	206		1,180
Variable lease cost(1)	Cost of goods sold	319		102

Variable lease cost(1)	SG&A expenses	—		1,468
Operating lease cost		1,437		6,448
Short- term lease cost:
Short-term lease cost	Cost of goods sold	120		195
Short-term lease cost	Research and development expenses	14		29
Short-term lease cost	SG&A expenses	103		245
Short-term lease cost		237		469
Finance lease cost:
Amortization of right-of use assets	Cost of goods sold	319		526
Amortization of right-of use assets	Research and development expenses	3,349		1,564
Amortization of right-of use assets	SG&A expenses	1,322		—
Interest on lease liabilities	Interest expense	3,336		1,056
Variable lease cost(1)	Cost of goods sold	4		28
Variable lease cost(1)	Research and development expenses	1		1
Variable lease cost(1)	SG&A expenses	3,160		585
Finance lease cost		11,491		3,760
Total lease cost		$	13,165	$	10,677

____________

(1) Variable lease cost primarily consists of common area maintenance, such as cleaning and repairs.

The following is a schedule by year of the maturities of lease liabilities with original terms in excess of one year, as of June 27, 2026 (in thousands):


	June 27, 2026
	Operating Leases		Finance Leases
Remainder of 2026	$	1,204	$	5,475
2027	1,957		9,592
2028	946		9,173
2029	654		9,264
2030	513		9,519
Thereafter	294		86,046
Total undiscounted future minimum lease payments	5,568		129,069
Less imputed interest	(348)		(50,272)
Total discounted future minimum lease payments	$	5,220	$	78,797

Weighted average remaining lease terms and weighted average discount rates were:


	June 27, 2026
	Operating Leases	Finance Leases
Weighted average remaining lease term (years)	3.4	12.2
Weighted average discount rate	4.7%	8.4%

Supplemental cash flow information (in thousands):


	Three Months Ended				Six Months Ended
	June 27, 2026		June 28, 2025		June 27, 2026		June 28, 2025
Cash paid for amounts included in the measurement of operating lease liabilities	$	435	$	1,568	$	1,048	$	3,823
Cash paid for interest on finance lease liabilities	$	1,656	$	2,082	$	3,336	$	2,082

Related Party Transactions	6 Months Ended
Related Party Transactions	Jun. 27, 2026
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions TPP In connection with the Company’s investment in TPP, a joint venture with PepsiCo, Inc., the Company sold certain products directly to the joint venture. As part of its Global Operations Review, in 2023, the Company made the decision to discontinue the Beyond Meat Jerky product line and discontinued it in 2024. See Note 1 2. The Company earned $0 in net revenues from TPP in each of the three and six months ended June 27, 2026 and June 28, 2025. Related Party Agreements Effective May 4, 2026, the Company hired the son of Seth Goldman, the Company’s Chair of the Board of Directors, for a full time, salaried position, as Senior Manager of Community Engagement, with a base salary of $130,000, target annual bonus of 10% and such other standard company benefits available to similarly situated employees of the Company. On June 29, 2026, the Company’s subsidiary, Beyond Meat BV, entered into an employment agreement with Adriaan Figee pursuant to which he will serve as General Manager, EMEA effective as of July 1, 2026. Prior to commencing his employment, the Company and Rijndijk Beheer BV (Moonlighters BV), on behalf of Mr. Figee, as the owner thereof, were parties to that certain Consulting Agreement dated April 8, 2026, pursuant to which Mr. Figee provided certain consulting services to the Company. In the three and six months ended June 27, 2026, the Company paid Mr. Figee $150,000 in connection with such services. The Company is party to various contracts with certain Zandbergen entities relating to distribution, manufacturing, cold storage and real estate in EMEA. Mr. Figee previously served in various C-suite roles for certain Zandbergen entities. Although Mr. Figee has resigned these positions, certain of his immediate family members are owners, officers and/or directors of these entities. See N ote 1 7.

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References

+ Details

Debt - Narrative (Details)							1 Months Ended	3 Months Ended		6 Months Ended
Debt - Narrative (Details)	Nov. 14, 2025 $ / shares	Oct. 31, 2025 USD ($) shares	Oct. 30, 2025 USD ($) shares	Oct. 15, 2025 USD ($) day shares	Sep. 29, 2025 USD ($) shares	Mar. 05, 2021 USD ($)	Oct. 31, 2025 USD ($)	Jun. 27, 2026 USD ($) shares	Jun. 28, 2025 USD ($)	Jun. 27, 2026 USD ($) shares	Jun. 28, 2025 USD ($)	May 01, 2026	Dec. 31, 2025 USD ($) shares	Dec. 22, 2025 $ / shares	Dec. 21, 2025 $ / shares	Oct. 16, 2025 USD ($)	Sep. 18, 2025 USD ($)	Jun. 26, 2025 USD ($)	May 07, 2025 USD ($) $ / shares shares	Mar. 12, 2021 USD ($)
Debt Instrument [Line Items]
Common stock, issued (in shares) \| shares		317,834,446	1,684,270	316,150,176
Net Carrying Amount								$ 323,796,000		$ 323,796,000			$ 415,740,000
Gain on debt extinguishment								$ 57,729,000	$ 0	$ 63,789,000	$ 0
Total common stock reserved for future issuance (in shares) \| shares								180,709,132		180,709,132			183,354,433
Class of warrant or right, number of securities called by warrants or rights (in shares) \| shares																			9,558,635
Class of warrant or right, exercise price of warrants or rights (in usd per share) \| $ / shares														$ 1.95	$ 3.26				$ 3.26
2018 Plan
Debt Instrument [Line Items]
Granted (in shares) \| shares										7,176,019
Total common stock reserved for future issuance (in shares) \| shares								10,024,113		10,024,113			10,310,481
Restricted Stock Units (RSUs)
Debt Instrument [Line Items]
Granted (in shares) \| shares										8,416,517
Restricted Stock Units (RSUs) \| 2018 Plan
Debt Instrument [Line Items]
Granted (in shares) \| shares										4,264,723
Performance Shares
Debt Instrument [Line Items]
Granted (in shares) \| shares										0
Performance Shares \| 2018 Plan
Debt Instrument [Line Items]
Total common stock reserved for future issuance (in shares) \| shares								20,309,683		20,309,683
Convertible Debt
Debt Instrument [Line Items]
Debt instrument, redemption price, percentage of outstanding debt declarable						25.00%
Debt instrument, debt default, period of special interest rate						365 days
Debt instrument, interest rate, increase (decrease)						0.50%
Debt issuance costs						$ 23,600,000
Convertible Senior Notes Due 2027 \| Convertible Debt
Debt Instrument [Line Items]
Debt, face amount						$ 1,000,000,000.0
Debt issuance costs								$ 0		$ 0			$ 0
Amortization of debt issuance costs									$ 1,000,000.0		$ 2,000,000.0
Annualized effective interest rate (in percent)									0.34%		0.34%
Gain on debt restructuring							$ 5,400,000
Maximum issuable principal amount			$ 5,938,000	$ 1,114,603,000
Percentage of aggregate principal of previously outstanding notes			97.44%	96.92%
Principal amount								29,459,000		29,459,000			29,459,000			$ 35,397,000
Net Carrying Amount								$ 29,459,000		$ 29,459,000			$ 29,459,000
Debt instrument, covenant, aggregate principal outstanding prior to maturity				$ 60,000,000.0
Remaining term (in years)										8 months 12 days
Additional Convertible Senior Notes Due 2027 \| Convertible Debt
Debt Instrument [Line Items]
Debt, face amount																				$ 150,000,000.0
Convertible Senior Notes Due 2030
Debt Instrument [Line Items]
Common stock, issued (in shares) \| shares								52,092,284		57,408,142
Reduction in debt carrying value								$ 100,000,000.0		$ 109,900,000
Decrease in fair value of embedded derivative from debt conversions								15,400,000		16,500,000
Gain on debt extinguishment								$ 57,700,000		$ 63,800,000
Total common stock reserved for future issuance (in shares) \| shares								86,660,407		86,660,407			120,000,000
Convertible Senior Notes Due 2030 \| Convertible Debt
Debt Instrument [Line Items]
Amortization of debt issuance costs								$ 1,000,000.0		$ 2,200,000
Maximum aggregate principal amount					$ 202,500,000
Maximum issuable shares (in shares) \| shares					326,190,370
Principal amount		$ 209,721,000					$ 209,721,000	224,269,000		224,269,000			$ 334,148,000
Exchange principal amount				196,217,000				62,600,000		$ 68,800,000
Common stock, issued (in shares) \| shares										57,408,142
Proceeds from issuance of convertible senior notes				12,500,000
Net Carrying Amount			$ 1,004,000	$ 208,717,000				208,705,000		$ 208,705,000			308,403,000
Interest, stated rate (in percent)				7.00%
Payment in kind, interest rate				9.50%								9.50%
Conversion ratio	0.5727784			1.0292716
Converted instrument, rate				10.00%
Debt instrument, covenant, consecutive trading days following settlement date \| day				20
Debt instrument, conversion price (in dollars per share) \| $ / shares	$ 1.7459
Debt instrument, covenant, minimum liquidity				$ 15,000,000.0
Debt instrument, redemption percentage				100.00%
Remaining term (in years)										4 years 3 months 18 days
Loan and Security Agreement \| Line of Credit \| Secured Debt
Debt Instrument [Line Items]
Debt, face amount								100,000,000.0		$ 100,000,000.0									$ 100,000,000.0
Debt issuance costs								$ 6,718,000		$ 6,718,000			$ 7,181,000						7,300,000
Annualized effective interest rate (in percent)								19.40%		19.40%			13.80%
Principal amount								$ 110,884,000		$ 110,884,000			$ 104,569,000				$ 60,000,000.0	$ 40,000,000.0
Covenant, minimum liquidity																			$ 15,000,000.0
Debt instrument, accumulated paid-in-kind interest								3,400,000		6,800,000
Interest expense								$ 500,000		$ 1,000,000.0
Loan and Security Agreement \| Line of Credit \| Secured Debt \| Minimum
Debt Instrument [Line Items]
Interest, stated rate (in percent)																			12.00%

Segment Information (Tables)

6 Months Ended

Jun. 27, 2026

Segment Reporting [Abstract]

Schedule of Segment Reporting

The following table presents the details of the significant segment expenses, segment net revenues, and the segment performance measure, net income (loss), in the periods indicated (in thousands):


	Three Months Ended				Six Months Ended
	June 27, 2026		June 28, 2025		June 27, 2026		June 28, 2025
Net revenues	$	68,832	$	74,958	$	127,038	$	143,689
Less:
Cost of goods sold	62,959		67,038		119,180		142,694
Research and development expenses	4,189		5,807		9,409		13,269
Selling expenses	6,790		6,741		13,117		13,712
Marketing expenses	9,426		8,061		15,054		20,150
General and administrative expenses	16,273		24,826		42,188		55,748
Interest expense	6,571		2,002		13,303		3,026
Remeasurement of delayed draw term loan warrant liability	76		—		(1,224)		—
Remeasurement of derivative liability	3,838		—		(8,053)		—
Gain on debt extinguishment	(57,729)		—		(63,789)		—
Equity in losses of unconsolidated joint venture	16		59		32		70
Other segment items, net(1)	19		(7,731)		(101)		(12,049)
Net income (loss)	$	16,404	$	(31,845)	$	(12,078)	$	(92,931)

___________

- Definition

Tabular disclosure of segment reporting. Includes, but is not limited to, reconciliation of reportable segment amount to corresponding consolidated total.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 34
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-34

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26A

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-15

+ Details

Debt (Tables)

6 Months Ended

Jun. 27, 2026

Debt Disclosure [Abstract]

Schedule of Debt Balances

The following is a summary of debt balances as of June 27, 2026 and December 31, 2025 (in thousands):


	June 27, 2026		December 31, 2025

2027 Notes	$	29,459	$	29,459
2030 Notes	224,269		334,148
Debt discount—2030 Notes issue date embedded derivatives, net(1)	(15,564)		(25,745)
Delayed draw term loans(2)	110,884		104,569
Debt issuance costs—Delayed draw term loans	(6,718)		(7,181)
Debt discount—Delayed draw term loan warrants	(18,534)		(19,510)

Total debt outstanding	$	323,796	$	415,740
Less: current portion of long-term debt	(29,459)		—
Long-term debt	$	294,337	$	415,740

_________

(2) Includes accrued PIK interest of $10.9 million and $4.6 million as of June 27, 2026 and December 31, 2025, respectively.

The following is a summary of the 2027 Notes as of June 27, 2026, included in Current liabilities in the Company’s unaudited condensed consolidated balance sheet (in thousands):


	Principal Amount		Unamortized Issuance Costs		Net Carrying Amount		Fair Value
							Amount		Leveling
2027 Notes	$	29,459	$	—	$	29,459	$	6,098	Level 2

The following is a summary of the 2027 Notes as of December 31, 2025, included in Long-term liabilities in the Company’s unaudited condensed consolidated balance sheet (in thousands):


	Principal Amount		Unamortized Issuance Costs		Net Carrying Amount		Fair Value
							Amount		Leveling
2027 Notes	$	29,459	$	—	$	29,459	$	6,098	Level 2

The following is a summary of the 2030 Notes as of June 27, 2026 (in thousands):


	Principal Amount(1)		Undiscounted Cash Flows(2)		Unamortized Derivative Discount(3)		Net Carrying Amount		Fair Value
									Amount		Leveling
2030 Notes, net	$	151,288	$	72,981	$	(15,564)	$	208,705	$	114,266	Level 2

__________

(2) Represents the remaining undiscounted future cash flows using the PIK election, including any amounts contingently payable.

The following is a summary of the 2030 Notes as of December 31, 2025 (in thousands):


	Principal Amount		Undiscounted Cash Flows(1)		Unamortized Derivative Discount(2)		Carrying Amount		Fair Value
									Amount		Leveling
2030 Notes, net	$	209,721	$	124,427	$	(25,745)	$	308,403	$	166,267	Level 2

__________

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.9-06)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-8

Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-7

Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-6

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480657/210-10-S50-9

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B

Reference 12: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E

Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482925/835-30-45-2

Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477734/942-470-50-3

+ Details

Income Taxes (Details) - USD ($)	3 Months Ended		6 Months Ended
Income Taxes (Details) - USD ($)	Jun. 27, 2026	Jun. 28, 2025	Jun. 27, 2026	Jun. 28, 2025
Income Tax Disclosure [Abstract]
Income tax expense	$ 0	$ 0	$ 0	$ 0
Accrued interest or penalties related to uncertain tax positions	$ 0		$ 0

- Definition

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 3A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-4

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-21

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-14

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 231
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482663/740-10-55-231

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-8

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-9

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-10

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(9))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Subparagraph (a)
-SubTopic 20
-Topic 740
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482659/740-20-45-2

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-SubTopic 10
-Topic 235
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

+ Details

Debt - Schedule of Debt Balances (Details) - USD ($) $ in Thousands	Jun. 27, 2026	Dec. 31, 2025	Oct. 31, 2025	Oct. 30, 2025	Oct. 16, 2025	Oct. 15, 2025	Sep. 18, 2025	Jun. 26, 2025	May 07, 2025	Mar. 05, 2021
Debt Instrument [Line Items]
Debt discount—Delayed draw term loan warrants	$ 323,796	$ 415,740
Less: current portion of long-term debt	(29,459)	0
Long-term debt	294,337	415,740
Convertible Debt
Debt Instrument [Line Items]
Debt issuance costs—Delayed draw term loans										$ (23,600)
Convertible Debt \| Convertible Senior Notes Due 2027
Debt Instrument [Line Items]
Long-term debt, gross	29,459	29,459			$ 35,397
Debt issuance costs—Delayed draw term loans	0	0
Debt discount—Delayed draw term loan warrants	29,459	29,459
Convertible Debt \| Convertible Senior Notes Due 2030
Debt Instrument [Line Items]
Long-term debt, gross	224,269	334,148	$ 209,721
Debt issuance costs, net	(15,564)	(25,745)
Debt discount—Delayed draw term loan warrants	208,705	308,403		$ 1,004		$ 208,717
Line of Credit \| Loan and Security Agreement \| Secured Debt
Debt Instrument [Line Items]
Long-term debt, gross	110,884	104,569					$ 60,000	$ 40,000
Debt issuance costs, net	(18,534)	(19,510)
Debt issuance costs—Delayed draw term loans	(6,718)	(7,181)							$ (7,300)
Debt instrument, accumulated paid-in-kind interest	$ 10,900	$ 4,600

Segment Information - Schedule of Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 27, 2026	Mar. 28, 2026	Jun. 28, 2025	Mar. 29, 2025	Jun. 27, 2026	Jun. 28, 2025
Segment Reporting [Line Items]
Net revenues	$ 68,832		$ 74,958		$ 127,038	$ 143,689
Less:
Cost of goods sold	62,959		67,038		119,180	142,694
Research and development expenses	4,189		5,807		9,409	13,269
Interest expense	6,571		2,002		13,303	3,026
Remeasurement of delayed draw term loan warrant liability	76		0		(1,224)	0
Remeasurement of derivative liability	3,838		0		(8,053)	0
Gain on debt extinguishment	(57,729)		0		(63,789)	0
Equity in losses of unconsolidated joint venture	16		59		32	70
Net income (loss)	16,404	$ (28,482)	(31,845)	$ (61,087)	(12,078)	(92,931)
Reporting Segment
Segment Reporting [Line Items]
Net revenues	68,832		74,958		127,038	143,689
Less:
Cost of goods sold	62,959		67,038		119,180	142,694
Research and development expenses	4,189		5,807		9,409	13,269
Selling expenses	6,790		6,741		13,117	13,712
Marketing expenses	9,426		8,061		15,054	20,150
General and administrative expenses	16,273		24,826		42,188	55,748
Interest expense	6,571		2,002		13,303	3,026
Remeasurement of delayed draw term loan warrant liability	76		0		(63,789)	0
Remeasurement of derivative liability	3,838		0		(1,224)	0
Gain on debt extinguishment	(57,729)		0		(8,053)	0
Equity in losses of unconsolidated joint venture	16		59		32	70
Other segment items	19		(7,731)		(101)	(12,049)
Net income (loss)	16,404		(31,845)		(12,078)	(92,931)
Interest income	1,500		500		3,000	1,400
Realized and unrealized foreign currency (losses) gains	$ (1,800)		$ 7,500		$ (3,100)	$ 11,000

Revenue Recognition

6 Months Ended

Jun. 27, 2026

Revenue from Contract with Customer [Abstract]

Revenue Recognition

At the end of each accounting period, the Company recognizes a contra asset to accounts receivable for estimated sales discounts that have been incurred but not paid which totaled $5.7 million and $6.2 million as of June 27, 2026 and December 31, 2025, respectively. The offsetting charge is recorded as a reduction of revenues in the same period when the expense is incurred.

Presentation of Net Revenues by Channel

The Company’s revenues are attributed to the country where the products are delivered. The following table presents the Company’s net revenues by channel (in thousands):


	Three Months Ended				Six Months Ended
	June 27, 2026		June 28, 2025		June 27, 2026		June 28, 2025

U.S.:
Retail(1)	$	29,637	$	32,909	$	56,191	$	64,269
Foodservice	8,005		11,055		14,624		20,468
U.S. net revenues	37,642		43,964		70,815		84,737
International:
Retail	18,479		15,867		32,188		28,549
Foodservice	12,711		15,127		24,035		30,403
International net revenues	31,190		30,994		56,223		58,952
Net revenues	$	68,832	$	74,958	$	127,038	$	143,689

_________________

(1) Includes net revenues from the DTC Channel.

One distributor accounted for approximately 14% of the Company’s gross revenues in the three months ended June 27, 2026 and two distributors accounted for approximately 14% and 10% of the Company’s gross revenues, respectively, in the three months ended June 28, 2025. One distributor accounted for approximately 12% and 14% of the Company’s gross revenues in the six months ended June 27, 2026 and June 28, 2025, respectively. No other customer or distributor accounted for more than 10% of the Company’s gross revenues in the three and six months ended June 27, 2026 and June 28, 2025.

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-7

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-9

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-10

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-15

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-13

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Topic 606
-Publisher FASB
-URI https://asc.fasb.org/606/tableOfContent

+ Details

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 27, 2026	Jun. 28, 2025
Cash flows from operating activities:
Net income (loss)	$ (12,078)	$ (92,931)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	13,549	15,682
Non-cash lease expense	985	2,889
Share-based compensation expense	13,919	10,157
Amortization of debt issuance costs and debt discount	3,652	1,970
Loss on sale and write-down of fixed assets	162	223
Equity in losses of unconsolidated joint venture	32	70
Remeasurement of delayed draw term loan warrant liability	(1,224)	0
Remeasurement of derivative liability	(8,053)	0
Gain on debt extinguishment	(63,789)	0
Unrealized losses (gains) on foreign currency transactions	3,093	(11,161)
Paid-in-kind interest	6,315	0
Net change in operating assets and liabilities:
Accounts receivable	168	(9,291)
Inventories	20,580	11,240
Prepaid expenses and other current assets	(8,540)	(2,850)
Accounts payable	5,140	25,710
Accrued expenses and other current liabilities	4,006	(3,638)
Prepaid lease costs, non-current	(155)	(3,888)
Operating lease liabilities	(918)	(2,156)
Net cash used in operating activities	(23,156)	(57,974)
Cash flows from investing activities:
Purchases of property, plant and equipment	(4,015)	(6,423)
Proceeds from sales of fixed assets	1,924	348
Payments of security deposits	(204)	0
Net cash used in investing activities	(2,295)	(6,075)
Cash flows from financing activities:
Proceeds from delayed draw term loan	0	40,000
Payments of debt issuance costs	0	(6,498)
Principal payments under finance lease obligations	(3,594)	(937)
Proceeds from exercise of stock options	0	6
Payments of minimum withholding taxes on net share settlement of equity awards	(3,019)	(312)
Net cash (used in) provided by financing activities	(6,613)	32,259
Effect of foreign currency exchange rate changes on cash	668	3,505
Net decrease in cash, cash equivalents and restricted cash	(31,396)	(28,285)
Cash, cash equivalents and restricted cash at the beginning of the period	217,531	145,554
Cash, cash equivalents and restricted cash at the end of the period	186,135	117,269
Cash paid during the period for:
Taxes	0	2
Non-cash investing and financing activities:
Conversion of 2030 Notes by issuance of common stock	54,627	0
Issuance of delayed draw term loan warrants	0	20,143
Non-cash additions to property, plant and equipment	161	1,345
Operating lease right-of-use assets obtained in exchange for lease liabilities	83	2,082
Reclassification of pre-paid lease costs to finance lease right-of-use assets	0	19,929
Non-cash additions to finance leases	$ 0	$ 10,091

Condensed Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($) $ in Thousands	Total	Convertible Senior Notes Due 2030	Common Stock	Common Stock Convertible Senior Notes Due 2030	Additional Paid-in Capital	Additional Paid-in Capital Convertible Senior Notes Due 2030	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2024			76,065,969
Beginning balance at Dec. 31, 2024	$ (601,208)		$ 8		$ 644,004		$ (1,241,531)	$ (3,689)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(61,087)						(61,087)
Issuance of common stock under equity incentive plans, net (in shares)			342,908
Issuance of common stock under equity incentive plans, net	(220)				(220)
Share-based compensation for equity classified awards	5,853				5,853
Foreign currency translation adjustment	(1,040)							(1,040)
Ending balance (in shares) at Mar. 29, 2025			76,408,877
Ending balance at Mar. 29, 2025	(657,702)		$ 8		649,637		(1,302,618)	(4,729)
Beginning balance (in shares) at Dec. 31, 2024			76,065,969
Beginning balance at Dec. 31, 2024	(601,208)		$ 8		644,004		(1,241,531)	(3,689)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(92,931)
Foreign currency translation adjustment	3,508
Reclassification of foreign currency translation to net income (loss), net of tax	0
Ending balance (in shares) at Jun. 28, 2025			76,597,624
Ending balance at Jun. 28, 2025	(687,797)		$ 8		653,855		(1,334,463)	(7,197)
Beginning balance (in shares) at Mar. 29, 2025			76,408,877
Beginning balance at Mar. 29, 2025	(657,702)		$ 8		649,637		(1,302,618)	(4,729)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(31,845)						(31,845)
Issuance of common stock under equity incentive plans, net (in shares)			188,747
Issuance of common stock under equity incentive plans, net	(86)				(86)
Share-based compensation for equity classified awards	4,304				4,304
Foreign currency translation adjustment	(2,468)							(2,468)
Foreign currency translation adjustment	2,468
Reclassification of foreign currency translation to net income (loss), net of tax	0
Ending balance (in shares) at Jun. 28, 2025			76,597,624
Ending balance at Jun. 28, 2025	(687,797)		$ 8		653,855		(1,334,463)	(7,197)
Beginning balance (in shares) at Dec. 31, 2025			453,688,312
Beginning balance at Dec. 31, 2025	(997)		$ 45		1,029,308		(1,022,507)	(7,843)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(28,482)						(28,482)
Issuance of common stock under equity incentive plans, net (in shares)			4,190,897
Issuance of common stock under equity incentive plans, net	(2,728)				(2,728)
Share-based compensation for equity classified awards	6,521				6,521
Issuance of common stock in conjunction with the conversion of a portion of 2030 Notes (in shares)				5,315,857
Issuance of common stock in conjunction with the conversion of a portion of the 2030 Notes		$ 4,220		$ 1		$ 4,219
Foreign currency translation adjustment	383							383
Ending balance (in shares) at Mar. 28, 2026			463,195,066
Ending balance at Mar. 28, 2026	(21,083)		$ 46		1,037,320		(1,050,989)	(7,460)
Beginning balance (in shares) at Dec. 31, 2025			453,688,312
Beginning balance at Dec. 31, 2025	(997)		$ 45		1,029,308		(1,022,507)	(7,843)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(12,078)
Foreign currency translation adjustment	(2,169)
Reclassification of foreign currency translation to net income (loss), net of tax	894
Ending balance (in shares) at Jun. 27, 2026			515,793,219
Ending balance at Jun. 27, 2026	56,757		$ 52		1,096,070		(1,034,585)	(4,780)
Beginning balance (in shares) at Mar. 28, 2026			463,195,066
Beginning balance at Mar. 28, 2026	(21,083)		$ 46		1,037,320		(1,050,989)	(7,460)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	16,404						16,404
Issuance of common stock under equity incentive plans, net (in shares)			505,869
Issuance of common stock under equity incentive plans, net	(278)				(278)
Share-based compensation for equity classified awards	7,399				7,399
Issuance of common stock in conjunction with the conversion of a portion of 2030 Notes (in shares)				52,092,284
Issuance of common stock in conjunction with the conversion of a portion of the 2030 Notes		$ 50,407		$ 6		$ 50,401
Issuance of equity classified warrants to purchase common stock	1,228				1,228
Foreign currency translation adjustment	(1,786)							(1,786)
Reclassification of foreign currency translation to net income (loss), net of tax	894							894
Ending balance (in shares) at Jun. 27, 2026			515,793,219
Ending balance at Jun. 27, 2026	$ 56,757		$ 52		$ 1,096,070		$ (1,034,585)	$ (4,780)

Share-Based Compensation - Schedule of Performance Stock Unit Valuation Assumptions (Details) - Performance Shares - Monte-Carlo	Mar. 01, 2024 $ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (years)	2 years 9 months 18 days
Expected volatility	78.70%
Average correlation	21.40%
Risk-free interest rate	4.36%
Dividend yield	0.00%
Measurement date stock price	$ 9.77

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(v)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iv)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (l)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 35
-Paragraph 1D
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 35
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480483/718-10-35-3

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(01)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(02)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(03)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(04)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(01)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(02)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(03)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 27, 2026	Dec. 31, 2025
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, authorized (in shares)	500,000	500,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, authorized (in shares)	3,000,000,000	3,000,000,000
Common stock, issued (in shares)	515,793,219	453,688,312
Common stock, outstanding (in shares)	515,793,219	453,688,312

- Definition

Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S45
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(20))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.6-05(4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(4)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(16)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(7))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

+ Details

- Definition

The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.

+ References + Details

- Definition

Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.

+ References + Details

- Definition

Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477657/942-210-S45-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478478/942-210-S50-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(19))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 11
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.6-05(4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(4)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(16)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(7))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3

+ Details

Cash and Cash Equivalents and Restricted Cash (Tables)

6 Months Ended

Jun. 27, 2026

Cash and Cash Equivalents [Abstract]

Schedule of Cash and Cash Equivalents


	June 27, 2026		December 31, 2025		June 28, 2025		December 31, 2024
Cash and cash equivalents	$	171,369	$	203,890	$	103,497	$	131,913
Restricted cash, current	5,516		4,350		1,172		1,041
Restricted cash, non-current	9,250		9,291		12,600		12,600
Total cash, cash equivalents and restricted cash	$	186,135	$	217,531	$	117,269	$	145,554

Schedule of Reconciliation of Cash and Cash Equivalents, Restricted Cash


	June 27, 2026		December 31, 2025		June 28, 2025		December 31, 2024
Cash and cash equivalents	$	171,369	$	203,890	$	103,497	$	131,913
Restricted cash, current	5,516		4,350		1,172		1,041
Restricted cash, non-current	9,250		9,291		12,600		12,600
Total cash, cash equivalents and restricted cash	$	186,135	$	217,531	$	117,269	$	145,554

Summary of Significant Accounting Policies (Policies)	6 Months Ended
Summary of Significant Accounting Policies (Policies)	Jun. 27, 2026
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the unaudited condensed consolidated financial statements include all adjustments necessary, which are of a normal and recurring nature, for the fair presentation of the Company’s financial position and of the results of operations and cash flows for the periods presented. These interim results are not necessarily indicative of the results to be expected for the fiscal year ending December 31, 2026 or for any other interim period or for any other future fiscal year. These unaudited condensed consolidated financial statements should be read in conjunction with the Company's audited financial statements and notes thereto included in the 2025 10-K. A detailed description of the Company's significant accounting policies can be found in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on April 9, 2026 (the “2025 10-K”). There have been no material changes in the Company’s significant accounting policies from those that were disclosed in the 2025 10-K, except as noted below.
Principles of Consolidation	Principles of Consolidation The unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany balances and transactions have been eliminated.
Management’s Use of Estimates	Management’s Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant accounting estimates made by the Company include trade promotion and discount accruals; useful lives of property, plant and equipment; valuation of long-lived assets including assets held for sale; valuation of deferred tax assets; valuation of inventory and related provision; incremental borrowing rate used to determine lease right-of-use assets and lease liabilities; assessment of contract-based factors, asset-based factors, entity-based factors and market-based factors to determine the lease term impacting right-of-use assets and lease liabilities; the probability of vesting and valuation of the fair value of stock options and performance stock units (“PSUs”) used to determine share-based compensation expense; the valuation and remeasurement of the fair value of warrant liability for the Delayed Draw Term Loan Warrants; the probability of vesting and the issuance date valuation of the BG Warrants; the valuation and remeasurement of the fair value of embedded derivatives; the number of underlying shares expected to vest, or for which vesting is probable, for equity-classified warrants, and liabilities and loss contingency accruals in connection with claims, lawsuits and administrative proceedings. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results could differ from those estimates and such differences may be material to the Company’s consolidated financial statements.
2030 Notes Conversions and Gain on Debt Extinguishment	2030 Notes Conversions and Gain on Debt Extinguishment The Company accounts for conversions of the 7.00% Convertible Senior Secured Second Lien PIK Toggle Notes due 2030 (the “2030 Notes”) issued pursuant to an indenture and security agreement dated as of October 15, 2025 (as supplemented, the “2030 Notes Indenture”) in accordance with accounting for convertible debt with a bifurcated conversion option whereby each conversion is accounted for as a debt extinguishment in accordance with ASC 470, “Debt” (“ASC 470”), and ASC 815, “Derivatives and Hedging” (“ASC 815”). Accordingly, at each conversion settlement date, the Company records the fair value of the shares issued and reduces, on a pro rata basis, the carrying value of the 2030 Notes, the related debt discount and the remeasurement value of certain embedded derivatives contained in the 2030 Notes that require bifurcation (the “2030 Notes Embedded Derivative”), respectively, as of the settlement date. An extinguishment gain or loss is recognized on the settlement date equal to the difference between (i) the fair value of the shares issued and (ii) the sum of the pro rata carrying amounts of the respective 2030 Notes, the related debt discount and the remeasurement value of the 2030 Notes Embedded Derivative extinguished. The extinguishment gain or loss recognized is included in Other income (expense), net, in the Company’s unaudited condensed consolidated statements of operations.
Equity-Classified Warrants Issued as Customer Consideration	Equity-Classified Warrants Issued as Customer Consideration The Company may issue warrants or other share-based instruments to customers or parties that purchase the Company’s products from its customers in connection with sales and distribution arrangements. When such instruments are not issued in exchange for a distinct good or service, the Company accounts for the instruments as consideration payable to a customer in accordance with ASC 606, “Revenue From Contracts With Customers” (“ASC 606”), and ASC 718, “Compensation - Stock Compensation” (“ASC 718”), and records the related amount as a reduction of the transaction price and, therefore, revenue. The Company measures and classifies such instruments at grant-date fair value in accordance with ASC 718. Warrants that are indexed to the Company’s common stock or contain only market, service or performance conditions, and that otherwise qualify for equity classification under ASC 718, are recorded in equity. The Company evaluates whether equity-classified warrants are required to be presented outside permanent equity under ASC 480, “Distinguishing Liabilities From Equity” (“ASC 480”). Warrants that qualify for equity classification and are not required to be presented outside permanent equity are recorded in additional paid-in capital and are not subsequently remeasured. If an equity-classified warrant is issued before the related revenue is recognized and the Company expects to recover the consideration through future purchases by the customer under the related arrangement, the grant-date fair value is initially recorded as a prepaid asset and amortized as a reduction of revenue as the related revenues are generated. For equity-classified warrants with service or performance conditions that affect vesting, the Company estimates the number of underlying shares expected to vest, or for which vesting is probable, and updates that estimate until the equity-classified warrants vest, or are forfeited, with changes reflected as adjustments to the transaction price.
Share-Based Compensation	Share-Based Compensation For details of the Company's share-based compensation policy related to various types of equity grants, see Note 2, Summary of Significant Account Policies, to the Notes to Consolidated Financial Statements included in the 2025 10-K. The Company’s performance-based units (MIP PSUs) are considered granted as of the date when the Company’s board of directors establishes relevant performance goals to be set based on metrics to be established upon recommendation from the Company’s human capital management and compensation committee. The MIP PSUs will be measured at the grant date fair value, which equals the Company’s stock price on the grant date. The Company will recognize compensation cost related to the MIP PSUs from the service inception date (which is the grant date) over the requisite service for the performance period only if it is considered probable that the performance condition will be satisfied.
New Accounting Pronouncements and Recently Adopted Accounting Pronouncements	New Accounting Pronouncements In November 2024, the FASB issued ASU 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses” (“ASU 2024-03”), in order to improve the disclosures about a public business entity’s expenses. The amendments in ASU 2024-03 apply to all public business entities and are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, with early adoption is permitted. The amendments can be applied either prospectively or retrospectively. The Company is currently assessing adoption timing, the method of adoption, and the effect that the amendments will have on the Company’s financial statement disclosures. On December 8, 2025, the FASB issued ASU 2025-11, “Interim Reporting (Topic 270),” which is intended to improve the navigability of the guidance in ASC 270, “Disclosure Requirements” (“ASC 270”) and clarify when it applies. Under the amendments, an entity is subject to ASC 270 if it provides “interim financial statements and notes in accordance with GAAP.” The ASU also addresses the form and content of such financial statements, adds lists to ASC 270 of the interim disclosures required by all other Codification topics, and establishes a principle under which an entity must “disclose events since the end of the last annual reporting period that have a material impact on the entity.” For public companies, the amendments in ASU 2025-11 are effective for interim reporting periods within annual reporting periods beginning after December 15, 2027. The Company is currently assessing adoption timing, the method of adoption, and the effect that the amendments will have on the Company’s financial statement disclosures. Recently Adopted Accounting Pronouncements On July 30, 2025, the FASB issued ASU 2025-05, “Measurement of Credit Losses for Accounts Receivable and Contract Assets,” which amends ASC 326-20 “Financial Instruments—Credit Losses: Measured at Amortized Cost,” to provide a practical expedient (for all entities) related to the estimation of expected credit losses for current accounts receivable and current contract assets that arise from transactions accounted for under ASC 606, “Revenue From Contracts With Customers.” ASU 2025-05 is effective for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods, with early adoption permitted. The Company adopted the amendments in ASU 2025-05 on January 1, 2026 on a prospective basis. The amendments in ASU 2025-05 did not have a material impact on the Company’s financial position, results of operations or cash flows. In November 2024, the FASB issued ASU 2024-04, “—Debt—Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments” (“ASU 2024-04”) to improve the relevance and consistency in the application of induced conversion guidance in Subtopic 470-20, “Debt—Debt with Conversion and Other Options.” The amendments in ASU 2024-04 clarify the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion. The amendments in ASU 2024-04 affect entities that settle convertible debt instruments for which the conversion privileges were changed to induce conversion. The amendments in ASU 2024-04 are effective for all entities for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. Early adoption is permitted for all entities that have adopted the amendments in ASU 2020-06. The amendments in ASU 2024-04 permit an entity to apply the new guidance on either a prospective or a retrospective basis. The Company adopted ASU 2024-04 on January 1, 2026 on a prospective basis. The adoption of ASU 2024-04 did not have a material impact on the Company’s financial position, results of operations or cash flows. On December 17, 2025, the FASB issued ASU 2025-12, “Codification Improvements” (“ASU 2025-12”), which addresses suggestions received from stakeholders on the Codification and makes other incremental improvements to GAAP. This evergreen project facilitates Codification updates for a broad range of topics arising from technical corrections, the unintended application of the Codification, clarifications, and other minor improvements. The Company adopted ASU 2025-12 beginning January 1, 2026. The amendments in ASU 2025-12 did not have a material impact on the Company’s financial position, results of operations or cash flows.

- Definition

Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.

+ References

+ Details

- Definition

Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-12

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-9

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482836/275-10-55-6

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-6

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-4

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-SubTopic 10
-Topic 275
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-SubTopic 10
-Topic 275
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-1

+ Details

Share-Based Compensation

6 Months Ended

Jun. 27, 2026

Share-Based Payment Arrangement [Abstract]

Share-Based Compensation

Amended and Restated 2018 Equity Incentive Plan

In connection with the Exchange Offer completed in October 2025, the board of directors of the Company approved an amendment and restatement (the “Amended and Restated 2018 Equity Incentive Plan”) of the Company’s 2018 Equity Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder. The final settlement date occurred on October 30, 2025 (the “Final Settlement Date”) and the stockholders approved the Amended and Restated 2018 Equity Incentive Plan on November 19, 2025.

Pursuant to the Amended and Restated 2018 Equity Incentive Plan, subject to the share counting provisions and the adjustment provisions under the Amended and Restated 2018 Equity Incentive Plan in the event of certain corporate transactions, the number of shares reserved for issuance is equal to the sum of the following:

•The number of shares of common stock reserved for issuance under the 2018 Equity Incentive Plan prior to the Amended and Restated 2018 Equity Incentive Plan Effective Date (which, as of September 27, 2025, was 27,349,482 shares); plus

•On the date following the Final Settlement Date, a number of shares of the Company’s common stock, representing 12.5% (rounded up to the nearest whole share) of the Fully-Diluted Shares Outstanding (as defined below) on the date following the Final Settlement Date (which number of shares of common stock was 69,009,600); plus

•On any date following the Final Settlement Date on which shares of the Company’s common stock are issued in respect of the 2030 Notes, including the conversion or equitization of the 2030 Notes (including any 2030 Notes issued as paid in kind interest) into shares of common stock, or payment of accrued interest or make-whole payments in the form of common stock, or otherwise (such shares of common stock, “Conversion Shares”), which shares are in excess of the sum of any Conversion Shares taken into account in a previous Anti-Dilution Increase (as defined below), an additional number of shares equal to 12.5% (rounded up to the nearest whole share) of the total number of additional Conversion Shares so issued. Each increase pursuant to this paragraph is referred to as an “Anti-Dilution Increase”; plus

•An annual increase on January 1 of each calendar year during the term of the Amended and Restated 2018 Equity Incentive Plan commencing January 1, 2027 and ending on and including January 1, 2035, equal to the lesser of (a) 3.0% of the Fully-Diluted Shares Outstanding on such date or (b) such number of shares of common stock determined by the administrator of the Amended and Restated 2018 Equity Incentive Plan.

Under the Amended and Restated 2018 Equity Incentive Plan, the term “Fully-Diluted Shares Outstanding” means, as of any date, the sum of:

•The number of shares of the Company’s common stock outstanding on such date (calculated on an as-converted basis after giving effect to the occurrence of the Final Settlement Date, which includes the shares of common stock reserved for potential issuance under outstanding warrants and any shares of the Company’s common stock issued in the Exchange Offer but excluding the shares of common stock issuable in the future (but not yet issued) under the 2030 Notes following such date); plus

•The number of shares of the Company’s common stock subject to the equity awards (including stock options) outstanding under the Company’s equity plans on such date (with the number of shares subject to performance-based equity awards calculated at the “maximum” level of performance); plus

•The number of shares of the Company’s common stock available for future issuance under the Company’s equity plans as of such date (for the avoidance of doubt, on the date following the Final Settlement Date, including the share reserve under the Amended and Restated 2018 Equity Incentive Plan as of such date after giving effect to the Exchange Offer).

Additionally, in 2025, the Company’s board of directors approved grants of RSUs and PSUs (the “MIP Awards”) under the Amended and Restated 2018 Equity Incentive Plan to certain key employees. The MIP Awards were granted, in part, out of the increase to the share reserve pursuant to the Amended and Restated 2018 Equity Incentive Plan (over the existing share reserve under the 2018 Equity Incentive Plan as in effect immediately prior to the Amended and Restated 2018 Equity Incentive Plan Effective Date), subject to the occurrence of the Final Settlement Date and subject, in part, to stockholder approval of the Amended and Restated 2018 Equity Incentive Plan. Each MIP Award recipient received awards with respect to a number of shares of the Company’s common stock equal to a specified percentage of the Fully-Diluted Shares Outstanding on the date following the Final Settlement Date, subject to certain antidilution adjustments.

The Amended and Restated 2018 Equity Incentive Plan may be amended, suspended or terminated by the Company’s board of directors at any time, provided such action does not impair the existing rights of any participant, subject to stockholder approval of any amendment to the Amended and Restated 2018 Equity Incentive Plan as required by applicable law or listing requirements. Unless sooner terminated by the Company’s board of directors, the Amended and Restated 2018 Equity Incentive Plan will automatically terminate on September 28, 2035.

The Amended and Restated 2018 Equity Incentive Plan provides for the grant of stock options (including incentive stock options and non-qualified stock options), stock appreciation rights, restricted stock, restricted stock units, performance units, and performance shares to the Company’s employees, directors, and consultants. As of January 1, 2026, the maximum aggregate number of shares that may be issued under the Amended and Restated 2018 Equity Incentive Plan was 96,359,368 shares. There were Anti-Dilution Increases totaling 7,176,019 shares, including shares reserved for Anti-Dilution Increases in respect of the PSU awards, resulting from the issuance of an aggregate of 57,408,142 Conversion Shares in the six months ended June 27, 2026. There was no automatic annual increase to the number of shares reserved for issuance on January 1, 2026 under the terms of the Amended and Restated 2018 Equity Incentive Plan.

The following table summarizes the shares available for issuance under the Amended and Restated 2018 Equity Incentive Plan:


						Shares Available for Issuance
Shares available for issuance at December 31, 2025(1)						10,310,481
Authorized						7,176,019
Granted						(11,106,936)
Shares withheld to cover taxes						3,234,470
Forfeited(2)						976,394
Shares available for issuance at June 27, 2026(3)						10,590,428

____________

(1) Shares available for issuance under the Amended and Restated 2018 Equity Incentive Plan includes 70,946 and 145,660 shares at June 27, 2026 and December 31, 2025, respectively, that may be issued pursuant to 2024 PSUs, if 200% of the applicable performance target is achieved.

(2) Includes forfeiture of 74,714 shares reserved for issuance for a potential 200% achievement of the Tranche 2 2024 PSUs. See Performance Stock Units—2024 PSUs below.

(3) Shares available for issuance under the Amended and Restated 2018 Equity Incentive Plan at June 27, 2026 after deducting 20,309,683 shares that are reserved for issuance under MIP PSU awards to certain key employees in 2025 (MIP PSUs), including 1,913,097 shares reserved for issuance pursuant to Anti-Dilution Increases in respect of the MIP PSUs, in the six months ended June 27, 2026, at maximum payout. Includes 70,946 shares reserved for issuance pursuant to 2024 PSUs if 200% of the applicable performance target is achieved.

At June 27, 2026 and December 31, 2025, there were 4,640,161 and 3,974,337 shares, respectively, issuable under stock options outstanding; 42,026,622 and 35,344,345 shares, respectively, issuable under unvested restricted stock units (“RSUs”) outstanding; 70,946 and 145,660 shares, respectively, issuable under unvested 2024 PSUs outstanding; 70,946 and 145,660 shares, respectively, reserved for issuance under unvested 2024 PSUs outstanding if 200% of the applicable performance target is achieved; 18,396,586 and 27,998,591 shares reserved for issuance under MIP PSUs if 150% of the applicable performance target is achieved; 1,913,097 and 126 shares reserved for Anti-Dilution Increases with respect to PSUs at maximum performance; 19,857,699 and 18,807,587 shares, respectively, issued for stock option exercises, RSU settlement and restricted stock grants; and 10,590,428 and 10,310,481 shares, respectively, available for grant under the Amended and Restated 2018 Equity Incentive Plan.

2026 Employment Inducement Equity Incentive Plan

Effective as of March 30, 2026, the board of directors of the Company approved the Beyond Meat, Inc. 2026 Employment Inducement Equity Incentive Plan (the “Inducement Plan”). The terms of the Inducement Plan are substantially similar to the terms of the Company’s Amended and Restated 2018 Equity Incentive Plan with the exception that incentive stock options may not be issued under the Inducement Plan and awards under the Inducement Plan may only be issued to eligible recipients under the applicable Nasdaq rules. The Inducement Plan was adopted by the board of directors without stockholder approval pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules. The board of directors has initially reserved 10,000,000 shares of the Company’s common stock for issuance pursuant to awards granted under the Inducement Plan. In accordance with Rule 5635(c)(4) of the Nasdaq Listing Rules, awards under the Inducement Plan may only be made to an employee who has not previously been an employee or member of the board of directors of the Company or any parent or subsidiary, or following a bona fide period of non-employment by the Company or a parent or subsidiary, if he or she is granted such award in connection with his or her commencement of employment with the Company or a subsidiary and such grant is an inducement material to his or her entering into employment with the Company or such subsidiary.

The following table summarizes the shares available for issuance under the Inducement Plan:


						Shares Available for Issuance
Shares available for issuance at December 31, 2025						—
Authorized						10,000,000
Granted						(566,315)
Forfeited						—
Shares available for issuance at June 27, 2026						9,433,685

Stock Options

Three Months Ended

Six Months Ended

June 27, 2026

June 28, 2025

June 27, 2026

June 28, 2025

Risk-free interest rate

4.0%

N/A

4.0%

N/A

Average expected term (years)

4.0

N/A

4.0

N/A

Expected volatility

113.9%

N/A

113.9%

N/A

Dividend yield

N/A

Option grants to employees in the six months ended June 27, 2026 generally vest 25% of the total award on the first anniversary of the vesting commencement date, and thereafter ratably vesting monthly over the remaining three-year period, subject to continued employment through the vesting date. There were no option grants in the six months ended June 28, 2025.

The following table summarizes the Company’s stock option activity during the six months ended June 27, 2026 under the Amended and Restated 2018 Equity Incentive Plan and the 2026 Inducement Plan:


	Number of Stock Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)	Aggregate Intrinsic Value (in thousands)(1)
Outstanding at December 31, 2025	3,974,337	$	25.24	5.3	$	—
Granted(2)	790,900	$	0.83	—	$	—
Exercised	—	$	—	—	$	—
Canceled/Forfeited	(125,076)	$	6.80	—	$	—
Outstanding at June 27, 2026	4,640,161	$	21.58	5.9	$	—
Vested and exercisable at June 27, 2026	3,384,913	$	27.73	4.8	$	—
Vested and expected to vest at June 27, 2026	4,485,683	$	22.19	5.8	$	—

____________

(2) Includes 236,221 options granted under the 2026 Inducement Plan.

In the three months ended June 27, 2026 and June 28, 2025, the Company recorded $1.0 million and $1.5 million, respectively, of share-based compensation expense related to options. In the six months ended June 27, 2026 and June 28, 2025, the Company recorded $2.0 million and $3.5 million, respectively, of share-based compensation expense related to options. Share-based compensation expense in the three and six months ended June 27, 2026, included $0.2 million for extending an option grant expiration date by an additional five years for an executive officer. The share-based compensation expense is included in cost of goods sold, research and development expenses and SG&A expenses in the Company’s unaudited condensed consolidated statements of operations.

As of June 27, 2026, there was $3.6 million in unrecognized compensation expense related to nonvested stock option awards which is expected to be recognized over a weighted average vesting period of 0.8 years.

Restricted Stock Units

RSU grants to employees in the six months ended June 27, 2026, generally vest: 25% of the total award on the first anniversary of the vesting commencement date, and thereafter vest quarterly over the remaining three years of the award, subject to continued employment through the vesting date. In addition, RSU awards in the six months ended June 27, 2026 included the Anti-Dilution Increases on RSU awards discussed below.

RSU grants to employees in the six months ended June 28, 2025 generally vest: (1) 25% of the total award on the first anniversary of the vesting commencement date, and thereafter vest quarterly over the remaining three years of the award; or (ii) 50% of the total award on the first anniversary of the vesting commencement date, and thereafter vest quarterly over the remaining four quarters of the award, each subject to continued employment through the vesting date. RSU grants to a non-employee consultant and a brand ambassador in the six months ended June 28, 2025 vest on varying dates, subject to continued service through the vesting dates.

RSU grants to directors on the Company’s board of directors in the six months ended June 27, 2026 vest on the earlier to occur of (i) the one-year anniversary of the grant date, and (ii) the day prior to the first annual meeting of stockholders following the grant date, in each case, subject to; continued service through the vesting

date, accelerated vesting upon a Change in Control (as defined in the Amended and Restated 2018 Equity Incentive Plan); and, if elected by the director, deferral of the receipt of the shares underlying the RSUs upon vesting of the RSUs in accordance with a deferral election provided by the Company. There were no RSU grants to directors in the six months ended June 28, 2025.

MIP Awards—RSUs

As mentioned above, in 2025, the Company granted to certain key employees MIP awards in the form of RSUs, a component of which vested on December 31, 2025. A portion of the MIP awards was also granted in the form of RSUs that vest over a two-year period, with 50% vesting at the end of the first year on December 31, 2026, and the remainder, thereafter vesting ratably at the end of each calendar quarter of the following year, fully vesting on December 31, 2027.

Anti-Dilution Increases

In the six months ended June 27, 2026, pursuant to the 2030 Notes Indenture (See Note 9—2030 Notes Indenture), the Company issued an aggregate of 57,408,142 Conversion Shares to certain holders of the 2030 Notes upon the conversion by such holders of $68.8 million in aggregate principal amount of 2030 Notes into shares of the Company’s common stock. As a result of this conversion and pursuant to their award agreements, the Company issued an aggregate of 4,264,723 anti-dilution RSUs to the recipients of the MIP awards in the six months ended June 27,2026.

The following table summarizes the Company’s RSU activity during the six months ended June 27, 2026 under the Amended and Restated 2018 Equity Incentive Plan and the 2026 Inducement Plan:


	Number of Units	Weighted Average Grant Date Fair Value Per Unit
Unvested at December 31, 2025	35,344,345	$	1.27
Granted(1)	8,416,517	$	0.48
Vested(2)	(1,029,982)	$	3.92
Canceled/Forfeited	(704,258)	$	1.68
Unvested at June 27, 2026	42,026,622	$	1.04

____________

In the three months ended June 27, 2026 and June 28, 2025, the Company recorded $6.2 million including $4.7 million in incremental share-based compensation expense related to the Exchange Offer, and $2.6 million, respectively, of share-based compensation expense related to RSUs. In the six months ended June 27, 2026 and June 28, 2025, the Company recorded $11.7 million including $8.4 million in incremental share-based compensation expense related to the Exchange Offer, and $6.2 million, respectively, of share-based compensation expense related to RSUs. The share-based compensation expense is included in cost of goods sold, research and development expenses and SG&A expenses in the Company’s unaudited condensed consolidated statements of operations. In the six months ended June 27, 2026, the Company paid $2.7 million in payments of minimum withholding taxes and withheld 2,870,960 shares on net share settlement of MIP RSU awards that vested in 2025 and Anti-Dilution Increases on those MIP RSU awards that occurred in the six months ended June 27, 2026.

As of June 27, 2026, there was $37.0 million in unrecognized compensation expense related to unvested RSUs which is expected to be recognized over a weighted average vesting period of 0.9 years.

Performance Stock Units

2024 PSUs

On March 1, 2024, the Company granted a target amount of $3.3 million in PSUs with market-based and service-based vesting conditions to certain executive officers (the “2024 PSUs”). The market-based performance condition is based on the Company’s total shareholder return (“TSR”) relative to a TSR comparator group (“Relative TSR Performance”) for each performance period. The TSR comparator group includes the companies included in the S&P Food and Beverage Select Industry Index, excluding companies in the S&P 500, as of the beginning of each of the three performance periods that apply to the 2024 PSUs (each performance period begins on January 1, 2024 and the performance periods end on December 31, 2024, December 31, 2025 and December 31, 2026 for a one-year, two-year and three-year performance period, respectively). The market-based performance condition allows for a range of vesting from 0% to 200% of the target amount, depending on the Company’s Relative TSR Performance for the applicable performance period, as determined by the Company’s Human Capital Management and Compensation Committee (“HCMCC”) within 60 days following the end of the performance period. In addition to the market-based vesting condition, these 2024 PSUs are subject to the continued service of the executive officers through the last day of the applicable performance period. 2024 PSUs that are unvested three months following the end of the performance period will be forfeited and returned to the Amended and Restated 2018 Equity Incentive Plan on that date, or such earlier date as determined by the HCMCC.

The fair value of 2024 PSUs is measured on the grant date using a Monte Carlo simulation. Each of the three performance periods is considered an individual tranche of the award referred to below as “Tranche I,” “Tranche II” and “Tranche III,” respectively.


	Number of Units	Grant Date Fair Value Per Unit		Performance Period
Tranche I	80,307	$	13.49	January 1, 2024 - December 31, 2024
Tranche II	74,714	$	14.50	January 1, 2024 - December 31, 2025
Tranche III	70,946	$	15.27	January 1, 2024 - December 31, 2026


Relative TSR Performance(1)						Percentage Applicable to the Relative TSR Performance
Less than 30th percentile						0%
30th percentile						50%
50th percentile						100%
80th percentile and above						200%

____________

On February 3, 2026 and February 4, 2025, the HCMCC determined that the Company’s Relative TSR Performance for the Tranche II PSUs and Tranche I PSUs, respectively, was less than the 30th percentile,

resulting in 0% of the Tranche II and Tranche I Target PSUs vesting. Accordingly, the unvested Tranche II and Tranche I Target PSUs were forfeited and returned to the Amended and Restated 2018 Equity Incentive Plan share reserve for future issuance under the Amended and Restated 2018 Equity Incentive Plan.

The market-based performance condition used for the 2024 PSU awards is based upon the Company’s Relative TSR Performance, which is considered to be a market condition under FASB ASC Topic 718, for each performance period. Consistent with FASB ASC Topic 718, the full grant date fair value (at target performance) for the market-related TSR component for all three tranches of the 2024 PSU awards is included in the amounts shown. As required by SEC rules, the amounts shown exclude the impact of estimated forfeitures related to service-based vesting conditions. The fair value of the 2024 PSUs is measured on the grant date using a Monte Carlo simulation. The following valuation assumptions were used in the Monte Carlo simulation for the 2024 PSUs granted on March 1, 2024:


Assumption						As of March 1, 2024
Expected term (years)						2.8
Expected volatility						78.7%
Average correlation						21.4%
Risk-free interest rate						4.36%
Dividend yield						0%
Measurement date stock price						$9.77

•Expected Term: The expected term is based on the grant date of the 2024 PSU awards (3/1/2024) through the end of the performance period (12/31/2026).

•Expected Volatility and Correlation Assumptions: Volatility and correlation measures were based on three years of daily historical stock price data through March 1, 2024.

•Starting TSR: Starting TSR was calculated for the Company and each of the companies in the TSR comparator group based on the closing price on the date of grant compared to the closing price on the trading day immediately preceding the beginning of each of the performance periods.

•Risk-Free Interest Rate: The risk-free interest rate is based on the U.S. Treasury constant maturities yields on the grant date as reported in the H.15 Federal Reserve Statistical Release with a term corresponding to the remaining length of the performance period.

•Dividend Yield Assumption: For purposes of calculating TSR, which is inclusive of dividend payments, the dividend yield assumption is zero (i.e., stock prices include amounts that would otherwise have been paid as dividends). For purposes of discounting projected payouts to determine the fair value, the dividend yield assumption is also zero because the Company is a non-dividend paying company.

The following table summarizes the Company’s 2024 PSU activity during the six months ended June 27, 2026:


	Number of Units	Weighted Average Grant Date Fair Value Per Unit
Unvested at December 31, 2025	145,660	$	14.88
Granted	—	$	—
Vested	—	$	—
Canceled/Forfeited	(74,714)	$	14.50
Unvested at June 27, 2026	70,946	$	15.27

The total grant date fair value of the 2024 PSUs was determined to be $3.3 million, with each tranche of 2024 PSUs representing $1.1 million of the total expense. The requisite service period for each tranche of 2024 PSUs is 10 months, 22 months and 34 months, respectively. Share-based compensation expense related to 2024 PSUs is recognized on a straight-line basis over their requisite service periods, regardless of whether the market vesting condition is ultimately satisfied. Share-based compensation expense is not reversed if the achievement of the market vesting condition does not occur.

In the three months ended June 27, 2026, the Company recorded $0.1 million of share-based compensation expense related to Tranche III of the 2024 PSUs. In the three months ended June 28, 2025, the Company recorded $0.2 million of share-based compensation expense related to Tranche II and III of the 2024 PSUs. In the six months ended June 27, 2026, the Company recorded $0.2 million of share-based compensation expense related to Tranche III of the 2024 PSUs. In the six months ended June 28, 2025, the Company recorded $0.5 million of share-based compensation expense related to Tranche II and III of the 2024 PSUs. The share-based compensation expense is included in SG&A expenses in the Company’s unaudited condensed consolidated statements of operations.

As of June 27, 2026, there was $0.2 million in unrecognized compensation expense related to unvested 2024 PSUs which is expected to be recognized over a weighted average vesting period of 0.5 years.

MIP PSUs

Pursuant to the Amended and Restated 2018 Equity Incentive Plan, in 2025, the board of directors of the Company approved aggregate awards of  27,998,717 PSUs (at “maximum” performance) to certain key employees (the “MIP PSUs”). The MIP PSUs will be earned based on the achievement of annual performance goals measured over two annual performance periods (2026 and 2027), with performance goals to be set based on metrics to be established by the Company’s board of directors upon recommendation from the Company’s human capital management and compensation committee. Earned MIP PSUs will vest as soon as practicable following the end of the applicable annual performance period and following certification of results (but in all events prior to the following March 15), subject to continued service through the vesting date.

As of June 27, 2026, 10,154,868 of the MIP PSU awards were deemed granted for purposes of ASC 718 upon establishment of the applicable company metrics and related performance goals based on net revenues and cost of goods sold per pound excluding extraordinary and/or nonrecurring items for the performance period of January 1, 2026 to December 31, 2026 and cash balance for the year ending December 31, 2026.

The following table summarizes the Company’s MIP PSU activity during the six months ended June 27, 2026:


	Number of Units	Weighted Average Grant Date Fair Value Per Unit
Unvested at December 31, 2025	—	$	—
Granted	10,154,868	$	—
Vested	—	$	—
Canceled/Forfeited	—	$	—
Unvested at June 27, 2026	10,154,868	$	—

As of June 27, 2026, the Company estimated that only a certain portion of the metrics were probable of vesting. Therefore, the share-based compensation expense related to MIP PSU awards for the first performance period was not significant.

Employee Stock Purchase Plan

As of June 27, 2026, the maximum aggregate number of shares that may be issued under the 2018 Employee Stock Purchase Plan (“2018 ESPP”) was 4,557,105 shares of common stock, including an increase of 536,130 shares effective January 1, 2026 under the terms of the 2018 ESPP. The 2018 ESPP is expected to be implemented through a series of offerings under which participants are granted purchase rights to purchase shares of the Company’s common stock on specified dates during such offerings. The administrator has not yet approved an offering under the 2018 ESPP.

Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 27, 2026

Accounting Policies [Abstract]

Schedule of Error Corrections and Prior Period Adjustments


Condensed Consolidated Statement of Operations (unaudited)
	Three Months Ended June 28, 2025
	As Previously Reported		Inventory Valuation		Debt Issuance Costs		As Corrected
Cost of goods sold	$	66,367	$	671	$	—	$	67,038
Gross profit	$	8,591	$	(671)	$	—	$	7,920
Selling, general and administrative expenses	$	37,696	$	—	$	1,932	$	39,628
Total operating expenses	$	43,503	$	—	$	1,932	$	45,435
Loss from operations	$	(34,912)	$	(671)	$	(1,932)	$	(37,515)
Loss before taxes	$	(29,183)	$	(671)	$	(1,932)	$	(31,786)
Net loss	$	(29,242)	$	(671)	$	(1,932)	$	(31,845)
Net loss per share available to common stockholders—basic and diluted	$	(0.38)	$	(0.01)	$	(0.03)	$	(0.42)


Condensed Consolidated Statement of Operations (unaudited)
	Six Months Ended June 28, 2025
	As Previously Reported		Inventory Valuation		Debt Issuance Costs		As Corrected
Cost of goods sold	$	136,163	$	6,531	$	—	$	142,694
Gross profit	$	7,526	$	(6,531)	$	—	$	995
Selling, general and administrative expenses	$	85,368	$	—	$	4,242	$	89,610
Total operating expenses	$	98,637	$	—	$	4,242	$	102,879
Loss from operations	$	(91,111)	$	(6,531)	$	(4,242)	$	(101,884)
Loss before taxes	$	(82,088)	$	(6,531)	$	(4,242)	$	(92,861)
Net loss	$	(82,158)	$	(6,531)	$	(4,242)	$	(92,931)
Net loss per share available to common stockholders—basic and diluted	$	(1.08)	$	(0.08)	$	(0.06)	$	(1.22)


Condensed Consolidated Statement of Comprehensive Loss (unaudited)
	Three Months Ended June 28, 2025
	As Previously Reported		Inventory Valuation		Debt Issuance Costs		As Corrected
Net loss	$	(29,242)	$	(671)	$	(1,932)	$	(31,845)
Comprehensive loss	$	(31,710)	$	(671)	$	(1,932)	$	(34,313)


Condensed Consolidated Statement of Comprehensive Loss (unaudited)
	Six Months Ended June 28, 2025
	As Previously Reported		Inventory Valuation		Debt Issuance Costs		As Corrected
Net loss	$	(82,158)	$	(6,531)	$	(4,242)	$	(92,931)
Comprehensive loss	$	(85,666)	$	(6,531)	$	(4,242)	$	(96,439)


Condensed Consolidated Statement of Cash Flows (unaudited)
	Six Months Ended June 28, 2025
	As Previously Reported		Inventory Valuation		Debt Issuance Costs		As Corrected
Net loss	$	(82,158)	$	(6,531)	$	(4,242)	$	(92,931)
Inventories	$	4,709	$	6,531	$	—	$	11,240
Prepaid expenses and other current assets	$	(8,473)	$	—	$	5,623	$	(2,850)
Net cash used in operating activities	$	(59,355)	$	—	$	1,381	$	(57,974)

Debt issuance costs	$	(5,117)	$	—	$	(1,381)	$	(6,498)
Net cash provided by financing activities	$	33,640	$	—	$	(1,381)	$	32,259

Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 27, 2026	Mar. 28, 2026	Jun. 28, 2025	Mar. 29, 2025	Jun. 27, 2026	Jun. 28, 2025
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 16,404	$ (28,482)	$ (31,845)	$ (61,087)	$ (12,078)	$ (92,931)
Other comprehensive income (loss), net of tax:
Foreign currency translation gain (loss), net of tax	1,786		(2,468)		2,169	(3,508)
Reclassification of foreign currency translation to net income (loss), net of tax	894		0		894	0
Comprehensive income (loss), net of tax	$ 19,084		$ (34,313)		$ (9,015)	$ (96,439)

- Definition

+ References + Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

- Definition

Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.

+ References + Details

Net Income (Loss) Per Share Available to Common Stockholders - Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss Per Share Available to Common Stockholders (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 27, 2026	Jun. 28, 2025	Jun. 27, 2026	Jun. 28, 2025
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	65,977,738	13,815,597	146,674,196	13,815,597
Employee Stock Option
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	4,640,161	4,100,689	4,640,161	4,100,689
Restricted Stock Units (RSUs)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	42,026,622	1,612,253	42,026,622	1,612,253
PSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	10,225,814	145,660	10,225,814	145,660
Convertible Debt \| 2027 Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	0	8,234,230	0	8,234,230
Convertible Debt \| 2030 Notes, net
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	0	0	80,696,458	0
Warrant \| Delayed Draw Term Loan Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	9,558,635	3,823,454	9,558,635	3,823,454
Warrant \| BG Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	4,166,667	0	4,166,667	0

Property, Plant and Equipment (Tables)

6 Months Ended

Jun. 27, 2026

Property, Plant, and Equipment [Abstract]

Schedule of Property, Plant and Equipment

A summary of property, plant, and equipment, net as of June 27, 2026 and December 31, 2025, is as follows (in thousands):


	June 27, 2026		December 31, 2025

Machinery and equipment	$	126,340	$	127,475

Leasehold improvements	16,322		16,885
Building	29,408		29,562
Finance leases	124,555		125,216
Software	2,654		2,688
Furniture and fixtures	899		900
Vehicles	595		595
Land	5,512		5,548
Assets not yet placed in service	5,379		6,371
Total property, plant and equipment	$	311,664	$	315,240
Less: accumulated depreciation and amortization	109,992		101,978
Property, plant and equipment, net	$	201,672	$	213,262

Share-Based Compensation - Schedule of Performance Stock Units (Details) - Performance Shares - $ / shares		6 Months Ended
	Feb. 04, 2025	Jun. 27, 2026
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Units (in shares)		0
Granted (in dollars per share)		$ 0
Vesting percentage		200.00%
Tranche I
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Units (in shares)		80,307
Granted (in dollars per share)		$ 13.49
Less than 30th percentile
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	0.00%	0.00%
30th percentile
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage		50.00%
50th percentile
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage		100.00%
80th percentile and above
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage		200.00%
Tranche II
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Units (in shares)		74,714
Granted (in dollars per share)		$ 14.50
Tranche III
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Units (in shares)		70,946
Granted (in dollars per share)		$ 15.27

Leases - Schedule of Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 27, 2026	Jun. 28, 2025	Jun. 27, 2026	Jun. 28, 2025
Leases [Abstract]
Cash paid for amounts included in the measurement of operating lease liabilities	$ 435	$ 1,568	$ 1,048	$ 3,823
Cash paid for interest on finance lease liabilities	$ 1,656	$ 2,082	$ 3,336	$ 2,082

Share-Based Compensation - Schedule of Fair Value Assumptions (Details) - Employee Stock Option	3 Months Ended	6 Months Ended
	Jun. 27, 2026	Jun. 27, 2026
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	4.00%	4.00%
Expected term (years)	4 years	4 years
Expected volatility	113.90%	113.90%

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

+ Details

Net Income (Loss) Per Share Available to Common Stockholders

6 Months Ended

Jun. 27, 2026

Earnings Per Share [Abstract]

Net Income (Loss) Per Share Available to Common Stockholders

Net income (loss) per share available to common stockholders—basic is computed by dividing net income (loss) by the weighted-average number of shares of our common stock outstanding.

For the calculation of net income per share available to common stockholders—diluted, net income per share available to common stockholders—basic is adjusted by the effect of dilutive securities. Net income per share available to common stockholders—diluted is computed by dividing net income by the weighted-average number of fully diluted common shares outstanding.

For periods in which the Company reports net losses, net loss per share available to common stockholders—basic and diluted are the same because potentially dilutive common shares are not assumed to have been issued if their effect is anti-dilutive.

The numerators and denominators for the calculation of net income (loss) per share available to common stockholders—basic and diluted are as follows (in thousands, except share and per share data):


	Three Months Ended				Six Months Ended
	June 27, 2026		June 28, 2025		June 27, 2026		June 28, 2025
Numerator:

Net income (loss) available to common stockholders—basic	$	16,404	$	(31,845)	$	(12,078)	$	(92,931)
Add: Dilutive effect of 2030 Notes, net(1)	(52,933)		—		—		—

Net loss available to common stockholders—diluted	$	(36,529)	$	(31,845)	$	(12,078)	$	(92,931)










Denominator:

Weighted average common shares outstanding—basic	501,304,934		76,491,594		476,742,903		76,348,524







Effect of dilutive shares:
2030 Notes, if converted(1)	90,563,957		—		—		—


Weighted average common shares outstanding—diluted	591,868,891		76,491,594		476,742,903		76,348,524


Net income (loss) per share
Net income (loss) per share available to common stockholders—basic	$	0.03	$	(0.42)	$	(0.03)	$	(1.22)
Net loss per share available to common stockholders—diluted	$	(0.06)	$	(0.42)	$	(0.03)	$	(1.22)

____________


	Three Months Ended		Six Months Ended
	June 27, 2026	June 28, 2025	June 27, 2026	June 28, 2025
Options to purchase common stock(1)	4,640,161	4,100,689	4,640,161	4,100,689
RSUs(1)	42,026,622	1,612,253	42,026,622	1,612,253
PSUs(1)	10,225,814	145,660	10,225,814	145,660
2027 Notes(2)	—	8,234,230	—	8,234,230
2030 Notes (if converted)	—	—	80,696,458	—
Delayed Draw Term Loan Warrants	9,558,635	3,823,454	9,558,635	3,823,454
BG Warrants	4,166,667	—	4,166,667	—
Total	65,977,738	13,815,597	146,674,196	13,815,597

____________

Share-Based Compensation - Schedule of PSU Activity (Details)	6 Months Ended
	Jun. 27, 2026 $ / shares shares
Performance Shares
Number of Units
Unvested, beginning balance (in shares) \| shares	145,660
Granted (in shares) \| shares	0
Vested (in shares) \| shares	0
Canceled/Forfeited (in shares) \| shares	(74,714)
Unvested, ending balance (in shares) \| shares	70,946
Weighted Average Grant Date Fair Value Per Unit
Unvested, beginning balance (in dollars per share) \| $ / shares	$ 14.88
Granted (in dollars per share) \| $ / shares	0
Vested (in dollars per share) \| $ / shares	0
Canceled/Forfeited (in dollars per share) \| $ / shares	14.50
Unvested, ending balance (in dollars per share) \| $ / shares	$ 15.27
MIP PSUs
Number of Units
Unvested, beginning balance (in shares) \| shares	0
Granted (in shares) \| shares	10,154,868
Vested (in shares) \| shares	0
Canceled/Forfeited (in shares) \| shares	0
Unvested, ending balance (in shares) \| shares	10,154,868
Weighted Average Grant Date Fair Value Per Unit
Unvested, beginning balance (in dollars per share) \| $ / shares	$ 0
Granted (in dollars per share) \| $ / shares	0
Vested (in dollars per share) \| $ / shares	0
Canceled/Forfeited (in dollars per share) \| $ / shares	0
Unvested, ending balance (in dollars per share) \| $ / shares	$ 0